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Abstract 
Governments in both advanced and emerging markets invest heavily into joint R&D 
projects to facilitate inter-firm collaboration and scientific productivity. As a science-
based cluster, nanotechnology is a highly R&D-intensive field with very complex 
interdisciplinary features that enables multiple interactions between scientists from 
diverse cultural backgrounds working for multi-faceted organizations across public 
and private sectors and through internationally regulated borders. In this thesis, I 
examine the main determinants of the dimensions of inter-firm collaboration in high-
tech industries particularly among nanotechnology R&D organisations across 
Europe. Also, I investigate the key factors that influence the innovation, financial and 
exit performance of nanotech companies during the commercialisation period and 
across 15 developed and developing countries, taking into consideration the 
involvement of venture capital (VC) firms. In order to methodically integrate the 
qualitative and quantitative features of my research study, I employed mixed method 
to analyse primary and secondary data collected via survey instruments and 
comprehensive databases; to gain valuable insights into the complexities around 
nanotech R&D organisations. 
The regression results show that a predictable legal system; a high level of tolerance 
for uncertainty; the proximity to key partners; a high level of export demand for high-
tech products; and expansionary economic policies, leads to highly valuable and 
long-term relationships which produces optimal partnership size with an effective 
organizational structure. I find that a high financial status of nanotech firms equips 
R&D project managers with sufficient tangible and intangible resources to engage 
into complex collaborative partnerships which yield innovative performing outcomes. 
Also, I find that nanotech R&D firms that exit venture capital investments via IPO are 
more likely to have their head offices in a big city; and access foreign capital to 
expand manufacturing operations. I conclude that the successful commercialisation 
of nanotechnology industries across the globe has been due to the substantial R&D 
public expenditures and private investments into the application and proliferation of 
nanotechnologies in key converging scientific fields which require robust inter-firm 
collaborative partnerships to rapidly develop and promote several portfolios of high-
tech products that continually satisfy consumer needs in disruptive ways and secure 
long-term profitability for nanotech R&D organisations.  
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Chapter 1: Introduction 
1.1 Background 
Research collaboration in scientific exploration can be developed among individual 
scientists in interdisciplinary groups; across public/private sectors such as university 
and industry; and between countries such as multi-national cooperative institutes 
(Fiaz, 2013; Ponomariov, 2013). Research collaboration is usually peculiar among 
experimental research due to its interdisciplinary features and the use of large or 
complex instrumentation such as telescopes and CT scanners (Lee, 1996; Bozeman 
and Corley, 2004). Governments around the globe have provided resources as well 
as incentives to promote rapid growth and dissemination of scientific knowledge as a 
means of facilitating international collaborations; in order to promote indigenous 
innovation, exploit research synergy, and enhance scientific excellence (Tang and 
Shapira, 2012).  
For instance, the European Commission actively invests into joint R&D projects, in 
conjunction with the private sector, to facilitate inter-firm collaboration and scientific 
performance in an attempt to foster global competitiveness (Paier and Scherngell, 
2011). A key challenge for European R&D policy makers is to define an optimal 
collaboration scale for fund mobilization across local, regional, national and 
international cooperative partnerships to promote a vibrant and prosperous socio-
economic environment. Through the Framework Programme (FP) for research 
funding, the European Commission has vigorously financed inter-firm R&D projects 
(Roediger-Schluga and Barber, 2006; Paier and Scherngell, 2011) to promote 
innovative performance in high-tech firms so as to enhance their global 
competitiveness (Scherngell and Lata, 2013). Globalization of science, technology 
and commerce has rapidly advanced human endeavour; making it essential for high-
tech firms to continually improve their product lines and manufacturing processes to 
meet the ever-increasing stakeholder expectations (Lo et al., 2011).  
Most policy initiatives and organizational strategies are geared towards facilitating 
collaboration, not only on the level of individual scientists (Wagner and Leydesdorff, 
2005), but also on a higher level of inter-firm cooperative engagements (Wong, Ho, 
and Chan, 2007). The merits of inter-firm collaborations in high technology industries 
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are the diversification of risks in an uncertain environment and the transfer of 
knowledge among cooperative partners (Park and Kang, 2013). It has been found 
that organizations that are highly involved in collaborative partnerships enhance their 
competitiveness, experience greater return on their investment and enjoy a much 
higher rate of success (Todeva and Knoke, 2005).  
As an engine for economic growth, job creation and radical innovation in knowledge 
-based economies (Protogerou et al., 2017); high-tech firms play an important role in 
establishing collaborative partnerships with universities (Caloghirou et al., 2001) in 
order to develop a portfolio of innovative products and pioneering systems (Nieto 
and Santamaria, 2007) which thrives despite the swift changes in the socio-
economic and technological environments (Baranenko, et al., 2014) that requires 
shorter product life cycles as a result of intense global competition (Deeds, 
DeCarolis and Coombs, 2000). The internationalization of economic activities and 
consumer preferences cause high-tech firms to become more strategic in pooling 
both internal and external R&D resources together through offshore outsourcing 
(Bertrand and Mol, 2013) or local collaborative networks (Bresciani and Ferraris, 
2014); with the objective of producing multi-technological goods which attract huge 
export demand from international markets (Narula, 2004).  
IBM Corporation is considered as one of the foremost organisation responsible for 
catapulting the study of nanotechnology to the forefront of physical science research 
due to the fact that its multinational Research Center in Europe developed the 
innovative scanning probe techniques (STM and AFM) which became prevalent in 
the field of instrumental analysis because of the volume of nano-meter-scale 
information these new scanning methods provide and this earned the scientists in 
1986, the Nobel Laureate Awards in Physics. R&D collaborations are critical to the 
technological development of high-tech firms (Laage-Hellman et al., 2017). Obtaining 
new competencies, conserving resources and extending complementary assets are 
the strategic and organisational benefits that inter-firm collaborations create (Hsu, 
2006). Previous studies view successful inter-firm R&D collaborative partnerships as 
voluntary arrangements between organizations, which enhance the development of 
new innovative products and/or services through the exchange of technology and 
sharing of expertise (Rosenfeld, 1996; Hagedoorn, 2002; Faems, Looy and 
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Debackere, 2005; Roijakkers and Hagedoorn, 2006; Schleimer and Faems, 2016). 
Inter-firm relationships can create corporate social capital such as organizational 
prestige, brand recognition, and reputational status, because inter-firm networks 
generate intangible assets that can be accumulated through human resources 
(Beaudry and Allaoui, 2012). 
However, collaborative partnerships divert organizational resources away from 
internal R&D investments (Park and Kang, 2013). Attention should be paid to the 
performance of collaborative partnerships in R&D projects, due to the limited internal 
resources of the organisations and the complexities in their external environment 
when participating in joint commercial arrangements. Inter-firm R&D collaboration 
structures can be measured by assessing the time periods in which the cooperative 
agreements are fulfilled between joint partners. This ranges from short-term 
contracts to medium-term mergers to long-term acquisitions. The governance 
mechanisms for robust collaborative partnerships in inter-firm R&D projects require a 
decentralized command system, which oversees a large amount of funds and 
organizes a vast amount of human capital in a specialized framework that stimulates 
useful, innovative engagements among all players (Scandura, 2016; Contractor and 
Lorange, 2002; Kumar and Dissel, 1996).  
The increasingly complex, extremely expensive and highly interdisciplinary features 
of modern scientific activities have resulted in the rise of inter-organisational R&D 
collaboration (Teece, 1986); as a cost effective means for high-tech firms to access 
and exchange new knowledge, secure additional human capital, develop innovative 
methods, improve value network and enter into heavily regulated markets (Matt, 
Robin and Wolff, 2012); in order to benefit from the diversification of risks, transfer of 
scientific knowledge, enhanced market competitiveness, greater return on 
investment, better rate of survival, improved reputational status and brand 
recognition. 
The antecedents to the successful commercialization of European nanotech R&D 
projects has been barely been covered in the literature (Von Raesfeld et al., 2012); 
hence, why I investigated the main internal factors which affects the innovative 
performance of nanotech firms across Europe; as they actively participate in a 
voluntary cooperative arrangement that is likely to facilitate the development of new 
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innovative products and/or services through the exchange of technology and sharing 
of expertise with university partners (Huang and Chen, 2016).  
 In the early 2000s, nanotechnology rapidly took a strategically important role among 
most governments in advanced countries as a result of the recognition of its 
tremendous economic potential. Certain key R&D policies were initiated to quickly 
facilitate the commercialisation of nano-products and the convergence of 
nanotechnology with other technologies. Emerging economies like China and Russia 
have enthusiastically jumped into the bandwagon which has spurred the 
globalisation of nanotechnology advancement. Some management research have 
looked into the classification of the historical developments and future trends based 
on scientific publications and patent applications usually employing textual mining 
techniques to observe useful information from global open sources such as 
SCI/SSCI databases (Kostoff, et al. 2006, 2007).  
There is the absence of a thorough empirical investigation which analyses the 
performance of nanotechnology firms and forecast the future trends for profitability of 
nano-products. In my study, I evaluated the key factors that influence the innovative 
and financial performance of nanotechnology firms from an investor’s perspective 
and I discuss the effects of national nanotechnology initiatives on the scientific 
productivity and innovative, especially at the turn of the 21st century, when various 
government initiatives was undertaken to expedite the commercialisation of 
molecular engineering. The comprehensive investigation of the antecedents for a 
successful R&D strategy in the commercialisation of nanotechnology firms has been 
documented (Fiedler and Welpe, 2010); however, in this research report I would 
endeavour to categorise the internal and external determinants of the performance of 
nanotechnology firms. 
1.2 Aims and Objectives 
From the early decades of the 20th century, nanotechnology research studies have 
focused on the development and application of techniques to examine physical 
phenomena (Kostoff et al., 2006; 2007). Nanotechnology can be described as a 
multipurpose application of science that has radical innovations in processes, 
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disruptive impact on existing industries and transformative effect in societies (Shea, 
2005).  
Nanotechnology will bring significant changes as profound as the industrial 
revolution, antibiotics, and nuclear weapons combined (Miyazaki and Islam, 2007). 
So, it is no surprise that governments around the world are aggressively funding 
nanoscience and nanotechnology in order to gain the upper hand in this very 
important field which would redefine many processes and systems in the near future 
(Shea et al., 2011). There are several motivations for nanotechnology research 
collaborations such as the rising costs of conducting experimental science; the 
availability of quick and avoidable transportation & communication facilities; the 
proliferation of scientific communities around the globe; the politicizing of research 
activities; and the strong demand for specialisation within the fields of science 
(Stichweh, 1996; Schott, 1991). 
Nanotechnology is an example of discontinuous innovation. It is a highly intensive 
research and technological development science-based cluster; with complex 
interdisciplinary features (Schummer, 2004; Rijnsoever and Hessels, 2011). 
Nanotech enables multiple interactions between scientists from diverse cultural 
backgrounds (Katz, 1994; Kostoff et al., 2006) working for multi-faceted 
organizations (Heinze, 2004; Cunningham and Werker, 2012) across public and 
private sectors (Miyazaki and Islam, 2007) and through internationally regulated 
borders (Romig Jr. et al., 2007). Academic and industrial actors, as well as 
governments at all levels (i.e., local, regional, national and international), have 
allocated a considerable amount of resources to exploring the organizational 
structure (Fiedler and Welpe, 2010) and the technological (Corbett et al., 2000), 
socio-economic (Teece, 1986; Cunningham and Werker, 2012), and regulatory (Kica 
and Bowman, 2012) framework of nanotechnology. They aim to redefine many 
processes and systems in the near future (Shea, Grinde and Elmslie, 2011). 
Nanotech R&D collaborations embrace a multipurpose application of science that 
has radical innovations in processes, disruptive impact on existing industries and 
transformative effect in societies. 
The research objective for this paper is to examine the main financial and non-
financial determinants of the exit performance of VC backed nanotech portfolio 
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companies in the United Kingdom. I want to evaluate the key performance indicators 
that influence the exit routes of VC backed nanotech companies. I aim to study the 
relationships that exist between predictors of financial performance and exit 
outcomes of VC investments in the UK. 
In this research study, I concentrated on the key performance indicators of inter-firm 
R&D collaborations in nanotech industries across Europe; as nanotechnology is a 
highly intensive R&D science-based cluster (Mangematin and Errabi, 2012) with 
complex interdisciplinary characteristics (Schummer, 2004; Rijnsoever and Hessels, 
2011) which promote multiple knowledge exchanges between scientists from 
different socio-economic backgrounds (Katz, 1994; Kostoff et al., 2006) employed in 
multi-faceted research organizations (Heinze, 2004; Cunningham and Werker, 2012) 
in both public and private sectors (Miyazaki and Islam, 2007) and across 
internationally regulated markets (Romig Jr. et al., 2007).  
1.3 Motivations and Contributions 
The motivation of my study was to investigate the main external influencers of 
effective collaboration in nanotech R&D projects across Europe. The key contribution 
of this research study is to provide policymakers and corporate strategists with useful 
insights into how to simplify the complexities of the environment in which nanotech 
firms operate. My study focuses on examining the major factors that influence the 
partnership size, governance mechanism, strength and duration of inter-firm 
relationships among nanotechnology institutions in Europe. I looked intensely at the 
country’s legal origins, cultural dimensions, rates of economic growth, export 
demand for technologically advanced products, and geographical and functional 
proximities to industrial and funding partners of nanotech firms; while controlling for 
their organizational size, VC participation, and innovative capacity. The key question 
asked in my study is: how do the external factors affect the dynamics of collaboration 
in nanotech R&D projects across Europe? 
The motivation of this study was dependent on my inquisitiveness in understanding 
the extent to which factors under management control influences the different types 
of innovative performance in nanotech R&D firms across the globe so as to provide 
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corporate strategists with valuable information on the internal intricacies which 
expedite creativity, productivity and profitability in nanotech firms.  
My study evaluates the main internal determinants of the amount of patents, quality 
of new product development and level of profitability of nanotech R&D organisations 
across the globe. I looked intensely at the human capital, financial resources and 
inventive assets of nanotech firms; while controlling for their previous cooperative 
experience, duration of collaboration and VC participation. One of the motivation of 
this study was dependent on my inquisitiveness in understanding the extent to which 
factors under management control influences the different types of innovative 
performance in nanotech R&D projects across Europe so as to provide corporate 
strategists with valuable information on the internal intricacies which expedite 
creativity, productivity and profitability in nanotech firms involved in R&D 
collaborations. My study focuses on evaluating the main internal determinants of the 
amount of patents, quality of new product development and level of profitability in 
collaborative partnerships of nanotech R&D projects across Europe. I looked 
intensely at the human capital, financial resources and inventive assets of nanotech 
firms; while controlling for their previous cooperative experience, duration of 
collaboration and VC participation.  
Another key contribution of my study is the evaluation of the impact of financial 
status, value network, organisational structure, absorptive capacity and partnership 
size on the innovative performance of nanotech R&D projects engaged in 
collaborative partnerships in Europe. I then conclude by ascertaining the core 
internal dynamics which corporate strategists and R&D project managers need to be 
aware of, so as to enhance a productive inter-firm collaboration that increases the 
competitive advantage of high-tech firm in the EU. One of the key contributions of 
this research study is to provide policymakers and corporate strategists with useful 
insights into the internal and external environment of nanotech firms. The major 
factors that influence the performance of nanotechnology institutions across the 
globe are the country’s legal origins, cultural dimensions, rates of economic growth, 
export demand for technologically advanced products of high-tech firms controlling 
for their organizational size, VC participation, and research intensity. I employed 
multiple regression and panel data analysis to evaluate the relationship between 
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successful nanotech R&D firms and key performance indicator variables. I then 
conclude by ascertaining the core internal dynamics which corporate strategists and 
R&D project managers need to be aware of, as the onus is on top managers of high-
tech organisations is to design simpler and flexible governance mechanisms which 
builds the firm’s capacity to retain and integrate new knowledge and innovative 
techniques into existing corporate systems during periods of high financial 
positioning with the intention of maximizing technological productivity and 
commercial performance. 
Traditional financial institutions such as banks are unable or unwilling to finance 
and monitor high-tech entrepreneurial activities due to their complexities, riskiness, 
illiquidity and untested markets and/or products. Over the years, VC has played an 
instrumental role in financing companies with little or no economic track record in 
order to capitalise on revolutionary discoveries in emerging and disruptive 
technologies like information & communication technologies (ICT) and bio-
nanotechnology. During the Dot-Com economic boom in the Mid 1990s, for instance, 
VC firms around the world provided seed finance and other kinds of support like 
accounting, marketing, legal, and industry network to lots of young IT companies so 
as to capitalise on the huge gains from the sale of these IT stocks through various 
exit platforms. Thiengtham (2010) describes ‘venture capital as a long term 
investment in equity capital of new, potentially high growth, and non-publicly traded 
companies that produce new and innovative products and services for new 
customers in new markets in return for capital gains rather than interest income and 
dividend yields’.  
Although, VC activities have considerably and rapidly spread across the globe; 
Schwienbacher (2005) argues that there still exist substantial differences between 
the U.S. VC industry and the rest of the world particularly in areas such as - the use 
of convertible securities, the need for change of management upon investment and 
the degree of deal syndication. Nevertheless, since the advent of globalisation in the 
1990s, the access OECD countries have to efficient capital markets; skilled 
workforce, effective intellectual property protection and sophisticated research 
facilities have significantly increased their VC activities (Djankov et al, 2008). 
According to Aizenman and Kendall (2008), the UK is regarded as one of the top net 
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recipients of foreign VC investments because the government has endeavoured to 
create conducive environment that enhances VC performance. Samila and Sorenson 
(2009) obverse that due to the positive effects VC has on a country’s sustainable 
economic growth and youth employment; governments around the world are eager 
to create a more favourable atmosphere for VC investments in order to meet 
stakeholders’ expectations.  
The demand for VC funds among young entrepreneurs is quite astonishing - about 
10% of the total numbers of business plans submitted to VC firms are thoroughly 
screened and only 1% of the entrepreneurial concepts secure financing from GPs. 
The factors that significantly affect the demand for VC funds are – quality of the 
prospective management team, viability and profitability of the business 
plan/concept, prevailing market conditions, level of youth unemployment, cultural 
perceptions associated with business success or failure, minimum capital amount 
required; and the tax regimes at the head office region of the start-ups. The supply of 
VC funds by LPs is largely due to the - track record of the VC directors, 
diversification benefits accrued to the VC fund supplier, regulatory burden, cost of 
VC capital, religious affinity, demography, liquidity considerations, legal structure, 
capital gains tax regime, fund size, level of private property protection, judicial 
independence and cultural obligation. This report would be focusing only on the 
supply-side of VC investments and exits. Government agencies around the world 
have participated in facilitating the demand for and supply of VC funds. Policy 
makers in various countries have adopted schemes and instituted vehicles that 
enhance VC activities in order to - reduce political risk, suppress youth 
unemployment figures, stimulate economic growth, encourage innovation  and foster 
wealth creation amongst its citizenry. 
According to Ewing (2004), VC plays a vital role in building a vibrant private sector in 
EMEs through the channelling of funds to young entrepreneurs unable to access 
seed capital from banks due to their very low appetite to finance unproven business 
ventures and industries. VC investments are highly essential to EMEs due to: 
knowledge transfer through partnerships; high liquidity which facilitate sustained 
economic growth; employment generation and youth empowerment; and the 
identification and funding of winning firms and ideas. VC in the United States and 
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Europe plays the most dominant role in global VC activities due to their superior 
governance and free market principles. China, on the other hand, has begun to 
embrace more liberal economic policies in recent years and it is no surprise their VC 
industry has significantly grown ever since. The VC in developed countries is 
primarily focused on funding Bio-tech and IT/Software firms while VC in emerging 
markets concentrate on finance for the manufacturing and agricultural industry. 
1.4 Research Questions 
What are the major complexities in inter-firm R&D collaborative partnerships in a 
high-tech industry across Europe? 
 Which external determinant influences the dimension (partnership size, 
governance mechanism, strength and duration) of inter-firm R&D collaborative 
partnerships in nanotech organisations across Europe? 
 Can the geographical and functional proximity to partners influence the 
dimension of collaboration in nanotech R&D projects? 
 Do cultural dynamics have an impact on the dimension of collaboration 
in nanotech R&D projects? 
 Is the legal origin of a country about to influence the dimensions of 
collaboration in nanotech R&D projects?  
 Does a country’s rate of economic growth affect the dimensions of 
collaboration in nanotech R&D projects? 
 
 Which key internal factor influences the innovation and financial performance 
(patents, new product development and long-term profitability) of nanotech 
R&D organisations? 
 How does the level of value network of nanotech R&D organisations 
affect the innovation and financial performance? 
 Does the absorptive capacity of nanotech R&D organisations influence 
their innovation and financial performance? 
 Can VC fund manager’s participation in nanotech R&D organisations 
influence their innovation and financial performance?  
What are the main factors that determine a country’s innovation and financial firm 
performances in nanotechnology industries during commercialization? 
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 How has nanotech R&D organisations across the globe performed in the 
period of commercialisation?  
 What were the historical developments in basic and applied research and the 
modern periods of nanotechnology commercialisation? 
What factors influence the exit performance of VC and non-VC backed nanotech 
portfolio companies? 
 What are the financial and non-financial factors that significantly influence the 
exit performance of VC backed nanotech portfolio companies?  
 Do VC financing affect the exit performance of nanotech portfolio companies? 
 Do foreign funded nanotech portfolio companies have better exit performance 
than their domestic funded counterparts? 
Figure 1.1:  Diagram of Research Questions linking other Sections 
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1.5 Thesis Structure 
The study is structured as follows: In chapter 2, I would introduce the theoretical 
framework of the study on the external complexities and develop the hypothesis. 
Section 2.3 outlines the research methodology. The empirical results are presented 
in section 2.4. The section 2.5 discusses these results and highlights research and 
policy implications. Section 2.6 concludes with the pa's contributions and its 
limitations and suggests for further research. Chapter 3 would focus on the internal 
intricacies affecting R&D collaborations. Chapter 4 and 5 focus on the organisational 
performance in terms of innovation, finance and exit behaviour. I introduce the 
theoretical framework of the study and develop the hypothesis. Section 4.3 and 5.3 
outlines the research methodology. The empirical results are presented in section 
4.4 and 5.4 show the results and highlights research and policy implications. Finally, 
Chapter six summarizes and concludes with future recommendations. 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
Chapter 2: External Complexities in Nanotechnology R&D Projects: Analysis of 
Inter-firm Collaborative Partnerships that Lead to Abundance 
 
2.1  Introduction 
From the early decades of the 20th century, nanotechnology research studies have 
focused on the development and application of techniques to examine physical 
phenomena (Kostoff et al., 2006; 2007). Nanotechnology can be described as a 
multipurpose application of science that has radical innovations in processes, 
disruptive impact on existing industries and transformative effect in societies (Shea, 
2005). Collaboration is usually peculiar among experimental research due to its 
interdisciplinary features and the use of large or complex instrumentation such as 
telescopes and CT scanners (Lee, 1996; Bozeman and Corley, 2004). One of the 
main reasons for the surge in scientific research collaborations is due to the growth in 
interdisciplinary research institutes such as nanotechnology departments, which rely 
on the combination of the expertise of researchers from different fields of study 
(Schummer, 2004).  
Research collaboration in nanotechnology could be observed as the meaningful 
cooperation of researchers in achieving a collective goal of creating and 
disseminating new scientific knowledge on an atomic scale. Collaboration in scientific 
exploration can be developed among individual researchers such as interdisciplinary 
groups; across public/private sectors such as university and industry; and between 
countries such as multi-national cooperative institutes (Fiaz, 2013; Ponomariov, 
2013). There are several motivations for nanotechnology research collaborations 
such as the rising costs of conducting experimental science; the availability of quick 
and avoidable transportation & communication facilities; the proliferation of scientific 
communities around the globe; the politicizing of research activities; and the strong 
demand for specialisation within the fields of science (Stichweh, 1996; Schott, 1991). 
The results of systematically assessing international research collaborations in 
nanotechnology elucidate the associations between national research policies and 
the development of transnational scientific networks (Romig et al., 2007). 
Governments around the globe have provided resources as well as incentives to 
promote rapid growth and dissemination of scientific knowledge as a means of 
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facilitating international collaborations; in order to promote indigenous innovation, 
exploit research synergy, and enhance scientific excellence (Tang and Shapira, 
2012). The pathway to a contemporary global scientific community usually goes 
through a transitionary period of strong nationalistic identity in science and 
technology (Heinze, 2004; Mehta et al., 2012). In order words, the nationalization of 
reference groups is compensated in due course by the addition of new processes 
and systems into an existing scientific community by means of a progressive internal 
differentiation of science and technology. Nanotechnology will bring significant 
changes as profound as the industrial revolution, antibiotics, and nuclear weapons 
combined (Miyazaki and Islam, 2007). So, it is no surprise that governments around 
the world are aggressively funding nanoscience and nanotechnology in order to gain 
the upper hand in this very important field which would redefine many processes and 
systems in the near future (Shea et al., 2011).  
The European Commission actively invests into joint R&D projects1, in conjunction 
with the private sector, to facilitate inter-firm collaboration and scientific performance 
in an attempt to foster global competitiveness (Paier and Scherngell, 2011). A key 
challenge for European R&D policy makers is to define an optimal collaboration scale 
for fund mobilization across local, regional, national and international cooperative 
partnerships to promote a vibrant and prosperous socio-economic environment 
Previous studies view successful inter-firm R&D collaborative partnerships as 
voluntary arrangements between organizations, which enhance the development of 
new innovative products and/or services through the exchange of technology and 
sharing of expertise (Rosenfeld, 1996; Hagedoorn, 2002; Faems, Looy and 
Debackere, 2005; Roijakkers and Hagedoorn, 2006; Schleimer and Faems, 2016). 
Inter-firm R&D collaboration structures can be measured by assessing the time 
periods in which the cooperative agreements are fulfilled between joint partners. This 
ranges from short-term contracts to medium-term mergers to long-term acquisitions. 
The governance mechanisms for robust collaborative partnerships in inter-firm R&D 
projects require a decentralized command system, which oversees a large amount of 
funds and organizes a vast amount of human capital in a specialized framework that 
stimulates useful, innovative engagements among all players (Scandura, 2016; 
                                                          
1
 Through its 7th framework programme for research funding which lasted from 2007 to 2013, the EU disbursed 
€28 billion and its current Horizon 2020 is estimated at €80 billion (EU report card, 2017). 
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Contractor and Lorange, 2002; Kumar and Dissel, 1996). Collaborative partnerships 
divert organizational resources away from internal R&D investments (Park and Kang, 
2013). Therefore, it is important that attention is paid to the size of collaborative 
partnerships in R&D projects, due to the limited internal resources of the 
organisations and the complexities in their external environment when participating in 
joint commercial arrangements. 
Nanotechnology is an example of discontinuous innovation. It is a highly intensive 
research and technological development science-based cluster; with complex 
interdisciplinary features (Schummer, 2004; Rijnsoever and Hessels, 2011). 
Nanotech enables multiple interactions between scientists from diverse cultural 
backgrounds (Katz, 1994; Kostoff et al., 2006) working for multi-faceted organizations 
(Heinze, 2004; Cunningham and Werker, 2012) across public and private sectors 
(Miyazaki and Islam, 2007) and through internationally regulated borders (Romig Jr. 
et al., 2007). Academic and industrial actors, as well as governments at all levels 
(i.e., local, regional, national and international), have allocated a considerable 
amount of resources to exploring the organizational structure (Fiedler and Welpe, 
2010) and the technological (Corbett et al., 2000), socio-economic (Teece, 1986; 
Cunningham and Werker, 2012), and regulatory (Kica and Bowman, 2012) 
framework of nanotechnology. They aim to redefine many processes and systems in 
the near future (Shea, et al., 2011). 
Most policy initiatives and organizational strategies are geared towards facilitating 
collaboration, not only on the level of individual scientists (Wagner and Leydesdorff, 
2005), but also on a higher level of inter-firm cooperative engagements (Wong, Ho, 
and Chan, 2007). The merits of inter-firm collaborations in nanotechnology industries 
are the diversification of risks in an uncertain environment and the transfer of 
knowledge among cooperative partners (Park and Kang, 2013). It has been found 
that organizations that are highly involved in collaborative partnerships enhance their 
competitiveness, experience greater return on their investment and enjoy a much 
higher rate of success (Todeva and Knoke, 2005). Inter-firm relationships can create 
corporate social capital such as organizational prestige, brand recognition, and 
reputational status, because inter-firm networks generate intangible assets that can 
be accumulated through human resources (Beaudry and Allaoui, 2012). 
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The motivation of my study was to investigate the main external influencers of 
effective collaboration in nanotech R&D projects across Europe. The key contribution 
of this research study is to provide policymakers and corporate strategists with useful 
insights into how to simplify the complexities of the environment in which nanotech 
firms operate. My study focuses on examining the major factors that influence the 
partnership size, governance mechanism, strength and duration of inter-firm 
relationships among nanotechnology institutions in Europe. I looked intensely at the 
country’s legal origins, cultural dimensions, rates of economic growth, export demand 
for technologically advanced products, and geographical and functional proximities to 
industrial and funding partners of nanotech firms; while controlling for their 
organizational size, VC participation, and innovative capacity. The key question 
asked in my study is: how do the external factors affect the dynamics of collaboration 
in nanotech R&D projects across Europe? 
In this study, both quantitative and qualitative research methods were used to 
generate secondary and primary data to enrich the sample and provide adequate 
observational data for the analysis. I collected secondary data on nanotechnology 
organizations and their industry affiliations, organizational size (total assets), number 
of patents, and VC participation from the Orbis database provided by Bureau van Dijk 
(BvD). As I was unable to find useful proxies for collaborative dynamics of 
nanotechnology organization in the secondary dataset, I then used a survey 
instrument to generate vital interview and questionnaire data. The responses were 
coded into ordinal observations on the dimensions of collaboration and the 
geographical and functional proximities to industrial and funding partners. I 
conducted 30 interviews with top executives of nanotech firms and provided 97 
questionnaires to senior administrators of nanotech R&D projects across 12 
European countries. Finally, I included the legal origin index developed by La Porta 
et al., (1999) for all the nanotech R&D projects in the dataset, and carried out 
ordinary least square (OLS) and logistic regressions to provide empirical tests for my 
hypotheses. 
The results show that external factors – such as the geographical and functional 
proximities to key partners, a country’s legal origin, cultural dimensions, economic 
growth and its export demand for advanced high-tech products – meaningfully 
influence the size and governance mechanism, strength and duration of collaboration 
29 
 
in nanotech R&D projects. The closeness, regarding geography and functional 
space, of nanotech R&D firms most influences the dimensions of their R&D 
collaborations. Also, nanotech firms operating in countries with French Civil Law 
origin are inclined to establish a centralized system of governance in their R&D 
collaborative partnerships, due to the high level of legal predictability. Countries with 
a legal origin in English Common Law are less predictable, while those with French 
Civil Law are less flexible (Beck et al., 2003). I also find that VC funding in nanotech 
R&D projects usually leads to VC’s active participation in the strategic management 
of these collaborative partnerships, in particular to influence the size and duration of 
the cooperative engagements. 
Moreover, my results show that the innovative capacity and organizational size of 
nanotech firms also affect the dimensions of their R&D collaborations (Fiedler and 
Welpe, 2010). I argue that, because nanotech R&D projects are inherently very 
complex, nanotech firms that operate with a more decentralized internal 
organizational structure and in a simpler external environmental framework will be 
more effective in their R&D collaborations and hence can produce better innovative 
outcomes for a more abundant world. My study concludes by identifying the possible 
opportunities and challenges for policy makers and organizational strategists to 
exploit or guard against, to enhance the dimensions of collaboration within the 
nanotechnology industry or similar emerging and discontinuous innovations. 
The study is structured as follows: In section 2.2 I introduce the theoretical 
framework of the study and develop the hypothesis. Section 2.3 outlines the research 
methodology. The empirical results are presented in section 2.4. The section 2.5 
discusses these results and highlights research and policy implications. Section 2.6 
concludes with the pa's contributions and its limitations and suggests for further 
research. 
2.2   Theoretical Framework 
Scientific activities are organised by individuals who operate under local, regional, 
national and international institutions at various levels of spatial proximity and who 
are in communication with one another in order to create and diffuse scientific 
knowledge (Ponds et al., 2007). Collaboration among scientists from different 
societies implicitly confirms and explicitly reinforces their belief in the virtues of 
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universal validity as it fosters consensus and facilitates diffusion within the scientific 
community (Katz and Martin, 1997). The prerequisite for a global diffusion of 
scientific knowledge is prevalent in the belief in universal validity, wider 
dissemination, and intensive collaboration (Lee and Bozeman, 2005). One of the 
salient determinants of the global interconnectedness of scientific communities is the 
complex dynamics of the internal differentiation of science (Corbett et al., 2000).  
The international interconnectedness of scientific communities is not due to the 
emergence of a unipolar world of scientists who have similar objectives or share a 
common set of normative and cognitive presumptions; but akin to continuous 
proliferation of ever new societies of scientists with increasingly constrained 
jurisdictions that standardizes the social and cognitive universe of science in a way 
which is irreconcilable with the confines of national scientific societies (Kica and 
Bowman, 2012). The factors contributing to collaboration within scientific 
communities as: changes in levels of funding; desire for visibility and recognition 
among researchers; increasing demand for the rationalisation of scientific 
manpower; rapid specialisation in science; and growing proliferation of science 
(Zheng et al., 2014). The custom among scientific research communities for some 
years now has been collaboration and this is due to the increasingly complex, very 
expensive and highly interdisciplinary characteristics of modern scientific endeavours 
(Teece, 1986). 
Collaboration on an international scale is a network of self-organising researchers 
with preferential attachments and social constraints (Wagner and Leydesdorff, 
2005). Most policy initiatives are geared at facilitating collaboration not on individual 
basis but on a higher level of public/private or foreign partnership (Fiedler and 
Welpe, 2010). National scientific institutions usually function as a policy initiative due 
to the reliance on state funds. In contrast to the European scientific community, 
emerging economies (such as the Chinese) scientific development was led by state 
actors and tailored towards the applied sciences (Macnaghten et al., 2005). The 
international collaborative networks are very dynamic, rapidly increasing, and highly 
influential. Collaboration in scientific communities provides several benefits such as 
the transfer of knowledge, skills and techniques; the cross-fertilisation of concepts 
and ideas; the provision of intellectual companionship; and enhancing of the 
prominence of research work.  
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Multi-author papers can be used as a proxy for measuring the level of collaboration 
among research groups (Smith, 1958). Although, co-authorships in scientific 
publications simply provide partial insight into the level of collaboration between two 
or more researchers due to the fact that; the accurate nature and size of 
collaboration cannot be clearly determined by survey techniques. Collaboration is a 
robust predictor of publishing productivity when the total number of scientific 
publication is used as its measurement but when the allocated contribution is 
weighted into the number of authors, collaboration does not significantly relate to 
publishing productivity as other factors are kept constant (Jong and Slavova, 2014). 
Scientific research is profoundly different from industrial innovation because the 
former is primarily concerned with adding and diffusing new knowledge into the 
existing body of knowledge while the latter is more interested in adding to the 
streams of income from the exclusive rights of hoarding private information 
(Bozeman and Gaughan, 2007). Intellectual property rights provide an acquisition 
platform for small and medium enterprises. The global exploitation of science and 
technology by multi-national corporations better describes the much greater rate of 
growth of international patent applications than the growth rate of national patent 
applications (Alcacer and Gittelman, 2006). 
According to the findings of Pond et al., (2007), when geographical proximity is high 
amongst science based technologies between universities, companies and 
government research institutes; collaboration in scientific research is apparently 
more likely to be successful since their physical distance is close because of the tacit 
character of knowledge which requires face-to-face interaction. High geographical 
proximity can compensate for the deficiencies in institutional differences during 
collaboration; that is, research collaboration concerning different types of 
organisations is more spatially localised because of shared interest in labour 
exchange, access to local funding, and mutual trust facilitated by informal contact 
and interactions. The closer potential collaborators are in geographical proximity; the 
more likely there could be an informal communication among them which leads to a 
collaborative event (Dietz and Bozeman, 2005). 
In terms of the legal factors that influence the level of collaboration within 
nanotechnology organisations, historically determined differences in the legal 
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traditions of countries could help explain the discrepancies in the collaborative size 
and efficiency of institutions within the global scientific community (Beck et al., 2003). 
I adopt the theory of law and finance initiated by La Porta et al., (1999) which proves 
that countries with English Common law origins generally possess stronger 
shareholder and creditor protection than countries with French, German or 
Scandinavian legal origins (La Porta et al., 2008). Countries that adopt the Common 
law better protect investors against expropriations due to the effectiveness of its 
legal enforcement which signifies the independence of the judiciary which reduces 
agency problems and results in higher dividend pay-outs (Djankov et al., 2008). 
Superior alternative financial markets are usually found in English Common law 
countries due to the fact that shareholder’s rights are better protected through the 
court system (Cumming, 2008). Also, stricter bankruptcy laws in a country attract 
greater external funding and direct investments into risky entrepreneurial ventures 
(Armour and Cumming, 2008).  
Inter-firm relations management capabilities can be defined as the structure, 
processes, and tools that equip companies to seize, distribute, accumulate and use 
information gathered from the collaborative activities carried out with other partners 
(Niesten and Jolink, 2015). Inter-firm relations management capabilities are vital 
determinants of effective collaboration, because they allow the partners in a 
cooperative arrangement to easily modify the key features of their relationship to 
mitigate any unforeseen external threat to it. Collaborative arrangements help reduce 
R&D costs and mitigate business risks in new projects. Partners with a higher level 
of inter-firm relations management capabilities tend to influence partners with lower 
levels in any collaborative partnership (Contractor and Lorange, 2002). 
2.2.1 Strength and duration of collaborative partnerships  
Figure 1 depicts a proposed model for the relationships between the strength and 
duration of collaboration and the size of the cooperative partnership. I see from the 
model below that the greater the strength and the longer the duration of R&D 
collaboration, the lesser the number of their partners. As the strength and duration 
increases, the sizes of both industrial and overall partners will most likely decrease, 
based on the interaction effects between the two variables. Thus, as a policy 
implication I can infer that for collaborative partnerships in high-tech industries to be 
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strong and lasting, the number of the partners must be reduced to the most optimal 
level. 
 
Figure 2.1:  Strength and Duration of Collaborative Partnership Models 
 
In figure 1 above, I illustrate that effective inter-firm collaboration is dependent not 
only on the number of partners but also on the quality of input delivered into the 
nanotech R&D projects over a sustained period of time. My proposed model is based 
on the data sample of this study. It was constructed from the relationships between 
three of my dependent variables, taking into account the partner’s size, the strength 
of the value network and the duration for completing the R&D projects. I observe that 
the strength of partners decreases from strong to weak the more partners a 
company has, because R&D projects tend to explore multiple concepts initially and 
later focus on a few productive trends that guarantee fast innovative outcomes. Also, 
the duration of partnership decreases from long-term to short-term the more partners 
a company has, because as R&D projects become more successful through the 
patenting of new ideas or development of new products, a centralized governance 
mechanism emerges and reduces the need for more industrial partners. 
2.2.2 Proximity as an influencer of R&D collaboration  
Proximity is considered to be the closeness between two economic actors in terms 
of their distance, network and firm size (Boschma, 2005). Collaborations in European 
nanotech companies are not random and are facilitated by different kinds of 
proximities such as organizational, technological, geographical, functional, cognitive, 
sectoral and social proximity (Cunningham and Werker, 2012). Social network and 
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spatial or geographical proximity have an important influence on the level of R&D 
collaboration among nanotech companies (Autant-Bernard et al., 2007). On the other 
hand, the physical closeness between collaborators is more important when there 
are institutional differences (Ponds et al., 2007). However, due to advances in 
information and communication technologies, the physical distance between 
companies does not singularly affect their ability to collaborate in R&D projects 
(Torre, 2008). Nevertheless, informal and face-to-face interaction among scientists is 
critical in facilitating research collaborations (Katz, 1994; Balland, 2012). The time 
and cost it takes to interact are more important than the pure distance between 
collaborators (Lundquist and Trippl, 2013). The functional linkages or proximity 
among cooperative partners facilitates their performance (Koch and Strotmann, 
2006). 
One of the main reasons for the surge in scientific research collaborations is due to 
the growth in interdisciplinary research institutes, which rely on the combination of 
the expertise of researchers from different fields of study. Scientific activities are 
organized by individuals or organizations that operate under local, regional, national 
and international institutions at various levels of spatial proximity, and who are in 
communication with one another to create and diffuse scientific knowledge. When 
geographical proximity is high, collaboration in scientific research development is 
apparently more likely to be successful, since a shorter physical distance is required 
in face-to-face interaction as a result of the tacit character of knowledge. High 
geographical proximity can compensate for the deficiencies in institutional 
differences during collaboration; that is, research collaboration concerning different 
types of organizations is more spatially localized because of shared interest in labor 
exchange, access to local funding, and mutual trust facilitated by informal contact 
and interactions. The closer potential collaborators are in geographical proximity, the 
more likely is informal communication among them, which could lead to a 
collaborative project.  
Functional proximity is regarded as the operational nearness in terms of the ease 
and timing of one-on-one conversations (Monge and Kirtse, 1980). It reflects the 
capability of partners within a collaborative arrangement to organize face-to-face 
meetings in a matter of one working day (Moodysson and Jonsson, 2007). 
Functional proximity facilitates inter-firm relationships, by identifying easier 
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communication and networking platforms that promote the emergence of a group or 
region-specific values (Belin and Monteil, 1999). Taking into account the quality of 
interactive channels and the shared areas within a geographical region provides 
partners with an opportunity to explore useable distances or passive contacts. 
Functional proximity changes over time, while geographical proximity is considered 
to be fixed. In Figure 2, I propose a proximity model where nanotech companies 
could be affected by two major forms of proximity: geographical and functional.  
  H1a: The higher the geographical proximity to key partners; the greater the number 
of partners, the more centralized the governance mechanism, the stronger the value 
network and the longer the duration of collaborative partnerships in nanotech R&D 
Projects. 
  H1b: The higher the functional proximity to key partners; the greater the partner’s 
size, the more centralized the governance mechanism, the stronger the value 
network and the shorter the duration of collaborative partnerships in nanotech R&D 
Projects. 
 
Figure 2.2: A proposed model for proximity influence on collaboration 
 
2.2.3 Effects of legal origin on R&D collaboration  
In the literature, the modern inter-firm networks are highlighted as hybrid 
arrangements, which are typically comprised of suppliers, customers, competitors, 
regulatory bodies, and financial institutions (Todeva and Knoke, 2005; Contractor 
and Lorange, 2002). The advent of globalization and the homogeneity of regulations 
in countries have created more opportunities for companies to collaborate 
internationally and increase their competitive advantage (Van Beers and Zand, 
2014). As a way of facilitating collaborations around the globe, governments have 
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provided resources and incentives to promote the rapid growth and dissemination of 
scientific knowledge, in order to encourage indigenous innovation, exploit research 
synergy, and enhance scientific excellence. The pathway to a contemporary global 
scientific community usually goes through a transitionary period of strong 
nationalistic identity in science and technology.  
The main external threats to effective international collaboration in R&D projects 
are foreign language predicaments, dissimilar legal systems, regulatory barriers, and 
domestic cultural difficulties (Bjorkman et al., 2007). Regarding the legal dynamics 
that impact the level of collaboration in nanotech organizations, historically 
determined variances in the legal traditions of countries could help explain the 
differences in the collaborative size and efficiency of institutions within the global 
scientific community (Beck et al., 2003). I adopted the theory of law and finance 
initiated by La Porta et al., (1999), which stipulates that countries with English 
Common Law origin generally possess stronger shareholder and creditor protection 
than countries with French, German or Scandinavian Law origins (La Porta et al., 
2008).  
In order words, countries that adopt the English Common Law better protect 
investors against expropriations due to the effectiveness of its legal enforcement, 
which highlights the independence of the judiciary and reduces agency problems 
that result in higher dividend pay-outs (Djankov et al., 2008). Superior alternative 
financial markets are found in countries with English Common Law origin, because 
shareholders’ rights are better protected through the court system (Cumming, 2008). 
Building on this literature, I propose that a country’s legal origin significantly 
influences the number of partners, the governance mechanism, strength and 
duration of R&D collaborations. 
H2a: If inter-firm R&D projects are carried out within the jurisdiction of countries 
with French Civil Law origins; the number of partners reduces, the governance 
mechanism is centralized, the duration decreases and there is a weak value network 
in the collaborative partnerships of nanotech firms when compared with English 
Common Law Countries.  
H2b: If inter-firm R&D projects are carried out within the jurisdiction of countries 
with German Civil Law origins; the number of partners reduces, the governance 
mechanism is centralized, duration decreases and there is a weak value network in 
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the collaborative partnerships of nanotech firms when compared with English 
Common Law Countries. 
H2c: If inter-firm R&D projects are carried out within the jurisdiction of countries with 
Scandinavian Civil Law origins; the number of partners reduces, the governance 
mechanism is centralized, duration decreases and there is a weak value network in 
the collaborative partnerships of nanotech firms when compared with English 
Common Law Countries. 
2.2.4 Cultural dimensions in R&D collaboration  
As R&D partnerships become more global, understanding national cultures 
becomes essential because it partly determines cooperative performance and affects 
the attainment of organizational goals (Franke et al., 1991). Culture is an established 
set of values that affects the way people think and behave within society, and which 
is passed down from generation to generation (Bosley, 1993). Globalisation has 
facilitated the increase of trade among nations, and this has resulted in the 
convergence of cultures and collision of linguistic practices (Basu and Yoshida, 
2012).  
Based on a cross-country study that analyzed certain cultural effects on business 
organizations, it could be argued that the attitudes of professionals can be derived 
from their religions and another cultural phenomenon (Hofstede, 1983). As such, 
cultural variables explain the discrepancies in investor protection rights better than 
the legal traditions of countries, and key indicators such as language and religion 
affect financial market and technology development. Cultural differences affect the 
transfer proficiencies of companies in global inter-firm relationships through vital 
determinants such as social assimilation and prospective absorption capacity 
(Bjorkman et al., 2007; Licht et al., 2001). 
 The careful consideration of the cultural dynamics in inter-firm relations is a useful 
skill 21st-century managers need to possess to develop trust and enhance creativity 
in collaborative engagements (Chua, Morris, and Mor, 2012). Cross-cultural 
collaborations in high-tech industries experience lots of difficulties, which could be 
circumvented by choosing the right R&D project to be subcontracted and by 
estimating its possible cooperative outcome (Krishna et al., 2004). There are four 
main cultural dimensions that act as differentiators to capture the complex nuances 
that describe culture (Hofstede, 1983). These cultural dimensions are: power 
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distance, which is the extent to which the masses within a society accept that power 
is unevenly distributed; uncertainty avoidance, which is the degree to which 
tolerance for uncertainty and ambiguity is allowed or acceptable; individualism vs 
collectivism, which is the level to which people within a society are interdependent 
and are easily integrated into and committed to groups; and masculinity vs 
femininity, which is the degree to which a society is influenced by historically 
masculine or feminine values. However, I focused on the tolerance level of 
uncertainty and scale of female participation in science and technology fields when 
compared with their male counterparts. We, therefore, propose the following 
hypotheses: 
H3a: The greater the degree of society’s intolerance for ambiguous and uncertain 
business ventures, the lower the overall partnership size, the more centralized 
governance mechanism, the weaker the value network and the shorter the duration 
of collaborative partnerships in nanotech R&D projects.  
H3b: The higher the degree to which masculine values prevail in society over 
feminine values, the greater the partnership’s size, the more centralized the 
governance mechanism, the shorter the duration and the weaker the value network 
of collaborative partnerships in nanotech R&D projects. 
2.2.5 Economic growth and R&D collaboration  
Cultural values are economic performance determinants, which provide a useful 
explanation for the cross-national variance in economic growth of nations (Franke, 
Hofstede, and Bond, 1991). There is a positive relationship between the economic 
growth rate within a country and their level of human capital accumulation (Strulik, 
2005). The rationale for R&D cooperation and the size, structure, and time-frame is 
solely dependent on the net gains from the collaborative partnerships (Van Beers 
and Zand, 2014). The motives behind organizations undertaking inter-firm 
collaboration vary vastly and are dependent on firm-specific features and multiple 
environmental factors. Motives include: to increase their capacity to produce; 
decrease internal weaknesses and external threats; achieve greater control and 
organizational flexibility; realize market potential and obtain competitive advantage, 
leading to enhanced profitability and rapid growth (Todeva and Knoke, 2005). 
Inter-firm cooperation has grown rapidly over the last 20 years because of the 
dynamic nature of the external environment of R&D projects. In other words, 
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companies that have several collaborative arrangements with diverse partners are 
expected to have a more synergetic outcome in product development and receive 
complimentary information in the organizational learning. Cooperative engagements 
between high tech companies are used as market entry strategies into industries 
tightly controlled by the government to circumvent regulatory constraints during 
periods of economic growth, thereby improve market conditions and strengthen their 
industry positions (Contractor and Lorange, 2002). In line with the literature I propose 
the following hypothesis: 
H4: The higher the rate of economic growth within a country, the greater the 
partner’s size, the more decentralized the governance mechanism, the stronger the 
value network and the longer the duration of collaborative partnerships in nanotech 
R&D projects. 
2.2.6 International demand for technologically-advanced products   
The main factors that determine the successful internationalization of commercial 
products are the harmonization of regulated markets and the technological 
sophistication of business ventures. These factors have different impacts on small- 
and medium-scale enterprises (SMEs) and large firms (Broocks and Van 
Biesebroeck, 2017).  Most SMEs are required to be systematic in their product 
selection and strategic planning, in order to circumvent the inherent weaknesses of 
not having an adequate market niche and financial flexibility.  
In contrast, large firms have sufficient financial resources to ensure that their focus 
is on non-price marketing instruments (i.e., product, promotion, and place) that could 
enhance international demand for their new or existing products (Cavusgil and 
Kirpalani, 1993). A firm’s export intensity is highly dependent on the quality of their 
products, because economic growth is significantly influenced by total factor 
productivity, which arises from the innovative performance of high-tech firms (Curzi 
and Olper, 2012). Higher export performance is usually associated with efficient, 
innovative firms that can create top-quality products at reasonably high prices for 
effective distribution to distant markets (Fajgelbaum, Grossman and Helpman, 
2011). Globalisation influences the scale and scope of multi-product firms via 
competition and demand effects (Eckel and Neary, 2010). 
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H5: The higher the export demand for a country’s technologically advanced 
products, the greater the number of partners, the more centralized the governance 
mechanism, the shorter the duration and the stronger the value network of 
collaborative partnerships in nanotech R&D projects. 
2.2.7 Organizational size and R&D collaboration  
The international collaborative networks are very dynamic, rapidly increasing, and 
highly influential. External networking compliments the internal R&D activities of 
SMEs when economies of scale and/or integration of diverse skills and technologies 
could be achieved (Mancinelli and Mazzanti, 2009). Compared with large 
companies, SMEs are significantly unable to establish the most suitable external 
network of partners for collaboration (Rothwell and Dodgson, 1991). As SMEs have 
smaller external relations than large companies, they are more confined to their local 
region because of the need to have direct interactions in tacit knowledge exchange. 
Large firms are far more likely to have a cooperative relationship with the vertical 
partners (such as universities, research institutes, and training centers) in their 
supply chain than SMEs. However, technology-driven SMEs are uniquely different in 
this regard. 
The inability of SMEs to engage in vast cooperative partnerships, outside their 
business relations, is due to the low financial resources available and the small 
number of employees capable of initiating and preserving network links (Kaufmann 
and Todtling, 2002). As far as external network relations are concerned, SMEs are 
focused more on developing regional partnerships than are large companies. Multi-
national corporations (MNCs) have a competitive advantage, resulting from their 
superior ability to transfer and combine competencies across geographically 
dispersed entities. The global exploitation of science and technology by MNCs better 
describes the much greater rate of growth of international patent applications than 
the growth rate of national patent applications (Todeva and Knoke, 2005; Bjorkman 
et al., 2007). However, it is extremely problematic for MNCs to pursue speculative 
opportunities and/or mitigate unestablished threats posed by disruptive innovations, 
due to their cultural and structural impediments (Lindsay and Hopkins, 2010). 
H6: The larger the organizational size of nanotech firms, the lesser the number of 
partners, the more centralized the governance mechanism, the shorter the duration 
and the stronger the value network of R&D collaborative projects. 
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2.2.8 VC Fund Manager’s Participation in R&D projects 
Venture capital (VC) is an independent, professionally managed, dedicated pool of 
capital that focuses on equity or equity-related investments in privately held, high-
growth companies (Gompers and Lerner, 2001). VC funds are a collective 
investment scheme used in making investments in various portfolio companies. A 
large portion of the global VC industry operations can be attributed to the 
entrepreneurial spirit prevalent in the United States. Also, the access OECD 
countries have to efficient capital markets, skilled workforces, effective intellectual 
property protection and sophisticated research facilities enhance their VC activities 
and performance (Djankov et al., 2008). VC plays a vital role in building a vibrant 
private sector by channeling funds to young entrepreneurs, who are unable to 
access seed capital from banks due to their reluctance to finance unproven business 
ventures and industries (Ewing, 2004). VC investments are essential to SMEs due 
to: knowledge transfer through partnerships; high liquidity, which facilitates sustained 
economic growth; employment generation and youth empowerment; and the 
identification and funding of winning firms and ideas.  
The internationalization of the VC industry in the 1990s has allowed for a vast and 
steady increase in cross-border VC investments around the world, such that foreign 
VC participation in local portfolio companies now accounts for one-third of global VC 
activities (Schertler and Tykvova, 2012). One of the effects of globalization has been 
the facilitation of cross-border VC activities, due to the relative ease of labor 
restrictions, capital controls and banking regulations among developed countries and 
emerging markets (Wang and Wang, 2011). VC fund managers participate in the 
strategic management of portfolio companies they have invested into, to monitor and 
influence the activities of the board of directors. As VC-funded companies usually 
reach maturity within 5-7 years, divestments become essential due to the need to 
ensure the liquidity of VC funds, distribute returns, evaluate performance and/or 
reallocate entrepreneurial finance. 
H7: The participation of VC fund managers in nanotech R&D projects increases the 
number of partners, centralizes the governance mechanisms, shortens the duration 
and strengthens the value network of collaborative partnerships. 
2.2.9 Innovative capacity and R&D collaboration  
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Collaboration in scientific communities provides several benefits, such as: the 
transfer of knowledge, skills, and techniques; the cross-fertilization of concepts and 
ideas; the provision of intellectual companionship; and increasing the prominence of 
research work. The use of intellectual asset strategies in preserving opportunities for, 
or avoiding threats from, disruptive innovations is critical to the survival of R&D 
organizations, because of the most likely loss in their market position (Lindsay and 
Hopkins, 2010). Patents and other intellectual property should be used to meet the 
needs of low-end and prospective customers.   
In university-industry partnerships, there are valid financial considerations for 
supplementing patents with publications. The fear of misappropriation and the cost of 
knowledge transfer impede the formation of inter-firm relationships, due to the 
knowledge intensity of firms and the stickiness in transferring vital information among 
their supply chain (Contractor and Lorange, 2002). The innovative capacity of a high-
tech organization is their ability to develop and commercialize innovative ideas, 
products, and services over a sustained period of time (Guan and Ma, 2003). It 
represents R&D firm management’s effectiveness in converting scientific and 
technical productivities into profitable, innovative marketable products, which could 
drive radical and/or disruptive technologies into the marketplace to dominate 
industries (Koc and Ceylan, 2007). 
H8: The greater the innovative capacity of nanotech firms involved in R&D projects, 
the lower the number of partners, the more centralized the governance mechanism, 
the shorter the duration and the stronger the value network of their collaborative 
partnerships. 
 
2.3  Research Design 
In this study, I employed a mixed research method to critically examine the external 
complexities that affect the dimensions of collaboration in nanotech firms. Figure 3 
shows the research outline of this study. The conceptual framework is based on 
theories of inter-firm relations, proximities in collaborative partnerships, national 
culture influences on inter-organizational behavior, legal origin as a determinant of 
financial development, and the international demand for technologically advanced 
products. These theories provide the basis for constructing and testing my 
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hypotheses to produce empirical results on the external factors that affect the 
dimensions of inter-firm collaborations in nanotech R&D projects across Europe. 
Figure 2.3:  Research outline of the study 
 
 
2.3.1 Data 
The collaborative R&D projects in my data sample involve various characteristics of 
nanoscience and nanotechnologies, such as the development of nanotubes and 
nanowires for electrical and biological consumption, plus the use of nanoparticles 
and the construction of nano-instruments for manufacturing and communication 
purposes. These nanotech R&D projects include but are not limited to: electrical 
discharge machining, multi-component injection molding, electroforming, powder 
injection molding, nanoimprinting, X-ray lithography, selective laser sintering, 
chemical vapor deposition, nanometer-scale measurement and future tooling 
technology. 
I adopted a mixed research method where both quantitative and qualitative data 
were used to enrich the process of data collection and analysis. I collected 
secondary data on the organizational size, some patents, VC participation and 
industry and academic links to nanotech R&D projects from the Orbis database of 
Bureau van Dijk (BvD). I also collected, from the World Bank database, the annual 
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GDP growth rates and export demand for high-tech products for the relevant 
countries during the period of the nanotech R&D collaborations. Due to insufficient 
quantitative data on the collaborative dynamics of nanotech firms, I used survey 
instruments to generate interview and questionnaire data on geographical and 
functional proximity, governance mechanism, strength and duration of the 
partnership. The responses were then coded into ordinal observations. I conducted 
30 interviews with top executives of nanotech firms and provided 97 questionnaires 
to senior administrators of nanotech R&D projects across 12 European countries. 
Finally, I incorporated the legal origin index developed by La Porta et al., (1999); 
and subsequently modified by Beck et al., (2003); Spamann, (2009); and Cooray, 
(2011). The legal origins index represents the political structure and legal adaptability 
of countries where collaborative partnerships in nanotech R&D projects took place. 
Therefore, my measurement for estimating the legal dynamic affecting the 
dimensions of nanotech R&D collaborations was based on the tenure of Supreme 
Court judges, judicial independence, and legal justification. Similarly, I adopted the 
national cultural dimension indexes proposed by Hofstede (1983; 1994) for all the 
collaborative partnerships in nanotech R&D projects in my dataset, using uncertainty 
avoidance and masculinity vs. femininity indexes to provide measures of societal 
attitude towards ambiguity and the level of public intolerance for feminine values. I 
then carried out ordinary least square (OLS) regressions to analyze my data and 
provide empirical tests of my research hypotheses. 
2.3.2 Dependent variable(s) 
The key variables of interest in my study are four dimensions of inter-firm relations, 
namely: partnership size; governance mechanism; the strength of value network, 
and; time-frame to secure a patent or develop a new product during collaboration in 
nanotech R&D projects. The main dependent or response variable in my study is the 
size of the cooperative partnerships; the number of total partners in a distinct 
nanotech R&D project. I also developed three other dependent variables to consider 
the other dimensions of collaboration in nanotech R&D projects. The second 
dependent variable is the type of organizational structure in the collaborative 
partnerships of nanotech R&D projects. This ranges from level 1 to 3, i.e. from 
centralized to distributive and then decentralized governance mechanisms. The third 
45 
 
response variable is the time frame (i.e., the duration) of R&D collaboration, which I 
group into short-, medium- and long-term periods. The final dependent variable is the 
ordinal scale of the strength of value network in nanotech R&D projects. This is 
ranked from 1 to 6 and contains three groupings of weak, medium and strong level of 
interactions with suppliers, consumers, regulators, legal bodies, open innovations 
and academic institutions. 
Table 2.1:  Key Variables, Expected Relationships, and Brief Description 
S/N Variables Effects Description 
1 Size of  
Partnership 
+ The total number of partners in a collaborative 
R&D project. 
2 Governance 
Mechanism 
+ The type of organizational structure (coded 1-3 
from centralized to distributive to decentralized). 
3 Innovative 
Capacity 
_ The number of patents held before the start of the 
nanotech R&D projects. 
4 Geographical 
Proximity  
+ The geographical nearness to industrial partners 
(coded 1-4 for international, national, regional, & 
local closeness. 
5 Functional 
Proximity 
+ Functional nearness to value networks, i.e. (1-4) 
no partnership, suppliers, customers and both. 
6 Venture 
Capital 
Participation 
+ A dummy variable for VC fund managers’ 
participation in nanotech R&D projects (coded 1 
and otherwise 0). 
7 Masculinity(vs) 
Femininity 
+ Cultural index of societal attitude towards feminine 
values. 
8 Uncertainty 
Avoidance 
_ Cultural index of tolerance for uncertainty and 
ambiguity. 
9 Organizational 
Size 
_ Dummy variable (1) for large firms and (0) for 
SMEs based on the total assets of nanotech R&D 
firms. 
10 Technological 
Advancement 
+ The country’s average export demand for high-tech 
products in the period of R&D collaboration. 
11 Academic 
Affiliation 
+ A dummy variable: (1) for academic involvement in 
nanotech R&D projects and (0) for otherwise. 
12 
  
Economic 
Growth 
+ The average rate of annual GDP growth during the 
period of R&D collaboration. 
13 French Civil  
Law 
_ Dummy variable for nanotech R&D projects that 
operate under the French Civil Law (1) and (0) 
otherwise 
14 German Civil 
Law 
_ Dummy variable for nanotech R&D projects that 
operate under the German Civil Law (1) and (0) 
otherwise 
15 Scandinavian 
Civil Law 
_ Dummy variable for nanotech R&D projects that 
operate under the Scandinavian Civil Law (1) and 
(0) otherwise. 
16 Biotechnology 
Industry 
+ A dummy variable, (1) for nano-biotechnology type 
of R&D projects and (0) for otherwise. 
17 
 
ICT Industry + A dummy variable, (1) for nano-ICT type of R&D 
projects and (0) for otherwise. 
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18 
 
Duration of 
Collaboration 
+ The time frame of R&D collaboration (coded 1-3 
short to medium to long term periods). 
19 
 
Strength of 
Value Network 
+ The level of interactions with suppliers, customers, 
etc (coded from 1-6). 
Source: Orbis & World Bank Databases and La Porta et al. (1999) & Hofstede (1994) Indexes. 
 
2.3.3 Independent variable(s) 
The independent variables remained, for the most part, the same in the four models 
used in my study. They were employed to determine the factors that influence the 
dimensions of collaborative partnerships in nanotech R&D projects, based on my 
theoretical framework. The independent variables help explain the variations in the 
dimensions of collaborative partnerships in nanotech R&D projects; they include: the 
geographical & functional proximity (coded 1-4 from nearness to industrial partners 
and value networks); legal origins (dummies for French, German and Scandinavian 
Civil Law, excluding the English Common Law as the base); Hofstede’s national 
cultural dimension indexes (Uncertainty Avoidance & Masculinity vs Femininity); 
average annual GDP growth rate; the level of the export demand for high-tech 
products during the period of the R&D collaborations; existing innovative capacity 
(the number of patents held by the nanotech R&D organisation before start of the 
collaborative partnerships); a dummy variable for VC fund manager’s participation in 
nanotech R&D projects; . Table 2.1 lists and describes most of the key variables and 
their expected relationship with the observed variable in model 1. 
 
2.3.4 Control variable(s) 
I control for the organizational size of the nanotech firms based on the total assets 
of nanotech R&D organisations collected form Orbis database. Also, I control for 
academic and industrial (Bio-tech and ICT) affiliations using dummy variables (1) to 
represent those Nanotech R&D organizations which had these unique affiliations 
during collaboration. Controlling these variables help me better understand the 
effects of my independent variables on the observed variable. 
2.3.5 Multiple regression models (OLS) 
Since collaborative partnership can be observed in several ways, I developed two 
multiple regression models aimed at incorporating the different forms of collaboration 
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in nanotech R&D projects. I adopted two different attributes of collaborative 
partnerships regarding the partner’s size and governance mechanism of nanotech 
R&D projects. I used multiple linear regression models to derive OLS estimates that 
minimize the squared residuals of best fit. I specify my initial regression models for 
this research study in equation 1 below: 
γi = β0 + β1Ҳi1 + β2Ҳi2 +…+ βkҲik + εi        i = 1, 2… n.   
Where γ is the response variable for the ith observation, which is the size of 
collaborative partnerships in all 97 R&D projects; β0 is the constant or intercept that 
depicts the relationship that exists without the inputs of my explanatory variables. β1 
to βk are the parameters and Ҳ1 to Ҳk are the coefficients, while ε is the error term 
that describes the random element of the linear relationships between explanatory 
and response variables. 
2.3.6 Logistic regression models 
I formulated two logistic regression models that estimate the likelihood of my binary 
dependent output, based on several predictor variables. These are generalized 
linear models, which were used to analyze the variations in my dichotomous 
response variable about the independent variable. I specify my logistic regression 
models for this research study in equation 2 below: 
log (
𝑝(𝑦=1)
1−𝑝
) = 𝛽o + 𝛽1 ∗ 𝑥𝑖1 + 𝛽2 ∗ 𝑥𝑖2 + ⋯ + 𝛽𝑘 ∗ 𝑥𝑖𝑘   𝑖 =  1 … 𝑘                                                                                             
Where logit (p/1-p) is the probability of the presence of long-term duration or strong 
value network and is transformed into the logged odds for the ith observation as the 
duration and strength of collaborative partnerships in all 30 R&D organizations. y is a 
binary response variable. yi = 1 if the duration is long-term or strength is strong; yi = 
0 if otherwise. x = (x1, x2, ... , xk) is the set of explanatory variables. xi is the observed 
value of the explanatory variables for observation i. 
2.4  Results 
The empirical findings of my regression models are presented below in this sub-
section. Descriptive statistics and the correlation matrix are presented in Table 2.2, 
and the multiple (models 1&2) and logistic (models 3&4) regression models are 
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presented in Table 2.3.  
2.4.1 Descriptive statistics 
Table 2.2 provides the mean, standard deviation and correlation matrix of my study. 
Of particular importance are the means of GDP growth and innovative capacity, 
which are (70.66667) & (632.9667) respectively. The standard deviation of German 
Civil Law and Biotechnology Industry are quite peculiar in their size. 
2.4.2  Inferential statistics 
In model 1, I concentrated on the factors that influence the sizes of partnerships 
among nanotech R&D organizations. I used the total number of partners involved in 
the R&D projects that lead to new product development. I find that a high 
geographical closeness between nanotech R&D collaborative partners positively 
influences the total amount of partners, despite the limited nanotech specialists and 
clusters within a local region. Effective R&D collaborations among nanotech firms 
are dependent on highly skilled scientists who operate on very complex and 
expensive scientific instruments that require a high level of geographical proximity to 
achieve innovative productivity within a specified period of time. Also, I find that a 
high functional closeness in inter-firm relations positively influences the number of 
partners in nanotech R&D projects, due to the extra effort employed by senior 
administrators to establish useful forms of interaction, which reduces the 
communication distance. 
Furthermore, my results show that, in countries with a high level of intolerance for 
ambiguous commercial ventures, there are a low number of total partners in 
nanotech R&D projects. Likewise, where the national culture of countries is that 
masculine values heavily dominate over feminine ones, there are usually fewer 
partners involved in nanotech R&D projects. 
Table 2.2:   Descriptive statistics and correlation matrix 
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The table shows the mean, standard deviation and correlation matrix of model 1. 
Regulatory barriers, as well as low female participation in science and technology, 
are possible reasons for these cultural effects on the size of collaborative 
partnerships in nanotech R&D projects. Also, my results show that the economic 
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expansion of a country enhances the sizes of collaborative partnerships in nanotech 
R&D projects, due to the additional sources of funds available for R&D expenditure. 
As expected, a high GDP growth positively influences the number of total partners in 
collaborative nanotech R&D projects. Similarly, an active VC fund manager’s 
participation in the strategic activities of nanotech firms significantly adds to the sizes 
of collaborative partnerships; I believe this is in order to monitor and supervise the 
R&D projects so that innovative performance is attained as early as possible. 
Nevertheless, there was weak support for some findings, notably the idea that 
countries with a legal origin in French Civil Law thwart more collaborative 
partnerships in nanotech R&D projects, compared with English Common Law, as a 
result of their rigid labor laws (La Porta et al., 1999). Larger nanotech firms are 
capable of collaborating with more partners in an R&D project, compared with their 
SME counterparts, because they have greater financial resources and better human 
capital (Zheng et al., 2014).  
Table 2.3:       Multiple & Logistic Regression Coefficients 
  (Model 1) (Model 2) (Model 3) (Model 4) 
  
Size of Total 
Partnership 
Governance 
Mechanism 
Duration of 
Collaboration 
Strength of 
Partnership 
Geographical Proximity 0.155*** -0.135 -0.851* 0.00981** 
  (6.02) (-1.63) (-5.44) (6.30) 
Functional Proximity 0.394** -0.0465* 0.212* 0.512* 
  (7.74) (-3.52) (4.99) (5.24) 
French Civil Law -0.0249* -0.103*** -0.000169 -0.00816** 
  (-3.28) (-8.96) (-1.67) (-6.19) 
German Civil Law -0.0676 -0.603** -0.116 -0.433 
  (-1.36) (-3.86) (-1.22) (-2.17) 
Scandinavian Civil Law -0.0244 -0.0701 -0.240** -0.108 
  (-2.10) (-1.39) (-6.52) (-1.92) 
Uncertainty Avoidance -0.0201** -0.0474*** -0.157*** -0.276** 
  (-5.53) (-4.86) (-14.82) (-8.29) 
Masculine v Femininity -0.0542*** -0.0639*** -0.364*** -0.545** 
  (-8.10) (-4.76) (-16.15) (-8.41) 
GDP Growth 0.0692*** 0.0674* 0.402*** 0.584** 
  (8.89) (3.08) (15.76) (8.48) 
Organizational Size -0.0189* -0.133** -0.353*** 0.628** 
  (-2.92) (-3.52) (-14.71) (8.67) 
VC Participation 0.398** -0.00825 -0.00189* 0.511 
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  (4.21) (-2.25) (-2.69) (2.05) 
Innovative Capacity -0.00131* -0.00163** -0.00526* 0.0863** 
  (-2.83) (-4.22) (-2.59) (6.47) 
High-Tech Advance 0.248* 0.0948* -0.0713* 0.171** 
  (3.13) (2.57) (-3.46) (3.66) 
Academic Affiliation 2.065* 0.635**   0.822* 
  (2.95) (4.02)   (5.28) 
Biotechnology Industry 0.0637 0.303* 0.738** 0.110** 
  (2.00) (2.44) (11.38) (4.40) 
ICT Industry -0.00373 0.0367* -0.0510** 0.0165 
  (-1.28) (2.45) (-7.62) (2.09) 
Constant 4.393*** 6.349*** 32.25*** 14.29** 
  (8.04) (6.80) (18.96) (5.02) 
No. of Observation 97 97 30 30 
Adjusted R2 0.85 0.80     
Pseudo R2     0.89 0.87 
Multiple and logistic regression coefficients for 4 models. The significance is ***1%, **5% &*10%. 
In model 2, I focused on the factors that affect the types of organizational structure 
in inter-firm collaborations of nanotech R&D projects across Europe. The main 
variable of interest is the kind of governance mechanism among partners in the R&D 
projects. I looked intensely at the method of control among collaborative partners 
(whether it was a decentralized, distributed or centralized system of governance) and 
how it was affected by external factors such as legal origin, cultural dimensions and 
geographical proximity of nanotech firms, while controlling for organizational size, 
academic affiliation and innovative capacity. My results show that legal origins 
significantly affect the governance mechanisms of collaborative partnerships in 
nanotech R&D projects. I find that nanotech firms that carry out their collaborative 
R&D projects in countries with French and German Civil Law origins have 
centralized governance mechanisms, compared with English Common Law origin, 
because of the need to tightly control the activities of their partners to adhere to 
stringent regulatory policies. 
Moreover, my results show that a country’s cultural attitudes concerning uncertainty 
and feminine values affect the way nanotech R&D projects are managed. A high 
intolerance for ambiguous nanotech R&D projects within a society brings about 
centralized governance mechanisms, which lead to less innovative outcomes. 
Likewise, a dominant masculine culture within a society means that nanotech R&D 
projects tend to have centralized governance mechanisms that seek to achieve 
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organizational objectives at the earliest possible time frame. Also, my results show 
that economic growth has a positive but weak impact on the governance 
mechanisms in collaborative partnerships of nanotech R&D projects. Here I argue 
that the availability of economic opportunities during boom times creates a tendency 
towards decentralized or distributed systems of governance, which foster innovative 
engagement among collaborative partnerships. Similarly, the export demand for 
high-tech products represents a form of a nation’s technological advancement: I find 
that, when it is high, it negatively affects the nature of the governance mechanisms 
employed by collaborative partnerships in nanotech R&D projects. I also find that a 
high innovative capacity and a large organizational size both facilitate centralized 
governance mechanisms in the collaborative partnerships of nanotech R&D firms. 
In model 3, I focused on the external factors that affect the durations of 
collaborative partnerships with nanotech R&D organizations. Model 3 specifies the 
determinants of the period in which R&D cooperative engagements take place in 
only two periods, i.e. short- and medium-term versus long-term durations. My results 
show that the likelihood of a long-term inter-firm relationship in nanotech R&D 
projects is reliant on the legal origins, cultural values, economic growth, 
organisational size and industry affiliations. Specifically, nanotech R&D projects that 
are carried out in countries with an origin in Scandinavian Civil Law are more likely to 
be shorter duration, compared with their counterparts in English Common Law 
countries. Also, a high intolerance for ambiguous R&D projects most likely reduces 
the duration of collaborative partnerships among nanotech firms. Likewise, a 
dominant masculine culture within a society increases the likelihood of short-term 
R&D collaboration. Also, a high GDP growth rate is more likely to have a positive 
effect on the time spent in nanotech collaborations, as funding from R&D 
expenditure increases. As funding prospects are enhanced during a period of 
economic expansion, underperforming nanotech R&D projects could continue to 
receive the financial resources needed to fund such operations, and thereby extend 
the duration and increase the manpower available to ensure that a new product is 
developed and/or patent secured. Finally, I find that organizational size and industry 
affiliations influence the duration of R&D collaborations among nanotech firms. The 
larger the organizational size, the more likely there were short- and medium-term 
R&D collaborations. Finally, nanotech R&D projects with biotechnology firms take 
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longer, while those with information and communication companies are more likely to 
take a shorter time frame. 
In model 4, I focused on external determinants of the strengths of value networks in 
inter-firm collaborative partnerships of nanotech R&D projects. I find that 
geographical proximity, legal origins, cultural values, economic growth, 
organizational size, innovative capacity, technology advancement and industry 
affiliations all significantly influence the strengths of value networks in nanotech 
collaborative partnerships. Specifically, I find that a high geographical proximity (not 
strongly but significantly) is likely to positively affect the strengths of the value 
networks of nanotech R&D projects. Also, countries with French Civil Law origins are 
likely to weaken the value networks of nanotech R&D projects, compared with those 
with legal origins in English Common Law countries. Likewise, countries where 
uncertainty avoidance is high, and where masculine values prevail over feminine 
values, are more likely to have a weaker value network. Also, a high economic 
growth rate and a high export demand for technologically advanced products are 
likely to have a positive impact on the strengths of value networks in nanotech R&D 
projects. Finally, a high innovative capacity, large nanotech organization, and 
affiliation to biotechnology industry are likely to have a positive effect on the 
strengths of value networks in R&D collaborations. 
2.5  Discussion and Implications 
In this section, I identify possible opportunities and challenges for policy-makers 
and organizational strategists to exploit or guard against, with the objective of 
enhancing various dimensions of collaborative partnerships within the nanotech R&D 
projects. 
2.5.1 Legal origins 
Countries with French Civil Law Origins have a less rigorous legal system (La Porta 
et al., 1999). Nanotechnology is an emerging technology that has few laws 
regulating its industry. The French and German legal systems provide a lesser 
degree of flexibility for securing patents and higher level of predictability for 
estimating litigation outcomes. This makes it less appealing to nanotech R&D 
collaborative partnerships, because there are lots of regulations that either restrict 
the nature and scale of research exploration and  commercial exploitation or that 
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could pose a huge threat and raise the possibility of large losses – unlike the English 
legal system, where there is an inherent rule to have minimum standards of care. 
 
The impact of nanoscience and nanotechnologies has been keenly highlighted by 
prominent individuals, interest groups (Royal Society and Royal Academy of 
Engineering) and even movies (“grey goo”), so as to promote thorough risk 
assessments and further regulatory activities, and ensure that a high level of ethical 
standards are employed during commercial development. These assurances have 
significantly reduced the British public’s concerns about the ambiguities in 
nanoscience and nanotechnology. Therefore, it is imperative for nanotech firms in 
countries with an English Common Law origin to take into consideration the 
additional cost required to make risk assessments about their R&D projects publicly 
available, in order to enhance public awareness and reduce the general intolerance 
for uncertainties associated with nanotechnology. 
2.5.2 Proximity 
Despite the advancements in information and communication technologies (ICT), 
as well as the free movement of capital and labor across Europe, geographical and 
functional closeness still matters greatly in determining the size, command chain, 
strength and duration of collaborative partnerships in nanotech R&D projects. Spatial 
nearness among scientists negatively influences the partnership size, but positively 
affects the organizational structure of collaborative partnerships in nanotech R&D 
projects (Knoben and Oerlemans, 2006). 
 
Nanotechnology is an interdisciplinary field that requires a great deal of physical 
closeness among R&D partners, who use very complex instruments to develop 
innovative products and services through a decentralized system of governance that 
minimizes contingency risks (Steinmo and Rasmussen, 2016). The lack of a 
concentration of nanotechnology experts within a local scientific community in the 
past has created a need for international collaborations with a distributive 
organizational structure, in spite of the drawbacks from their geographical closeness 
(Kabo et al., 2014). 
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Functional proximity relates to the nearness of partners regarding their basic 
operations and areas of specialty during the R&D collaborations. The quality of the 
value network is strengthened when there was a substantial division of labor and 
clearly defined roles, which enabled partners to uniquely contribute to the nanotech 
R&D project within a strategic time frame to attain specified commercial objectives. A 
strong value network and long-term R&D collaboration among nanotech firms are 
more likely to be negatively affected if there are high levels of functional closeness 
within the partnership. I argue that the absence of institutional diversity impedes the 
overall ability of the collaborative partnership to maintain a steady development of 
new and innovative products or secure exclusive rights to intellectual property. 
2.5.3 Cultural dimensions 
The level of tolerance for uncertainty within a nation reveals their cultural attitude 
towards risks and ambiguity (Sriwindono and Yahya, 2012). A country with a high 
uncertainty avoidance index is more likely to have rigid belief systems that are 
intolerant of unorthodox and risky behaviors, because the majority of people with 
such cultural values are sensitive to, and feel uncomfortable with, unstructured or 
changeable environments. However, a low uncertainty avoidance index evinces that 
members of a society are more likely to be forbearing towards ambiguous or 
uncertain R&D ventures, because they are entrepreneurial in nature and are likely to 
feel comfortable in risky and less structured environments. In these countries, 
nanotech R&D project managers can take advantage of the politically active and 
informed populations by making quick decisions that exploit innovative concepts. 
 
Feminine values are another important cultural trait to seriously consider, as this 
trait affects the dimensions of collaborative partnerships in nanotech R&D projects. A 
high proportion of female involvement in science and technology within a country 
would more likely increase the strength of value networks and reduce the time period 
of collaborative partnerships in nanotech R&D projects. In contrast, a more dominant 
male presence usually leads to ego-oriented inter-firm relationships that promote 
fierce competition and focus on profit maximization, irrespective of the impact on the 
external environment. Cultural values do not easily change in the short run and are 
usually passed from one generation to another, so it is expedient for policy-makers 
and corporate strategists interested in nanotech R&D collaborations to understand 
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the possible implications and predictable behaviors relating to risk tolerance, 
procedural controls, and adherence to norms within a community that they operate 
in, so as to promote discussions that alleviate unproven claims, improve negotiating 
processes, and reduce litigation costs (Hong, Heikkinen, and Blomqvist, 2010). 
2.5.4 Economic growth 
Periods of economic growth positively affect the size, mechanism, strength and 
timeframe of collaborative partnerships in nanotech R&D projects, as a result of the 
availability of several funding prospects, the prevalence of commercial opportunities, 
and the rise in labor participation. In knowledge-based economies, the expansion of 
economic activities usually leads to a rise in R&D expenditures. Most universities 
normally obtain huge funds from research councils and industry partners to finance 
their R&D projects, with the aim of building innovation centers and fostering regional 
economic development (This corresponds with the findings of Bilbao-Osorio and 
Rodriguez-Pose, 2004; Guerrero, Cunningham, and Urbano, 2015). 
 
The university-industry collaborative partnership is a key ingredient that stimulates 
productivity in innovative ventures (Jong and Slavova, 2014) and accelerates the 
growth of economic activities in advanced countries. An increase in the external R&D 
activities of high tech firms has resulted in the rapid rise of inter-organizational 
relationships, which lead to patent licensing agreements and the development and 
production of new products. The commercialization of R&D activities via university-
industry collaborative partnerships has brought not only economic development but 
also the technological advancement of nations, due to the international demand for 
their high-tech products, which are usually emerging or disruptive know-how. Having 
exclusive rights to an innovative product in the form of a patent provides nanotech 
firms with the required protection for their intellectual property and encourages more 
R&D projects in the future. 
2.5.5 Technological advancement 
As a result of globalization, many countries have been able to unlock localized 
industries by taking advantage of new and existing export opportunities for high-tech 
products and services around the world (Mehta et al., 2012). World trade 
organization has alleviated most barriers and challenges in international commerce, 
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as advanced nations and large corporations are able to attract high-skilled labor and 
sophisticated investments into emerging and disruptive industries to provide 
technologically-advanced products and services for worldwide consumption. The 
export demand for high-tech products evinces the level of technological 
advancement in a country. Most MNCs have their internal R&D capabilities at their 
headquarters, and many external R&D projects are organized in their home country. 
Nanotech firms that operate in advanced technological nations are more likely to sell 
their newly developed innovative products to international markets. They are also 
more likely to spend less time in collaboration, due to their centralized governance 
mechanisms and comprehensive value networks. 
2.6  Conclusion 
Collaboration in nanotech R&D projects usually involves large funds and expertise, 
which divert managerial resources away from internal R&D projects. Institutionalizing 
collaborative partnerships is extremely challenging, because R&D projects demand 
new organizational structures and procedures that harness available resources to 
achieve set objectives. My study shows that large nanotech R&D organizations have 
fewer industrial partners who spend less time to develop new products, due to their 
strong value networks and centralized systems of governance in collaborative 
partnerships. Meanwhile, smaller nanotech R&D firms require more time and a 
greater number of industrial partners to develop new products, as a result of their 
willingness to impose a decentralized organizational structure in R&D collaborative 
partnerships. 
 
As a discontinuous innovation-based technology, nanotechnology has few laws that 
regulate its industry. It requires highly skilled scientists from different disciplines to 
work in close proximity and operate complex instruments to create innovative new 
products within a specified period of time. Nanotechnology is an interdisciplinary field 
that requires a great deal of physical closeness among R&D partners, despite the 
advancements in ICT as well as the free movement of capital and labor across 
Europe. Globalisation has helped many countries to unlock localized industries, by 
taking advantage of new and existing export opportunities for high-tech products 
across the globe. Advanced nations and large corporations are able to attract high 
skilled labor and sophisticated investments into emerging and disruptive industries to 
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provide technologically advanced products and services for worldwide consumption. 
The European Commission has briskly funded inter-firm R&D collaboration through 
its Framework Programme for research and technological development. 
 
Certain legal systems, which provide both a greater level of flexibility for securing 
patents and a higher level of predictability for estimating litigation outcomes, are 
likely to be more appealing to nanotech R&D project managers, because there is 
little regulation restricting the nature and scale of research exploration and 
commercial exploitation or that could pose a huge threat and the possibility of large 
losses. However, a collaborative partnership among nanotech organizations could 
be employed as a market entry corporate strategy into tightly controlled industries to 
circumvent regulatory constraints. In countries that seem to have a low level of 
uncertainty avoidance, most members of their public are more likely to be tolerant 
towards ambiguous or uncertain R&D ventures because of their entrepreneurial 
mindset, which is at ease with risky and unstructured environments. Culture doesn’t 
change easily and is usually inter-generational, providing an understanding of the 
possible consequences and predictable behaviors relating to risk tolerance, 
procedural controls, and adherence to norms within a community – suggesting a 
need to encourage public debate and general awareness.  
 
Countries with high uncertainty avoidance index are more likely to have rigid belief 
systems that are intolerant of unconventional and hazardous behaviors, because the 
majority of the population feels anxious about unpredictable environments. A low 
uncertainty avoidance index evinces that members of the public are more likely to be 
tolerant towards ambiguous or uncertain R&D ventures because of their 
entrepreneurial mindset which is at ease with risky and unstructured environments. 
Also, a high proportion of female involvement in science and technology within a 
country would likely increase the strength of value networks and reduce the period of 
collaborative partnerships in nanotech R&D projects. 
 
Universities involved in discontinuous innovation-based R&D projects have 
specialized interdisciplinary centers, which are capable of collaborating with more 
industrial partners because of their access to additional financing. Patents and other 
intellectual property should be used to meet the needs of low-end and prospective 
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customers. Also, academic institutions are now benefiting from the legitimate 
financial considerations of supplementing patents with publications. The existence of 
VC funding in nanotech R&D projects indicates that there are significant commercial 
opportunities available, and that entrepreneurial prowess is prevalent in such 
collaborative partnerships. There are other significant variables, not included in this 
model, that influence the ability of nanotech companies to collaborate with a large 
number of industrial partners. Certain key features of a company – such as its age, 
size, market position, and financial status – could be useful tools for predicting the 
propensity to enter successful collaborative partnerships. A much larger sample size, 
incorporating more countries in which nanotech companies operate, would provide 
useful insights into the legal and cultural determinants of the level, size, and timing of 
collaborative partnerships. 
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Chapter 3:  Internal Intricacies and Innovative Performance of Collaborative 
Partnerships in Nanotechnology R&D Organisations 
 
3.1  Introduction  
As an engine for economic growth, job creation and radical innovation in knowledge-
based economies (Protogerou et al., 2017); high-tech firms play an important role in 
establishing collaborative partnerships with universities (Caloghirou et al., 2001) in 
order to develop a portfolio of innovative products and pioneering systems (Nieto and 
Santamaria, 2007) which thrives despite the swift changes in the socio-economic and 
technological environments (Baranenko, et al., 2014) that requires shorter product life 
cycles as a result of intense global competition (Deeds, DeCarolis and Coombs, 
2000). Through the Framework Programme (FP) for research funding, the European 
Commission has vigorously financed inter-firm R&D projects (Roediger-Schluga and 
Barber, 2006; Paier and Scherngell, 2011) to promote innovative performance in 
high-tech firms so as to enhance their global competitiveness (Scherngell and Lata, 
2013). Globalization of science, technology and commerce has rapidly advanced 
human endeavour; making it essential for high-tech firms to continually improve their 
product lines and manufacturing processes to meet the ever-increasing stakeholder 
expectations (Lo et al., 2011). Consequently, the internationalization of economic 
activities and consumer preferences cause high-tech firms to become more strategic 
in pooling both internal and external R&D resources together through offshore 
outsourcing (Bertrand and Mol, 2013) or local collaborative networks (Bresciani and 
Ferraris, 2014); with the objective of producing multi-technological goods which 
attract huge export demand from international markets (Narula, 2004).  
 
Previous organisational studies have shown that knowledge creation and the 
assimilation of information through universities is significant for industrial innovation, 
as high-tech firms are well-known to develop and accumulate vital technological 
capabilities based on formal and informal modes of organisational learning 
(Belderbos, Carree and Lokshin, 2004; Czarnitzki, Ebersberger and Fier, 2007; 
Maietta, 2015; Thoma, 2017). The absorptive capacity of high-tech firms is their 
ability to access sources of valuable information and develop contractual 
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relationships that could be transformed into a set of exclusive rights on intellectual 
property which enriches the prospect of their survival; increases the likelihood of a 
sustainable stream of revenue; and fosters productivity and profitable expansion into 
new markets (Mowery, 2011). The increasingly complex, extremely expensive and 
highly interdisciplinary features of modern scientific activities have resulted in the rise 
of inter-organisational R&D collaboration (Teece, 1986); as a cost effective means for 
high-tech firms to access and exchange new knowledge, secure additional human 
capital, develop innovative methods, improve value network and enter into heavily 
regulated markets (Matt, Robin and Wolff, 2012); in order to benefit from the 
diversification of risks, transfer of scientific knowledge, enhanced market 
competitiveness, greater return on investment, better rate of survival, improved 
reputational status and brand recognition. 
 
Nanotech R&D collaborations embrace a multipurpose application of science that 
has radical innovations in processes, disruptive impact on existing industries and 
transformative effect in societies. In this research study, I concentrated on the key 
performance indicators of inter-firm R&D collaborations in nanotech industries across 
Europe; as nanotechnology is a highly intensive R&D science-based cluster 
(Mangematin and Errabi, 2012) with complex interdisciplinary characteristics 
(Schummer, 2004; Rijnsoever and Hessels, 2011) which promote multiple knowledge 
exchanges between scientists from different socio-economic backgrounds (Katz, 
1994; Kostoff et al., 2006) employed in multi-faceted research organizations (Heinze, 
2004; Cunningham and Werker, 2012) in both public and private sectors (Miyazaki 
and Islam, 2007) and across internationally regulated markets (Romig Jr. et al., 
2007). The antecedents to the successful commercialization of European nanotech 
R&D projects has been barely been covered in the literature (von Raesfeld et al., 
2012); hence, why I investigated the main internal factors which affects the innovative 
performance of nanotech firms across Europe; as they actively participate in a 
voluntary cooperative arrangement that is likely to facilitate the development of new 
innovative products and/or services through the exchange of technology and sharing 
of expertise with university partners (Huang and Chen, 2016).  
 
The motivation of this study was dependent on my inquisitiveness in understanding 
the extent to which factors under management control influences the different types of 
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innovative performance in nanotech R&D projects across Europe so as to provide 
corporate strategists with valuable information on the internal intricacies which 
expedite creativity, productivity and profitability in nanotech firms involved in R&D 
collaborations. My study focuses on evaluating the main internal determinants of the 
amount of patents, quality of new product development and level of profitability in 
collaborative partnerships of nanotech R&D projects across Europe. I looked 
intensely at the human capital, financial resources and inventive assets of nanotech 
firms; while controlling for their previous cooperative experience, duration of 
collaboration and VC participation. The main research question for my study is how 
do internal factors affect the innovative performance of nanotech R&D projects across 
Europe? My research objective is to provide nanotech managers of R&D projects with 
valuable knowledge on how the structural internal dynamics of collaborative 
partnerships affects the attainment of patents, new product development and 
profitability.  
I employed multiple regression analysis to evaluate the relationship between 
successful nanotech R&D projects and key performance indicator variables. I 
collected secondary data from Orbis and Zephyr databases as well as primary data 
from survey instruments in order to observe the internal dynamics of collaborative 
partnerships in nanotech R&D projects. The key contribution of my study is the 
evaluation of the impact of financial status, value network, organisational structure, 
absorptive capacity and partnership size on the innovative performance of nanotech 
R&D projects engaged in collaborative partnerships in Europe. I then conclude by 
ascertaining the core internal dynamics which corporate strategists and R&D project 
managers need to be aware of, so as to enhance a productive inter-firm collaboration 
that increases the competitive advantage of high-tech firm in the EU. More so, I 
conclude that since nanotech R&D activities are inherently complex and at times with 
uncertain outcomes, the onus on top managers of high-tech organisations is to 
design simpler and flexible governance mechanisms which builds the firm’s capacity 
to retain and integrate new knowledge and innovative techniques into existing 
corporate systems during periods of high financial positioning with the intention of 
maximizing technological productivity. In the following sections, I would present the 
theoretical framework, research methodology, empirical findings, discussion, and the 
conclusion of this research study. 
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3.2 Theoretical Framework  
3.2.1 SCIENTIFIC PRODUCTIVITY THROUGH RESEARCH COLLABORATIONS 
The convention among research communities for some years now has been 
collaboration due to the increasingly complex, very expensive and highly 
interdisciplinary features of modern scientific endeavour (Teece, 1986). Effective 
collaboration in science and technology is the meaningful cooperation of researchers 
in achieving a collective goal of creating and disseminating new scientific knowledge 
(Fiaz, 2013); which could be developed among individual researchers such as 
department/faculty groups; across public/private sectors such as university and 
industry cooperation; and between countries such as multi-national interdisciplinary 
research association (Ponomariov, 2013). It can be argued that collaboration among 
individual scientists from different research societies implicitly confirms and explicitly 
reinforces their belief in the virtues of universal validity as it fosters consensus and 
facilitates diffusion within the global scientific community (Lee and Bozeman, 2005). 
The prerequisite for a global diffusion of scientific knowledge is prevalent in the belief 
in collective rationality, wider dissemination, and intensive collaboration (Schott, 
1991). According to Katz (1994), the factors which promote collaboration among 
individuals within scientific communities are: changes in levels of funding; desire for 
visibility and recognition among researchers; increasing demand for the 
rationalisation of scientific manpower; rapid specialisation in science; and growing 
proliferation of science. Lee and Bozeman (2005) observes that the incentive for 
research collaborations among individual scientists are the rising costs of conducting 
experimental science; the availability of quick and avoidable transportation & 
communication facilities; the proliferation of scientific communities around the globe; 
the politicizing of research activities; and the strong demand for specialisation within 
the fields of science.  
 
The growth of scientific clusters in universities has led to the geographical 
concentration of research activities and the recurrent interactions between cluster 
members (Mangematin and Errabi, 2012); policy initiatives which seek to foster 
research collaboration in science and technology within socio-economic regions 
(Vecchiato and Roveda, 2014) have created several benefits such as the transfer of 
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new knowledge, skills and techniques; the cross-fertilisation of revolutionary 
concepts and innovative ideas; the provision of intellectual companionship and 
proprietary; and enhancing of the prominence of research work and technological 
advancement. Research collaboration is used not only as a robust predictor of 
publishing productivity but also as an important metrics for assessing the scientific 
performance of research organisations (Kostoff et al., 2007). Previous studies have 
shown that the amount of co-authorships in peer-review journals partially determine 
the extent to which valuable interaction among research entities could be measured 
(Smith, 1958).  
 
Figure 3.1: Hierarchical Accomplishments in University and Industry R&D 
Collaborative Partnerships for High-Tech Invention 
 
Source: This model was adopted from OECD’s National Innovation Systems 1997 future research 
recommendations for measuring innovative performance of R&D projects 
 
However, scientific productivity as a function of academic publications is profoundly 
different from industrial innovation because the former is primarily concerned with 
adding and diffusing new knowledge into the existing body of knowledge while the 
latter is more interested in adding to the streams of income from the exclusive rights 
of hoarding private information (Dietz and Bozeman, 2005). As a result of the 
commercialisation of academic research and the rise in academic entrepreneurship, 
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some research activities have been geared towards building strong collaborative 
value networks that are organised to acquire intangible intellectual assets which 
could further be developed into innovative products that could likely disrupt existing 
market structures or improve inefficient industrial systems; but ultimately try to 
generate an additional source of revenue for all stakeholders in a knowledge 
economy (Siegel and Wright, 2015).  
Figure 3.1 depicts the phases in which new knowledge is produced and 
commercially secured, then further developed into innovative product/service for 
market consumption. The scientific productivity to technological profitability model 
describes the hierarchical success levels of inter-organisational R&D collaborations. 
The active interaction between academic scientists and industrial researchers in 
developing innovative products in high-tech industries is critical to building 
comparative advantage in knowledge-based economy. The growth of academic 
entrepreneurs has led to the commercialization of novel concepts derived from 
scientific endeavours.  
 
3.2.2  INNOVATIVE PERFORMANCE FROM COLLABORATIVE PARTNERSHIPS IN HIGH-TECH 
INDUSTRIES 
Many government policies have strengthened the collaboration among university 
and industry in order to facilitate the transfer of technology and stimulate economic 
development (D’Este and Patel, 2007). These R&D cooperative partnerships usually 
produce innovative concepts which are intellectually protected by the European 
Patent Office since its inception in 1973 and by the Bayh-Dole Act of 1980 in the US, 
as it provides the legal basis for university scientists’ to obtain sets of exclusive rights 
for their inventions (Poyago-Theotoky et al., 2002; LaFlame, 2009). Institutionalizing 
cooperative engagement is quite challenging in high-tech industries due to the 
demand for new organisational structures, procedures and strategies (Todeva and 
Knoke, 2005). The survivability and success of companies operating in high-tech 
industries with highly complex and knowledge-intensive environment depends 
considerably more on collaboration rather than competition (Barbolla and Corredera, 
2009). University-industry partnership accelerates learning and innovation in R&D 
organisations (Carayannis, 1999), for the purpose of sharing knowledge and other 
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valuable resources in order to enhance existing or create new processes, products 
or services (Un and Asakawa 2015). Despite the numerous benefits, the major 
obstacle in this inter-organisational relationship is the convergence of the key 
objective of academia which is to proliferate and exchange knowledge through open 
sources and those of the industry which is to acquire and protect proprietary 
information for commercial profits (Steinmo, 2015). The conflict of interests in 
university-industry partnerships; as Ponds et al. (2007) observe is that scientists are 
keen on openly sharing scientific knowledge for wider dissemination and universal 
citation while corporate managers are eager to closely protect innovative information 
for commercial gains and competitive advantage.  
 
Patents provide reasonable inducements for scientists to embark on commercially 
profitable R&D projects which could be converted into strategic capabilities and core 
competencies for high-tech firms in knowledge-based economies (Huang and Chen, 
2016). These technological innovations upon been patented could be made known 
to the general public as per the security from the exclusive rights granted to the 
inventors. Also, high-tech firm managers are required to carefully evaluate the 
optimal strategy for securing trade secrets from internal R&D investments when 
acquiring new knowledge through collaborative partnerships, such that their 
competitive advantage is not diluted but enhanced (Torugsa et al., 2016).  
 
Besides, the major contributors to innovation in young high-tech companies are 
their external network contacts for collaboration and the level of R&D outlay (Keizer 
et al., 2002). Usually, the burdens of and complexities in carrying out R&D activities 
facilitates the use of external networks by high-tech firms in order to cultivate 
complementary resources which overcome uncertainties related to new technology 
development and circumvent innovation barriers due to limited human and financial 
resources (Zeng et al., 2010). External networks are explored to supplement for the 
internal R&D deficiencies in high-tech firms; customarily when economies of scale 
and/or scope could be achieved through the integration of trailblazing conceptions 
and know-hows (Mancinelli and Mazzanti, 2009). Once exclusive rights to an 
invention are specified, then the development of new products/services and their 
ensuing profitability becomes the focal mission of managers in high-tech firms 
(Torugsa et al., 2016). 
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Figure 3.2: Internal (and External) Factors that influence the Innovative Performance 
of High-Tech Firms in Knowledge-based Economies 
 
Analytical framework of the internal and external determinants of innovative performance 
 
 
In figure 3.2, I constructed a model that identifies the internal as well as the external 
determinants of commercially successful technological innovations from R&D 
collaborative partnerships in high-tech industries. In this study, I focus on three 
internal determinants of innovative performance based on the factors of scientific 
production: human capital, financial resources, innovative assets and excluding 
natural reserves. Managers of high-tech firms should also be aware of the external 
environment in which they operate in, so as to, identify potential opportunities and 
minimize likely threats to the profitability of new products been developed through 
R&D collaborations. The external factors which affect the innovative productivity of 
high-tech firms are: macroeconomic conditions, technological advancement, cultural 
dimensions, legal framework and proximity concerns (Islam et al., 2018).  
3.2.3  HUMAN CAPITAL FACTOR IN SUCCESSFUL R&D PROJECTS 
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3.2.3.1 Partner’s Size  
Rothwell and Dodgson (1991) argue that in an innovation process, small and 
medium-sized enterprises (SMEs) possess several behavioural advantages over 
large companies such as: efficient internal communication mechanisms, interactive & 
dynamic management systems and organisational flexibility in swiftly responding to 
external threats. Although, large firms enjoy some merits of their own such as: the 
ability to disseminate risk over a range of new products, ease in expanding 
operations to other regions and capability to fund long-term strategic R&D projects. 
When compared with large companies, SMEs are significantly unable to establish 
the most suitable external network of partners for collaboration. Kaufmann and 
Todtling (2002) observe that SMEs have smaller external relations than large 
companies which make them more confined to their local region because of the need 
to have direct interactions in tacit knowledge exchange. Large firms are far more 
likely to have cooperative relationship with the vertical partners (such as universities, 
research institutes and training centres) in their supply chain than SMEs. However, 
technology-driven SMEs are uniquely different in this regard.  
 
The inability of SMEs to engage in vast cooperative partnerships outside their 
business relations is due to the small number of employees capable of initiating and 
preserving network links. As far as external network relations are concerned, SMEs 
are focused more on developing regional partnership than multinational corporations 
(MNCs). Lindsay and Hopkins (2010) assert that it is very problematic for MNCs to 
pursue speculative opportunities and/or mitigate unestablished threats posed by 
disruptive innovations due to their cultural and structural impediments. Zeng et al 
(2010) argue that the access SMEs have to external resources and expertise from 
their cooperative partnerships provides stimulus for innovation. Harris (2000) argue 
that MNCs are faced with the onus of creating an organisational culture that 
embraces diversity in order to harness fully the skills and talents of all their 
employees. Bjorkman et al (2007) observe that MNCs have competitive advantage 
from their superior ability to transfer and combine competencies across 
geographically dispersed entities. Todeva and Knoke (2005) argue that MNCs are 
networks of intra and inter-firm cooperation which covers national orders and 
industrial sectors.  
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H1: The larger a partner’s size is in nanotech R&D collaboration, the greater the 
innovative performance the high-tech firm would experience. 
 
3.2.3.2 Strength of Value Network 
Allee (2008) observe that value network is a firm’s ability to convert tangible and 
intangible assets such as employee know-how, internal structures, company 
reputation, and business relationships into negotiable forms of value. Value network 
is a grid of interactions which create real and artificial wealth through multifaceted 
vigorous relationships between members of an enterprise system. Analysing the 
value network of a company is a treasured channel through which important 
information on cooperative opportunities is received and in turn influences the 
behaviour and performance of collaborations with partners (Gulati, 1998). One of the 
most significant environmental influences of an organisation is the key internal 
activities and external contacts in their value network (Powell and Smith-Doerr, 
1994). Management require collaboration within and across departments, 
organisations and industries to achieve key objectives of their firms (Bedwell et al., 
2012). Building trust-based relationships is critical for converting internal and external 
firm resources into transactional assets for commercial purposes; and it is the 
foundational dynamic in knowledge based economies (Taug, 2004). Members within 
a value network make full use of all their available resources by developing roles 
which add more value to existing assets in order to maximize shareholder wealth. 
The future success of firms is mostly dependent on the efficiency of its management 
in transforming strong and dynamic relationships and their intangible assets into 
marketable products and services (Allee, 2008).) An indispensable factor which 
affects the likelihood of a high-tech firm innovating successfully is its ability to 
efficiently meet or exceed customer expectations through value networking 
(Christensen and Rosenbloom, 1995). Therefore, in order to effectively alter the 
cognizance of a challenging condition and organise a collective action plan to 
enforce any transformation, the unidentified interactive movement which powers 
organisational procedures should be observed to produce prognostic management 
information about the uncertainties associated with innovative performance. 
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H2: The stronger the value network in nanotech R&D collaborations, the higher the 
level of success of high-tech firms in securing a patent, developing new products 
which become very profitable. 
 
3.2.3.3 Previous Collaborative Experience 
Collaborative experience in R&D projects involves the accumulation of 
organisational knowledge through inter-firm relations with multiple sets of partners 
and from the repeated association with certain partners over a period of time. 
Bruneel et al., (2010) observe that the factors that mitigate the obstacles to fruitful 
collaborations are: past collaborative experience, inter-firm trust and comprehensive 
interactive channels. Hoang and Rothaermel (2010) conclude that the internal 
exploration proficiency permits firms to leverage their external exploitation 
experience successfully. Simonin (1997) asserts that for previous collaborative 
experience to have a positive effect on new R&D partnerships, organisational 
knowledge has to first be internally developed by the firm and then properly 
managed to contribute to successful future collaborative outcomes. Hoang and 
Rothaermel (2005) argue that based on the theory of organisational learning, past 
collaborative experience influence the innovative performance of high-tech firms.  
Therefore, it is very essential for the management of high-tech firms to put in place 
an organisational learning arrangement which converts previous and continuous 
R&D collaborative experiences into organisational knowledge that could then be 
applied in future cooperative engagements (Simonin, 1997).  
 
H3: The longer the numbers of years in past R&D collaborative partnership coupled 
with an organisational learning structure which transforms firm’s experience into 
know-how, the higher the level of innovative performance nanotech R&D projects 
enjoy.  
 
3.2.3.4 Decentralised Organisational Structure  
The governance mechanisms for robust collaborative partnerships in inter-firm R&D 
projects require a decentralised command system which oversees large amount of 
funds and organises vast number of human capital in specialised framework that 
stimulates useful innovative engagements among all players (Scandura, 2016). 
Institutionalizing collaborative partnerships are extremely challenging because R&D 
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projects demands new organisational structure and procedure which is able to 
harness available resources in achieving agreed objectives (Contractor and Lorange, 
2002). Nanotechnology as an interdisciplinary field which requires a great deal of 
physical closeness among R&D partners using very complex instruments to develop 
innovative products and services through a decentralised system of governance 
which minimizes contingency risks (Steinmo and Rasmussen, 2016). The lack of a 
concentration of nanotechnology experts within a local scientific community in the 
past has created a situation where there is the need for international collaborations 
with a distributive organisational structure; in spite of the drawbacks from their 
geographical distance (Kabo et al., 2014). The geographical closeness positively 
influences the type of governance mechanism employed during an inter-firm 
collaborative partnership in nanotech R&D projects across Europe because 
developing a coherent organisational structure facilitates the attainment of initial 
objectives. The adoption of a decentralised chain of command in the organisational 
structure of collaborative partnership in nanotech R&D projects across borders are 
determined by a high level of geographical distance between actors involved, all 
other things being equal (Islam et al., 2018).  
Likewise, legal origins significantly affect the governance mechanism of 
collaborative partnerships in nanotech R&D projects. Particularly, countries with 
English common law origins positively influence the organisational structure of 
cooperative arrangement towards a decentralised or distributed chain of command 
due to flexibility of its legal system and the adaptability of judge-made law. A 
country’s cultural behaviours concerning tolerance for uncertainty & ambiguity and 
women’s equality affects the way nanotech R&D projects are managed so as to 
ensure that new product development are successful. Islam et al. (2018) asserts that 
a positive but weak relationship exist between a nation’s tolerance level for 
avoidance and the governance mechanism used to supervise and monitor nanotech 
R&D projects such that a high tolerance level increases the possibility of having a 
decentralised chain of command and thereby  more innovative new products. Also, 
economic growth has a positive impact on the governance mechanisms in 
collaborative partnerships of nanotech R&D projects. The availability of economic 
opportunities during boom times provides the tendency for organisational structure 
with a decentralised or distributed system of governance which fosters innovative 
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engagement among collaborative partnerships. The control structure of collaborative 
projects could take different forms but as Kogut (1991) suggests, it used be a 
platform where high-tech firms could explore business uncertainties and devise 
strategies to take advantage of opportunities in a fast growing and diverse market.  
 
H4: The more decentralised and distributive system of governance in collaborative 
partnerships of nanotech R&D projects is, the greater the innovative performance. 
 
3.2.4 Financial Indicators of the Innovative Performance of High-Tech Firms 
3.2.4.1 VC Fund Participation 
Venture capital (VC) could be defined as an independent, professionally managed, 
dedicated pools of capital that focus on equity or equity-related investments in 
privately held, high growth companies (Gompers and Lerner, 2001). Venture capital 
funds are a collective investment scheme used in making investments in various 
portfolio companies. A large portion of the global VC industry operations can be 
attributed to the entrepreneurial spirit prevalent in the United States. Also, the access 
OECD countries have to efficient capital markets, skilled workforce, effective 
intellectual property protection and sophisticated research facilities enhance their VC 
activities and performance (Djankov et al., 2008). VC plays a vital role in building a 
vibrant private sector through the channelling of funds to young entrepreneurs 
unable to access seed capital from banks due to their very low appetite to finance 
unproven business ventures and industries (Ewing, 2004). VC investments are 
highly essential to EMEs due to: knowledge transfer through partnerships; high 
liquidity which facilitate sustained economic growth; employment generation and 
youth empowerment; and the identification and funding of winning firms and ideas.  
VC participation has a negatively impact on the governance structure of 
collaborative partnership as these specialist financiers seek to gain a controlling 
interest in nanotech R&D projects which in turn could lead to a centralised chain of 
command that stifles innovative engagement among partners. Similarly, VC 
participation increases the possibility of short term duration and a strong value 
network during collaborative partnership in nanotech projects due to the specialised 
services provided by venture capitalists such as monitoring, industry affiliations, 
financial resources, etc. and their emphasis on timely divestments. Also, the 
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likelihood of a long term collaborative partnership in nanotech R&D project depends 
on strong value network but reduces partnership size and vice versa. The existence 
of VC funding in nanotech R&D projects gives indications that there is significant 
commercial opportunities available and also a substantial entrepreneurial prowess 
prevalent in such collaborative partnerships. 
 
H5: The higher the level of VC funding in nanotech R&D project, the greater the 
innovative performance of the collaborative partnership. 
 
3.2.4.2 Financial Positioning 
One of the financial resource influencers in developing innovative and profitable 
products by nanotech firms is the financial status… 
Todeva and Knoke (2005) observe that the level of collaboration in inter-firm 
partnership is affected by the companies’ long term objective of stakeholder wealth 
maximization as well as their past economic rationalities. In order words, when 
creating an organisational network or contractual agreement, the major factor which 
significantly influences the nature and extent of cooperation is the long term solvency 
and profitability of both companies. 
 
H6a: The higher the solvency ratio in nanotech R&D firms, the greater the 
innovative performance from their collaborations. 
H6b: The higher the liquidity ratio in nanotech R&D firms, the greater the innovative 
performance from their collaborations. 
H6c: The higher the profitability ratio in nanotech R&D firms, the greater the 
innovative performance from their collaborations. 
 
3.2.5 Innovative Asset Determinant of Commercially Profitable Consumer Products  
3.2.5.1 Absorptive Capacity 
Lane and Lubatkin (1998) define absorptive capacity as the ability of the firm to 
value, integrate and exploit new knowledge from external sources. The conventional 
measure for absorptive capacity is the R&D intensity (Lichtenthaler, 2016). Lindsay 
and Hopkins (2010) further argue that the use of intellectual asset strategies in 
preserving opportunities for or avoiding threats from disruptive innovations is critical 
to the survival of large corporations because of the most likely loss in their market 
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position. According to Lindsay and Hopkins (2010), patents and other intellectual 
property should be used to meet the needs of low-end and prospective customers.  
Lindsay and Hopkins (2010) further argue that there are legitimate financial 
considerations for supplementing patents with publications.  
 
H7: The higher the absorptive capacity in nanotech R&D firms, the greater the 
innovative performance from their collaborations. 
 
3.2.5.2 R&D Intensity 
Littler et al (1995) argue that companies team up in R&D projects: to share the 
burden in satisfying customer needs, to explore opportunities in the market place, to 
counter technological changes, and reduce costs & risks associated with new 
product development. An innovative asset for successful collaborative partnerships 
in nanotech industries is vital tool for acquiring external technological know-how has 
been through the outsourcing of R&D activities (Grimpe and Kaiser, 2010). 
According to Bougrain and Haudeville (2002), R&D intensity does not severely 
influence the chances of a successful innovative project. The global exploitation of 
science and technology by MNCs better describes the much greater growth rate of 
international patent applications. Hoang and Rothaermel (2005) find that the 
collaborative experience of biotechnology partners significantly and positively 
influences the innovative performance of R&D projects. 
 
H8: The higher the research intensity in nanotech R&D firms, the greater the 
innovative performance from their collaborations.  
 
3.3 Research Design 
I used mixed research method to systematically evaluate the internal intricacies 
that influence the performance of collaborative partnerships in nanotech R&D 
projects. Figure 3.3 shows the research outline of this study – the conceptual 
framework is based on theories which provide the foundation for constructing and 
testing my hypotheses in order to produce empirical results on the extent to which 
the internal factors affect the success of inter-firm collaborations in nanotech R&D 
projects across Europe.  
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Figure 3.3:   Research outline of the study 
 
 
 3.3.1  Data 
The collaborative R&D projects in my data sample involve various characteristics of 
nanoscience and nanotechnologies such as the development of nanotubes and 
nanowires for electrical and biological consumption plus the use of nanoparticles and 
the construction of nanoinstruments for manufacturing and communication purposes. 
Specifically, these nanotech R&D projects include but not limited to: electrical 
discharge machining, multi-component injection moulding, electroforming, powder 
injection moulding, nanoimprinting, x-ray lithography, selective laser sintering, 
chemical vapour deposition, nanometer scale measurement and future tooling 
technology. 
I adopted mixed research method where both quantitative as well as qualitative 
data were used to enrich the process of data collection and analysis. I collected 
secondary data on the organisational size, number of patents, VC participation and 
industry and academic links to nanotech R&D projects from Orbis database of 
Bureau van Dijk (BvD). Also, I collected from World Bank database, the annual GDP 
growth rates in the period of the nanotech R&D collaboration. Due to insufficient 
quantitative data on collaborative dynamics of nanotech firms, I used survey 
instruments to generate interview and questionnaire data on geographical proximity, 
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governance mechanism, strength and duration of partnership; the responses were 
then coded into ordinal observations. I conducted 30 interviews with top executives 
of nanotech firms and provided 97 questionnaires to senior administrators of 
nanotech R&D projects across 12 European countries. 
3.3.2 Dependent variable(s) 
The key variables of interest in my study are three features of inter-firm innovative 
performance namely: acquiring intellectual property rights to an invention, developing 
a new product(s) which are commercialised and achieving profitability within five 
years during collaboration in nanotech R&D projects. The main dependent or 
response variable in my study is the number of patents secured during cooperative 
partnerships; the number of total patent(s) in a distinct nanotech R&D project. I also 
developed two other dependent variables in order to consider the other success of 
collaboration in nanotech R&D projects. The second dependent variable is the 
number of new products developed in the collaborative partnerships of nanotech 
R&D projects. The third response variable is the profitability of the R&D collaboration 
with groupings into low, medium and high levels of profit margins.  
3.3.3 Independent variable(s) 
While, the independent or explanatory variables varies depending on the different 
models used in my study and is considered to be the determinants of innovative 
performance for the collaborative partnerships in nanotech R&D projects based on 
my theoretical framework. Among the internal factors that help explain the variations 
in the innovation and financial performance of collaborative partnerships include: 
financial positioning (profitability, liquidity, and solvency ratios); human capital 
(dummy for previous collaboration experience, strength of the value network, the 
type of governance mechanism and partners size); and innovative assets (the R&D 
intensity ratio and a dummy for the absorptive capacity). The external factors 
constitute the average economic (GDP) growth rate; the geographical proximity; the 
legal origin index and dummies for industry affiliations (biotech and I.CT.). 
3.3.4 Control variable(s) 
I controlled for academic affiliations and venture capital participation in nanotech 
R&D organisations, using dummy variables. The number of patents held before the 
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R&D collaborative partnerships are also used as a proxy of determines for financial 
performance. This would help me better understand the effects of my independent 
variables on the observed variable.  Table 3.1 shows the dependent, independent 
and control variables in my models and their likely effects on the collaborative 
structure of nanotech firms. 
 
Table 3.1:  Key Variables, Expected Relationships and Brief Description 
S/N Variables Effects Description 
1 Size of  
Partnership 
+ The total number of partners in a collaborative R&D 
project. 
2 Governance 
Mechanism 
+ The type of organisational structure (coded 1-3 from 
centralised to distributive to decentralised). 
3 Absorptive  
Capacity 
+ Dummy variable (1) for the existence of a knowledge 
bank for IP & NPD in R&D project and (0) otherwise. 
4 Geographical 
Proximity  
+ The geographical nearness to industrial partners – 
i.e. (1-4) international, national, regional, & local 
closeness. 
5 French Civil Law _ Dummy variable for (1) legal origins with French Civil 
(0) otherwise. 
6 English Common 
Law 
+ Dummy variable for (1) legal origins with English 
Common law (0) otherwise. 
7 Venture Capital 
Participation 
+ Dummy variable for VC fund manager’s participation 
in nanotech R&D projects 1 and otherwise 0. 
8 Strength of 
Value Network 
+ Level of Vertical & Horizontal Integration in nanotech 
R&D collaborative partnerships from survey 
observations.   
9 New Products 
Developed 
+ The number of new products developed due to R&D 
collaborations in nanotech industry.  
10 Patents + Number of patents secured due to R&D 
collaborations in nanotech industry.  
11 Technological  
Advancement 
+ The country’s average export demand for high-tech 
products in the period of R&D collaboration. 
12 Academic  
Affiliation 
+ Dummy variable, (1) for academic involvement in 
nanotech R&D projects and (0) for otherwise. 
13 
 
Economic 
Growth 
+ The average rate of annual GDP growth during the 
period of R&D collaboration. 
14 Duration of R&D 
Collaboration 
+ Dummy variable, (1) for University-Industry R&D 
Collaboration and (0) for otherwise.  
15 Biotechnology 
Industry 
+ Dummy variable, (1) for nanobiotechnology type of 
R&D projects and (0) for otherwise. 
16 I.C.T Industry + Dummy variable, (1) for nano-ICT type of R&D 
projects and (0) for otherwise. 
17 R&D Intensity + The percentage of R&D investments divided by the 
nanotech firm sales revenue.  
18 Solvency + Solvency rations from nanotech organisations 
involved in R&D collaborations. 
19 Liquidity + Liquidity rations from nanotech organisations 
involved in R&D collaborations. 
20 Profitability + Profit margins in nanotech organisations involved in 
R&D collaborations. 
Sources: Orbis, Zephyr, FAME, Preqin, World Bank Open Data, IMF Data, and La Porta et al (1999) & 
Hofstede (1994) Indexes. 
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3.3.5 Multiple regression models (OLS) 
Since collaborative partnership can be observed in several ways, I developed three 
regression models which are aimed at incorporating the different forms of 
collaboration in nanotech R&D projects. In this research study, I adopted three 
different performance attributes of collaborative partnerships in terms of its patents, 
new product development and profitability. I use multiple linear regression models to 
derive OLS estimates which minimize the squared residuals of best fit. I specify my 
initial regression models for this research study in the equation 1 below: 
𝛾𝑖 =  𝛽0 + 𝛽1𝑋1,𝑖 + 𝛽2𝑋2,𝑖 + ⋯ + 𝛽𝑘𝑋𝑘,𝑖 + 𝜀𝑖            𝑖 = 1,2 … 𝑛 
Where γ is the response variable for the ith observation which is the size of 
collaborative partnerships in all 97 R&D projects; β0 is the constant or intercept 
which depicts the relationship that exists without the inputs of my explanatory 
variables. β1 to βk are the parameters and Ҳ1 to Ҳk are the coefficients while ε is the 
error term which describes the random element of the linear relationships between 
explanatory and response variables.  
 
3.4 Results 
In this section, the findings of the regression models are presented. Descriptive 
statistics and the correlation matrix are presented in Table 3.2 and the multiple and 
logistic regression models are presented in Table 3.3. 
3.4.1 Descriptive statistics 
In Table 3.2, the mean and standard deviation depicts the measures of central 
tendency and dispersion of my dataset.  
3.4.2 Inferential statistics 
In this study, I presented three different performance attributes of collaborative 
partnerships in terms of its patents, new product development and profitability. In 
Model 1, I focused on the factors which determine the innovation performance of 
nanotech R&D organisations; using the number of total patents secured in a distinct 
nanotech R&D project, as a proxy for innovation performance. In Model 2, I focused 
on the determinants of new products developed in the collaborative partnerships of 
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nanotech R&D projects; using the total number of new product developments in a 
distinct nanotech R&D project, as another proxy for innovation performance. And in 
Model 3, I concentrated on the influencers of the financial performance of nanotech 
R&D organisations; using the levels of profit margin in a distinct nanotech product or 
service.  
Table 3.2:   Descriptive statistics and correlation matrix 
 
Table 3.2 depicts the mean, standard deviation and correlation matrix 
Variables
Mean
Std. Dev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
1
Patents
2.079107
0.7563398
1
2
English Common Law
3.261364
0.9528459
-0.0574
1
3
Size of Partnership
1.875
0.7847225
0.202
0.2026
1
4
Absorptive Capacity
16.9696
5.903146
-0.0236
0.0421
-0.0155
1
5
VC Participation
0.2061856
0.4066669
0.1563
-0.3195
0.063
0.252
1
6
Strength of Value Network
0.0343229
0.1427487
0.3861
0.0082
0.1
0.0198
0.1105
1
7
New Product Development
0.6591614
8.335254
0.1419
-0.0045
0.0104
0.1043
-0.0626
-0.2386
1
8
Profitability
1.255989
7.886193
-0.0217
-0.0775
0.0323
0.2635
0.1082
0.6214
-0.2355
1
9
Liquidity
0.0481982
0.241778
-0.1763
0.0702
-0.0053
0.3855
-0.0115
-0.2181
0.0191
0.0925
1
10Solvency
0.7438308
1.521452
-0.2878
-0.0139
-0.1326
-0.4072
-0.2871
-0.1052
0.6618
-0.1007
-0.1228
1
11Previous Experience
3.247423
0.8295447
-0.0784
0.0018
0.4318
0.0441
0.0255
-0.058
0.0128
-0.0947
0.1291
-0.0233
1
12Governance Mechanism
2.175258
0.841753
-0.0885
-0.136
0.2129
-0.0171
0.3246
-0.1179
0.2566
-0.0326
-0.2369
0.2523
0.0849
1
13Geographical Proximity
1.814433
0.6820603
0.0255
0.0939
-0.4166
-0.115
-0.1412
0.0683
0.0783
0.0454
-0.1376
0.1076
-0.7247
-0.246
1
14Duration of R&D Collaboration
3.010309
1.015452
0.1135
0.2433
0.3361
-0.0585
-0.1672
0.2
-0.1308
0.0034
0.0988
-0.1073
0.182
-0.34
-0.106
1
15Biotechnology Industry
0.0103093
0.1015346
-0.1746
0.1055
-0.1568
0.1725
-0.0747
-0.1772
-0.0231
-0.0466
0.0093
-0.0684
-0.0664
0.1206
0.0599
-0.053
1
16I.C.T Industry
0.1134021
0.3187308
0.2117
0.1212
0.0343
0.0531
-0.1733
0.0242
0.2009
-0.0464
0.2495
0.0749
0.128
-0.0808
-0.063
0.1444
-0.0407
1
17Academic Affiliation
0.0309278
0.1740216
-0.0493
-0.1342
-0.1013
0.1143
0.1142
-0.0996
-0.0362
0.0037
0.3052
-0.0997
0.0499
0.1721
-0.069
-0.0756
-0.025
-0.058
1
18Economic Growth Rate
4.1874845
8.1154894
-0.0388
-0.1426
0.2395
0.0727
-0.4836
-0.2337
0.5093
0.1933
-0.0775
0.0323
0.1135
0.1958
0.0323
0.2433
0.1082
-0.32
-0.078
1
19French Civil Law
2.5468987
5.15184
-0.0939
0.6226
0.0191
-0.1051
-0.3301
0.0058
-0.304
-0.6232
0.0702
-0.0053
-0.1746
0.0424
-0.005
0.1055
-0.0115
0.032
0.1212
0.0242
1
20Export Demand for High-Tech
29.1584
4.71239
0.2521
-0.193
-0.0081
0.0121
0.2496
0.0112
0.1481
0.0557
-0.0139
-0.1326
0.2117
0.3591
-0.133
0.1212
-0.2871
0.193
-0.134
-0.1
0.3361
1
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Table 3.3:     Multiple Regression Coefficients for Nanotech R&D Projects 
 (Model 1) (Model 2) (Model 3) 
 Intellectual 
Property 
New Product 
Development 
Long-Term 
Profitability 
English Common Law -0.0365   
 (-0.65)   
Partner’s Size -0.0335 1.508* -0.667 
 (-0.36) (2.20) (-1.94) 
Absorptive Capacity -0.0812*** 0.870*** 0.911*** 
 (-6.19) (10.91) (12.15) 
VC Participation -0.0930 1.617 -1.729** 
 (-0.63) (1.41) (-3.33) 
Value Network 2.792*** -21.86*** 8.402** 
 (6.12) (-4.89) (3.12) 
NPD 0.0943***  -0.831*** 
 (9.25)  (-9.76) 
Profitability -0.00517 -0.0713  
 (-0.65) (-1.13)  
Liquidity 0.0873 -2.394 3.032* 
 (0.25) (-0.85) (2.50) 
Solvency -0.575*** 5.838*** 4.376*** 
 (-9.07) (18.32) (8.28) 
R&D Intensity 
 
0.325 
(0.07) 
0.243 
(0.09) 
0.137 
(0.04) 
Previous Experience -0.246* 1.014 -0.110 
 (-2.14) (1.15) (-0.26) 
Govt. Mechanism -0.0165 -0.481 0.425 
 (-0.19) (-0.68) (1.43) 
Geographic Proximity -0.266* 2.315* 0.302 
 (-2.07) (2.21) (0.61) 
Duration -0.0258 -0.457 0.285 
 (-0.30) (-0.77) (1.19) 
Biotechnology -0.0737 0.228 -3.167* 
 (-0.18) (0.07) (-2.39) 
ICT 0.242 0.684 -1.126 
 (1.24) (0.40) (-1.50) 
Academia -0.0235 1.566 0.604 
 (-0.08) (0.62) (0.60) 
GDP Growth  4.420  
  (1.11)  
Intellectual Property   7.029*** 4.283*** 
  (9.89) (5.59) 
French Civil Law -0.0414   
 (-0.78)   
Constant 5.220*** -39.91*** -26.44*** 
 (7.23) (-7.20) (-7.30) 
Observations 
Adjusted R2 
58 
0.7585 
63 
0.8929 
55 
0.9515 
The p-value is in parenthesis and the statistical significance is ***1%, **5% & 10%. 
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The multiple regression results show that the innovation and financial performance 
of collaborative partnerships in nanotech R&D projects are significantly affected by 
certain internal factors namely: the absorptive capacity, strength of value network, 
level of solvency and liquidity, size of partnership, and previous experience in R&D 
collaborations. Also, nano-biotechnology alliances and the geographical proximity 
influence the commercial success of collaborative partnerships in nanotech R&D 
projects. I find that the most important internal determinants of nanotech R&D firms 
is its ability to recognise and acquire external knowledge for useful applications in 
order to successful develop nano-products which have long term profitability.  
More so, I find that the strength of the value network of the collaborative 
partnerships in nanotech R&D projects positively influence the attainment of patents 
and long term profitability but negatively affects the development of new products. I 
also find that the larger the collaborative partnership size, the greater the 
development of new products. The results show that the geographical distance in 
nanotech R&D collaborative partnerships negatively affect the acquisition of patents 
but positively influence the development of new nanotech products. Successful R&D 
collaborations in nanotech organisations reliant on highly skilled scientists which 
operate on very complex instruments that require some level of proximity in order to 
enhance productivity within a stated period of time.  
 
3.5  Discussion and Implications 
In this section, I would identify possible opportunities and challenges for policy 
makers and organisational strategists to exploit or guard against; in order to enhance 
various dimensions of collaborative partnerships within the nanotech R&D projects.  
3.5.1 Human Capital 
A large number of partners in nanotech R&D collaborative partnership provide a 
bundle of diversification benefits which influences the creativity and productivity in 
R&D projects. However, large partner’s sizes in R&D collaborations only facilitate the 
development of new products and do not significantly affect the securing of patents 
or the profitability of newly developed products. It means that R&D project managers 
or organisational strategists must focus on unique procedures which integrates each 
aspect of the collaborative partnership in such a way that all parties involved are 
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required to understand and appreciate the legal and commercial external dimensions 
of the R&D project so that early profitable opportunities are identified, legal barriers 
are mitigated, intellectual property rights are secured and future market trends are 
recognised and exploited. 
The value network of a collaborative partnership in nanotech R&D projects is 
considered to be very strong when it is deeply integrated vertically and horizontally 
from their supply-chain in order to meaningfully enhance the innovative performance 
of R&D projects. However, a strong value network does not necessarily mean that 
new products will be developed because of the complexities in nanotechnology 
production. Nonetheless, R&D project managers are required to maximize human 
resources in a way that circumvents the challenges and riskiness of developing new 
products which are safe and viable in the market place. This would require having a 
structural procedure in place which seeks to facilitate timely interactions among all 
partners in such a way that the conceptualisation of new products are harmonised at 
inception and strategically evaluated by top managers so that adequate resources 
could be channelled into the development of these new products on time.   
Previous experiences provide ample ammunitions to R&D project managers in the 
form of collaborative knowledge. Having an awareness of what to look out for and 
guiding against common pitfalls are some of the advantages of obtaining useful 
previous experiences in R&D collaboration. However, R&D project managers should 
be mindful of the fact that previous experience is only a guide and do not necessarily 
affect future R&D collaborations. This means that old organisational procedures and 
strategies should be moderated to accommodate new types of partners and new 
ways of collaboration to maximize the contributory effects on the innovative 
performance of nanotech R&D projects. It must be emphasized that adequate 
documentation of previous collaborative partnerships is imperative because of the 
need for constant referrals on what works or on what should be avoided. 
3.5.2 Financial Positioning 
A high financial position or status of nanotech firms equips R&D project managers 
with sufficient tangible and intangible resources to engage into complex collaborative 
partnerships which yield innovative performing outcomes. In order words, a highly 
profitable, solvent and liquid nanotech firm would be able to form large collaborative 
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partnerships with international reach so as to coordinate useful networks which are 
more likely to contribute significantly to the development of new products during R&D 
collaborations. The presence of a financially stable nanotech firm in collaborative 
partnerships provides implicit guarantees and explicit endorsements that the R&D 
projects would likely succeed due to the availability of additional resources which 
could be deployed if needed. For instance, a high solvency in nanotech firms creates 
a huge valuable financial position which is able to ensure initial funding from long-
term reserves and relative stability in R&D operations during constricting economic 
periods and in times of rising unexpected litigation costs.  
Also, financial institutions and government agencies are willing to participate in the 
funding of nanotech R&D projects when the firms in collaborative partnerships have 
serviceable debt levels which do not bring additional economic liabilities or legal 
constraints. Nanotech firms with evidence of strong past financial performance in 
terms of profitability and liquidity are placed on a higher status during negotiations as 
weaker or smaller new partners are happy to make some concessions in other to be 
part of an exclusive R&D project which has a good chance of success. In general, 
some financial performance indicators could provide a significant insight on factors 
that influence the innovative performance of R&D projects. The presence of VC 
funding in collaborative nanotech R&D projects means that a much specialised 
financial expert would provide useful counsel on the most commercially viable path 
to pursue in the quest to create an innovative product which meets profitable 
consumer needs because of the active participation and strong influence VC fund 
managers usually obtain through contractual obligations.  
3.5.3  Innovative Assets 
Innovative assets are considered as a main determinant of innovative performance 
in R&D projects (He and Wang, 2009). The ability of a nanotech firm to retain 
previous knowledge and integrate it into their current operating system means that 
new external knowledge would likely be efficiently managed to stimulate innovative 
outcomes because the best industry practice and successful previous processes 
would be adopted effectively to take advantage of key business opportunities which 
enhance the innovative performance of nanotech R&D projects. A critical issue here 
could be developing a governance mechanism which provides nanotech R&D project 
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managers with a reasonable level of discretion in making key resource reallocation 
decisions and gives their financial sponsors adequate monitoring tools to reduce 
information asymmetry.  
3.5.4  Industry and Academic Affiliations 
Also, industrial affiliation could provide commercial opportunities for innovative 
nanotech R&D projects due to the conglomeration of specialist high-tech firms in 
different pioneering sectors. I argue that the absence of institutional diversity 
impedes on the overall ability of the collaborative partnership to maintain a steadfast 
development of new and innovative products or secure exclusive rights to an 
intellectual property. Biotechnology organisations are usually bombarded with stricter 
regulatory requirements which increase the complexities in collaborative 
partnerships for nanotech R&D projects and usually lead to delays in securing 
patents or developing a new product. Whereas, academic affiliations in whichever 
field can simplify nanotech R&D projects due to emphasise on open sources and 
established methodologies which are easily verifiable by regulatory authorities. 
3.5.5 Legal Origins 
Nanotechnology is an emerging technology that has few laws which regulate its 
industry. The French and German legal systems provide a greater level of flexibility 
for securing patents and higher scale of predictability for estimating litigation 
outcomes; which makes it appealing to more nanotech R&D collaborative 
partnerships because there is little regulation restricting the nature and scale of 
research exploration and  commercial exploitation or which could pose a huge threat 
and possibility of large losses, as opposed to the English common legal system, 
where there is an inherent rule to have minimum standard of care. The negative 
effects of nanotechnology highlight the need for a thorough risk assessment to be 
carried out along with the pace of vast commercial developments. It is imperative for 
nanotech firms in common law countries to take into consideration the additional cost 
required to make available to the public risk assessments about the possible effects 
of their R&D projects in order to enhance public awareness and reduce the general 
tolerance for uncertainties associated with nanotechnology.  
3.5.6 Proximity 
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Despite the advancements in information and communication technologies (ICT) as 
well as the free movement of capital and labour across Europe, the geographical 
distance still matters greatly in determining the innovative performance of 
collaborative partnerships in nanotech R&D projects. The spatial nearness among 
scientists negatively influences the securing of intellectual property rights but 
positively affects the development of new products and service in nanotech R&D 
projects (Knoben and Oerlemans, (2006). Nanotechnology as an interdisciplinary 
field which requires a great deal of physical closeness among R&D partners using 
very complex instruments to develop innovative products and services through a 
decentralised system of governance which minimizes contingency risks (Steinmo 
and Rasmussen, 2016).  
The lack of a concentration of nanotechnology experts within a local scientific 
community in the past has created a situation where there is the need for 
international collaborations with a distributive organisational structure; in spite of the 
drawbacks from their geographical distance (Kabo et al., 2014).  However, proximity 
that relates to the nearness of partners in terms of their operations and area of 
specialty during the R&D collaborations should be the focus of management. The 
quality of the value network are strengthened when there were substantial division of 
labour and clearly defined roles which enable partners uniquely contribute into the 
nanotech R&D project; within a strategic time frame that seeks to attain specified 
commercial objectives. A strong value network and a long-term R&D collaboration 
among nanotech firms are more likely to be negatively affected if there are high 
levels of functional closeness within the partnership.  
3.5.7 Cultural dimensions 
Cultural value do not easily change in the short run and is usually passed from one 
generation to another; making it expedient for policy makers and corporate 
strategists interested in nanotech R&D collaborations to understand the possible 
implications and predictable behaviours relating to risk tolerance, procedural 
controls, and adherence to norms within a community that they operate in, so as to 
promote discussions that alleviate unproven claims, improve negotiating processes, 
and reduce litigation costs (Hong, Heikkinen, and Blomqvist, 2010). The level of 
tolerance for uncertainty within a nation reveals her cultural attitude towards risks 
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and ambiguity (Sriwindono and Yahya, 2012). Countries which have high uncertainty 
avoidance indicators are more likely to have a rigid belief system that could be 
intolerant of unorthodox and risky behaviours due to the fact that the majority of 
people with such cultural values are sensitive to, and feel uncomfortable with 
unstructured or changeable environments.  
However, countries with low uncertainty avoidance indexes evince that members of 
a society are more likely to be forbearing towards ambiguous or uncertain R&D 
ventures because they are entrepreneurial in nature and are likely to feel 
comfortable in risky and less structured environments. In these countries, nanotech 
R&D project managers can take advantage of the politically active and very informed 
population, by making quick decisions which exploit innovative concepts. A high 
proportion of female involvement in science and technology within a country would 
more likely increase the strength of value networks and reduce the time period of 
collaborative partnerships in nanotech R&D projects. Whereas a more dominant 
male presence usually leads to ego oriented inter-firm relationships which promote 
fierce competitions and focus on profit maximization, irrespective of the impact on 
the external environment. 
3.5.8 Economic growth 
Periods of economic growth positively affects the innovative performance of 
collaborative partnerships in nanotech R&D projects as a result of the availability of 
several funding prospects, the prevalence of commercial opportunities and the rise in 
labour participation. In knowledge-based economies, the expansion of economic 
activities usually leads to a rise in R&D expenditures. Most universities normally 
obtain huge funds from research councils and industry partners to finance their R&D 
projects with the aim of building innovation centres and fostering regional economic 
development (Bilbao-Osorio and Rodriguez-Pose, 2004; Guerrero, Cunningham, and 
Urbano, 2015).  
University-Industry collaborative partnership is a key ingredient that stimulates 
productivity in innovative ventures (Jong and Slavova, 2014) and accelerates the 
growth of economic activities in advanced countries. An increase in the external R&D 
activities of high tech firms has resulted in the rapid rise of inter-organisational 
relationships which lead to patent licensing agreements and the development and 
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production of new products. The commercialization of R&D activities via university-
industry collaborative partnerships has brought not only economic development but 
also the technological advancement of nations due to the international demand for 
their high-tech products which is usually an emerging or disruptive know-how. 
Having exclusive rights to an innovative product in the form of a patent provides 
nanotech firms with the required protection for their intellectual property and 
encourages more R&D projects in the future. 
3.5.9 Technological advancement 
As a result of globalisation, many countries have been able to unlocked localised 
industries by taking advantage of new and existing export opportunities for high-tech 
products and services around the world (Mehta, et al. 2012). Most barriers and 
challenges in international commerce have been alleviated by world trade 
organisation as advanced nations and large corporations are able to attract high 
skilled labour and sophisticated investments into emerging and disruptive industries 
to provide technologically advanced products and services for worldwide 
consumption. The export demand for high-tech products evinces the level of 
technological advancement in a country. Most MNCs have their internal R&D 
capabilities at their headquarters and many external R&D projects are organised in 
their home country. Nanotech firms that operate in technological advanced nations 
are more likely to sell their newly developed innovative product to international 
markets; and also more likely to have a shorter time period in collaboration due to 
their centralised governance mechanisms and comprehensive value networks. 
3.6 Conclusion 
Collaboration in high-tech R&D projects usually involves huge funds and expertise 
which divert strategic resources away from internal R&D investments. However, 
most large high-tech firms deliberately seek to capitalise on economic opportunities 
from their existing portfolio of intellectual properties in order to take advantageous 
position in negotiations and strengthen their bargaining chips for cross-licensing 
other patented technologies. The bundle of diversification benefits which a large 
number of partners provide in a high-tech collaborative partnership influences the 
scientific productivity and innovative performance in nanotech R&D projects. For 
instance, the existence of a financially stable and profitable high-tech firm in 
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collaborative partnerships provides implicit guarantees and explicit endorsements 
that such R&D projects would likely succeed due to its accessibility to additional 
resources which could be deployed to ensure support and provide some valuable 
liquidity for R&D operations during periods of economic decline and unexpected 
litigation costs.  
Also, large high-tech firms usually employ intellectual properties as a strategic 
instrument to stifle competition. Globalisation has helped many countries to unlock 
localised industries by taking advantage of new and existing export opportunities for 
high-tech products across the globe. Advanced nations and large corporations are 
able to attract high quality human capital and sophisticated investments into 
emerging and disruptive industries to provide technologically advanced products and 
services for worldwide consumption. The value network of a collaborative 
partnership in nanotech R&D projects is strong when it is intensely incorporated 
vertically and horizontally from their supply-chain in order to meaningfully enhance 
the innovative performance of R&D projects. However, a strong value network does 
not necessarily mean that new products will be developed because of the 
complexities in nanotechnology production. Institutionalizing collaborative 
partnerships are extremely challenging because R&D projects demands new 
organisational structure and procedure which harness available resources to achieve 
set objectives.  
As a discontinuous innovation-based technology, nanotechnology has few laws 
which regulate its industry, requires highly skilled scientists from different disciplines 
to work in close proximity and operate on very complex instruments in order to 
create innovative new products within a specified period of time. Nanotechnology as 
an interdisciplinary field which requires a great deal of physical closeness among 
R&D partners despite the advancements in ICT as well as the free movement of 
capital and labour across Europe. Legal systems which provide a greater level of 
flexibility for securing patents and higher scale of predictability for estimating 
litigation outcomes; are likely to be more appealing to nanotech R&D project 
managers because there is little regulation restricting the nature and scale of 
research exploration and commercial exploitation or which could pose a huge threat 
and possibility of large losses.  
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Universities that involve in discontinuous innovation-based R&D projects have 
specialised interdisciplinary centres which are capable of collaborating with more 
industrial partners because of their reliance on additional financing to. Patents and 
other intellectual property should be used to meet the needs of low-end and 
prospective customers.  In addition, academic institutions are now benefiting from 
the legitimate financial considerations of supplementing patents with publications. 
The existence of VC funding in nanotech R&D projects gives indications that there is 
significant commercial opportunities available and also a substantial entrepreneurial 
prowess prevalent in such collaborative partnerships. There are other significant 
variables not included in this model which still influences the ability of nanotech 
companies to collaborate with large number of industrial partners. Certain key 
features of a company such as its age, size, market position, and financial status, 
could be useful tools in predicting the propensity to enter successful collaborative 
partnerships. A much larger sample size which incorporates more countries that 
nanotech companies operate in would provide useful insights into legal and cultural 
determinants of the innovative performance of collaborative partnerships. 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
Chapter 4: Innovative and Financial Firm Performance of Nanotechnology R&D 
Organisations in the Commercialisation Era 
 
4.1 INTRODUCTION 
The beginnings of nanotechnology could be traced to the now famous lecture 
delivered by Scientist Richard Feynman on the 29th of December 1959 at the 
American Physics Society’s meeting in California Institute of Technology. It was a 
visionary discourse which was titled ‘there’s plenty room at the bottom’ and 
envisaged the possibility of developing minuscule machines which could ‘arrange the 
atoms the way we want’ and perform chemical synthesis through mechanically 
manipulating matter on an atomic scale. In 1974, Japanese Professor Norio 
Taniguchi coined the term ‘nano-technology’ at the Tokyo Science University, when 
he tried to describe the accurate creation of materials with the tolerances of 
nanometer. The profound breakthrough in the study of nanoscience and 
nanotechnology came when few researchers at one of IBM’s global research 
laboratories in Zurich, Gerd Binnig and Heinrich Rohrer in 1981 invented the 
scanning tunneling microscope (STM) which used specimens that conduct electric 
current only; and then Binnig and some other scientists in 1982 created a more 
versatile nano-instrument called the Atomic Force Microscope (AFM).  
Among scientists, there is a strong consensus that these two inventions brought 
about the accelerated march into the modern nanoworld with the enhanced ability to 
image and manipulate molecules at the nanoscale. Consequently, IBM Corporation 
is considered as one of the foremost organisation responsible for catapulting the 
study of nanotechnology to the forefront of physical science research due to the fact 
that its multinational Research Center in Europe developed the innovative scanning 
probe techniques (STM and AFM) which became prevalent in the field of 
instrumental analysis because of the volume of nano-meter-scale information these 
new scanning methods provide and this earned the scientists in 1986, the Nobel 
Laureate Awards in Physics. In the same year, Eric Drexler published the ‘Engines of 
Creation: The coming Era of Nanotechnology’ which became the basis of his MIT 
doctoral thesis in 1991. Researchers became equipped with the ability to evaluate 
structures measuring just a few billionths of an inch, as scientists Donald Eigler and 
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Erhard Schweizer in 1991 at IBM's Research Center in the US made it known that 
they have been able to draw letters on a cold nickel crystal by prudently arranging a 
handful of xenon atoms in sequence.  
Most policymakers and top scientists highlighted the numerous benefits that accrue 
to the economy and the entire society. The key role that R&D policies would play 
became even more obvious, over the years and across the globe, in the value-
creation process of judiciously exploring and economically exploiting portfolios of 
nanotechnology products and services which are deeply entrenched in my everyday 
life. In the late-1990s, after almost two decades of incessant scientific productivity in 
the field of nanotechnology, most liberal democracies and emerging market 
economies where seeking to enhance the domestic prospect and international 
position of this key high-tech industry so as to gain competitive technological 
advantage in an ever-increasing globalised socio-economic environment. President 
Clinton in 1997 said that we have to “Imagine a new century, full of promise, 
moulded by science, shaped by technology, powered by knowledge. We are now 
embarking on our most daring explorations, unravelling the mysteries of our inner 
world and charting new routes to the conquest of disease”. 
As an engine for economic growth, job creation and radical innovation in 
knowledge-based economies (Protogerou et al., 2017); high-tech firms play an 
important role in establishing collaborative partnerships with universities (Caloghirou 
et al., 2001); securing government and private R&D investments (Roco, 2011); in 
order to develop a portfolio of innovative products and pioneering systems (Nieto 
and Santamaria, 2007) which thrives despite the swift changes in the socio-
economic and technological environments (Baranenko, et al., 2014) that requires 
shorter product life cycles as a result of intense global competition (Deeds, 
DeCarolis and Coombs, 2000). Through R&D initiatives, government has vigorously 
financed inter-firm R&D projects (Roediger-Schluga and Barber, 2006; Paier and 
Scherngell, 2011) to promote innovative performance in high-tech firms so as to 
enhance their global competitiveness (Scherngell and Lata, 2013).  
Globalization of science, technology and commerce has rapidly advanced human 
endeavour; making it essential for high-tech firms to continually improve their product 
lines and manufacturing processes to meet the ever-increasing stakeholder 
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expectations (Lo et al., 2011). Consequently, the internationalization of economic 
activities and consumer preferences cause high-tech firms to become more strategic 
in pooling both internal and external R&D resources together through offshore 
outsourcing (Bertrand and Mol, 2013) or local collaborative networks (Bresciani and 
Ferraris, 2014); with the objective of producing multi-technological goods which 
attract huge export demand from international markets (Narula, 2004). In the early 
2000s, nanotechnology rapidly took a strategically important role among most 
governments in advanced countries as a result of the recognition of its tremendous 
economic potential. Certain key R&D policies were initiated to quickly facilitate the 
commercialisation of nano-products and the convergence of nanotechnology with 
other technologies. Emerging economies like China and Russia have enthusiastically 
jumped into the bandwagon which has spurred the globalisation of nanotechnology 
advancement. Some management research have looked into the classification of the 
historical developments and future trends based on scientific publications and patent 
applications usually employing textual mining techniques to observe useful 
information from global open sources such as SCI/SSCI databases (Kostoff, et al. 
2006, 2007).  
There is the absence of a thorough empirical investigation which analyses the 
performance of nanotechnology firms and forecast the future trends for profitability of 
nano-products. In my study, I evaluated the key factors that influence the innovative 
and financial performance of nanotechnology firms from an investor’s perspective 
and I discuss the effects of national nanotechnology initiatives on the scientific 
productivity and innovative, especially at the turn of the 21st century, when various 
government initiatives was undertaken to expedite the commercialisation of 
molecular engineering. The comprehensive investigation of the antecedents for a 
successful R&D strategy in the commercialisation of nanotechnology firms has been 
documented (Fiedler and Welpe, 2010); however, in this research report I would 
endeavour to categorise the internal and external determinants of the performance of 
nanotechnology firms. 
Previous organisational studies have shown that knowledge creation and the 
assimilation of information through universities is significant for industrial innovation, 
as high-tech firms are well-known to develop and accumulate vital technological 
capabilities based on formal and informal modes of organisational learning 
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(Belderbos, Carree and Lokshin, 2004; Czarnitzki, Ebersberger and Fier, 2007; 
Maietta, 2015; Thoma, 2017). The increasingly complex, extremely expensive and 
highly interdisciplinary features of modern scientific activities have resulted in the rise 
of inter-organisational R&D partnerships (Teece, 1986); as a cost effective means for 
high-tech firms to access and exchange new knowledge, secure additional human 
capital, develop innovative methods, improve value network and enter into heavily 
regulated markets (Matt, Robin and Wolff, 2012); in order to benefit from the 
diversification of risks, transfer of scientific knowledge, enhanced market 
competitiveness, greater return on investment, better rate of survival, improved 
reputational status and brand recognition. 
The motivation of this study was dependent on my inquisitiveness in understanding 
the extent to which factors under management control influences the different types 
of innovative performance in nanotech R&D firms across the globe so as to provide 
corporate strategists with valuable information on the internal intricacies which 
expedite creativity, productivity and profitability in nanotech firms. My study 
evaluates the main internal determinants of the amount of patents, quality of new 
product development and level of profitability of nanotech R&D organisations across 
the globe. I looked intensely at the human capital, financial resources and inventive 
assets of nanotech firms; while controlling for their previous cooperative experience, 
duration of collaboration and VC participation. The main research question for my 
study is how do internal and external factors affect the innovative and financial 
performance of nanotech R&D firms across the globe? My research objective is to 
provide nanotech managers of R&D projects with valuable knowledge on how the 
structural internal and external dynamics of nanotech firms affects the attainment of 
significant patents, new product development and profitability.  
The key contribution of this research study is to provide policymakers and 
corporate strategists with useful insights into the internal and external environment of 
nanotech firms. The major factors that influence the performance of nanotechnology 
institutions across the globe are the country’s legal origins, cultural dimensions, rates 
of economic growth, export demand for technologically advanced products of high-
tech firms controlling for their organizational size, VC participation, and research 
intensity. I employed multiple regression and panel data analysis to evaluate the 
relationship between successful nanotech R&D firms and key performance indicator 
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variables. I then conclude by ascertaining the core internal dynamics which 
corporate strategists and R&D project managers need to be aware of, as the onus is 
on top managers of high-tech organisations is to design simpler and flexible 
governance mechanisms which builds the firm’s capacity to retain and integrate new 
knowledge and innovative techniques into existing corporate systems during periods 
of high financial positioning with the intention of maximizing technological 
productivity and commercial performance. 
I collected secondary data on nanotechnology organizations and their industry 
affiliations, organizational size (total assets), number of patents, and VC participation 
from the Orbis database provided by Bureau van Dijk (BvD). The results show that 
external factors – such as a country’s legal origin, cultural dimensions, economic 
growth and its export demand for advanced high-tech products – meaningfully 
influence the size and governance mechanism, strength and duration of 
collaboration in nanotech R&D projects. The closeness, regarding geography and 
functional space, of nanotech R&D firms most influences the dimensions of their 
R&D collaborations. Also, nanotech firms operating in countries with French Civil 
Law origin are inclined to establish a centralized system of governance in their R&D 
collaborative partnerships, due to the high level of legal predictability. Countries with 
a legal origin in English Common Law are less predictable, while those with French 
Civil Law are less flexible (Beck et al., 2003). I also find that VC funding in nanotech 
R&D firms usually leads to VC’s active participation in the strategic management in 
order to influence their innovative and financial performance. 
Moreover, my results show that the innovative capacity and organizational size of 
nanotech firms also affect the dimensions of their R&D collaborations (Fiedler and 
Welpe (2010). I argue that, because nanotech R&D projects are inherently very 
complex, nanotech firms that operate with a more decentralized internal 
organizational structure and in a simpler external environmental framework will be 
more effective in their R&D collaborations and hence can produce better innovative 
outcomes for a more abundant world. My study concludes by identifying the possible 
opportunities and challenges for policy makers and organizational strategists to 
exploit or guard against, to enhance the dimensions of collaboration within the 
nanotechnology industry or similar emerging and discontinuous innovations. The 
research study is structured as follows: In section 4.2 I introduce the theoretical 
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framework of the study and develop the hypothesis. Section 4.3 outlines the 
research methodology. The empirical results are presented in section 4.4. The 
section 4.5 discusses these results and highlights research and policy implications. 
4.2 LITERATURE REVIEW 
Nanotechnology is a scientific phenomenon that is creating an international gold 
rush from its transformative technological usefulness in revolutionising the energy, 
defence, IT & Communications, healthcare, agriculture and the environmental 
sectors (Jiao et al., 2016). As an enabling innovative system, it relies on the 
continuous development of its basic science but also the exploitation of different 
commercial attractions in its industrial application. However, the challenge is to 
derive an optimal R&D strategy which doesn’t sacrifice genuine scientific 
breakthroughs for exorbitant financial payoffs (Rao et al., 2013). The review of the 
extant literature of my study and develop hypotheses for testing. I observe how the 
theoretical framework, scientific discoveries and commercial applications of 
nanosciences and nanotechnologies evolved to become one of the new frontiers of 
science and technology around the world. 
4.2.1 Historical Developments in Basic and Applied Nanotechnology Research  
Kostoff et al., (2006b) defines nanotechnology as the development and application 
of techniques. Shea (2005) suggests that nanotechnology is a multipurpose 
application of science that has radical innovations in processes, disruptive impact on 
existing industries and transformative effect in societies. Kostoff et al., (2006) using 
visual inspection of the historical records of seminal papers categorize research 
studies in nanotechnology into solid state electronic structure; optics/spectroscopy; 
surfaces/films/layers; instrumentation and materials. The extant literature in 
nanotechnology consists of two main periods of intellectual heritage: pre- and post- 
1985. From the early decades of the 20th century, nanotechnology research studies 
have focused on the development and application of techniques to examine physical 
phenomena. Mie (1908) proposes the conventional electrodynamic study of the 
extinction cross-section which was the early development of optical extermination of 
light by an insulated circular element to size and rate of recurrence.  
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Fowler and Nordheim (1928) develop a model to explain the electron emission from 
metals for current densities and tunneling currents. Also, models like the effective 
medium where developed by Bruggeman (1935) to solve the inhomogeneous media 
so that the various stages are randomly dispersed in terms of particles of an arbitrary 
size, shape, and orientation. One of the post-world war 2 advances in nanoscience 
was the appropriate interpretation of X-ray diffractometry to study microstructures. 
Stoner and Wohlfarth (1948) design a model that could depict the magnetization 
reversal of a single-domain nanoparticle. In 1964, Rotenberg and Kohn postulated 
the density-functional theory used in explaining the ground state of predetermined 
electron structures. Meanwhile, Rietveld (1969) develops a technique for profile 
refinement of nuclear and magnetic systems which directly incorporated the profile 
forces derived from step-scanning metrics of neutron powder structure. Shannon 
(1976) ascertains the effective ionic radii which produces a useful platform for 
calculating crystal structures. Ceperley and Alder (1980) employ the critical addition 
of the quantum many-body algorithm to electronic system assessments which uses a 
random technique to calculate ground-state of the electronic gas. Sze and Churchill 
(1981) propose the fundamental dynamics and operational features of all key bipolar, 
unipolar, special microwave, and optoelectronic procedures. However, since the 
transition from nanoscience to modern nanotechnology in the mid-1980s due to the 
commercial availability of and technical advancements in instruments that allow for 
adequate scanning and probing at the nanoscale level; construction of structures in 
the nanoscale size range has been the focus of and trend in nanotechnology 
research.  
The development of the Scanning Tunneling Microscope (STM) in 1981 and Atomic 
Force Microscope (AFM) in 1986 from about the ability to carry out current 
nanotechnology research demands the advancement of many technical disciplines 
(Kostoff et al., 2006).  Katz and Martin (1997) define research collaboration as the 
meaningful cooperation of researchers in achieving a collective goal of creating and 
disseminating new scientific knowledge. Katz and Martin (1997) observe that 
collaboration could be developed among individual researchers such as 
interdisciplinary groups; across public/private sectors such as university and 
industry; and between countries such as multi-national cooperation. Katz and Martin 
(1997) argue that the motivations for research collaborations are the rising costs of 
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conducting experimental science; the availability of quick and avoidable 
transportation/communication facilities; the proliferation of scientific communities 
around the globe; the politicizing of research activities; and the strong demand for 
specialisation within the fields of science. Ponds et al (2007) observes that one of 
the main reasons for the surge in scientific research collaborations is due to the 
growth in interdisciplinary research institutes which rely on the combination of the 
expertise of researchers from different fields of study.  
4.2.2  Commercialisation of Nanotechnology Industries in Advanced and Emerging 
Economies at the turn of the 21st Century 
Nanotechnology is considered to be the first main international initiative of the 21st 
century because it serves as a platform for technological solutions across industries 
and a junction for convergence with other enabling technologies. It provides the 
common groundwork for and unique enablement of new innovations relevant to 
several industries and the societies at large (Mangematin and Walsh, 2012). 
Knowledge commercialisation became prominent in the 1980s and is a process 
where value is created from knowledge through the practical application and market 
introduction of R&D outcomes (Taheri and Geenhuizen, 2016). Government 
approaches to facilitating successful national innovation systems lies between 
market-driven policies and state-control mechanisms which facilitates strategic 
coordination for constant exchange of information between industry and academia 
(Rao et al., 2013). 
At the turn of the 21st Century, some government R&D policies in developed 
countries pursued the commercialization and industrial regulation of nanotechnology 
products and services for lucrative but safe public consumption, after a twenty year 
period of intensive basic research and applied laboratory experimentations. The 
need for an effective government R&D strategy was astutely echoed by the then 
leader of the free world - US President Bill Clinton, in a speech he gave on the 21st 
January 2000 at the California Institute of Technology which stated that “Some of my 
research goals may take twenty or more years to achieve, but that is precisely why 
there is an important role for the federal government”. Specifically, in 2003, the 
United States played an important role when President George W. Bush enacted the 
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Nanotechnology Research and Development Act2 which led to a $3.63 billion initial 
budget funding that was authorised for capital expenditure between five government 
agencies to finance the National Nanotechnology Initiative (NNI) aimed at: facilitating 
global collaborative partnerships in nanotechnology R&D projects; enhancing the 
structural transfer and legal exchange of newly innovative technologies among 
nanotechnology R&D organisations for scientific productivity and commercial 
developments; creating interdisciplinary scientific groups and multipurpose 
nanotechnology research centres for developing highly skilled scientific workforce 
and new educational resources; and the provision of adequate infrastructures and 
monitoring tools which advance nanotechnology industrialisation and promote 
responsible and sustainable development across a myriad of industries such as 
healthcare, information & communication systems, agriculture, defence, energy, and 
the environment for public benefit in the not too distant future.  
 
Figure 4.1:       Funding from the National Nanotechnology Initiative (NNI) 
Source: https://www.nano.gov/node/1128 
                                                          
2
 Mihail Roco first proposed the initiative in 1999, while President Bill Clinton in 2000, advocated for a twenty year 
holistic strategy to the development of nanotechnology in the United States and later in the year created the 
National Nanotechnology Initiative.  
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It should be stated that at the end of the fiscal year of 2016, the cumulative NNI 
investments made by the United States government was almost $21 billion and that 
NNI now functions as the principal hub which brings together expertise from all US 
federal agencies that are capable of effectively advancing very complex 
nanotechnology research with different modes of communication, cooperation, and 
collaboration. The US government invested over $20 billion in nanotechnology from 
2001 – 2015 (Jiao et al., 2016). 
Similarly, the first major European Strategy for Nanotechnology was devised in 
2004 by the European Commission (EC) which funded almost 200 EU nanotech 
R&D projects under the Framework Programme (FP6 & FP7) in different clusters 
formations which then were used to describe and explain the various scientific 
productivities and technological innovations within the nanotechnology industry and 
around the environment. As the general public was typically sceptical about 
nanotech projects, it was especially important for EU R&D policy makers to select 
and structure relevant information and use appropriate methodologies to reach target 
audiences in order to communicate meaningfully nanotechnology research to all 
stakeholders and foster societal discussion as part of essential R&D policy initiatives. 
Consequently, EU citizens were able to understand why nanotechnology is one of 
the core frontiers of scientific development today and how it is deeply embedded into 
our daily lives and affects us all.  
As from 2005 the European Commission has supported nanotechnology R&D 
collaborations through her Joint Research Centres predominantly to facilitate R&D 
partnerships which leads to the rapid development of scientific productivity and 
innovative performance in order to enhance the competitive advantage for the 
region. There are two differing approaches applied by the policy makers in the US 
and EU. The US initiatives favoured a purely market driven approach towards the 
development of nanotechnology through the provision of adequate basic R&D 
resources and ensuring strict to adherence to minimum safety guidelines. While the 
other hand, the EU has favoured a careful government intervention in setting the 
agenda for the development of nanotechnology by adopting a demand-driven 
approach which significantly considers the safety of society and environment. This 
has cumulated into the protection of intellectual properties and industry oversight of 
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nanotechnology products for consumer use and constituted the essence of the 
centralised R&D initiatives in EU countries.  
The European Commission actively invests into joint R&D projects, in conjunction 
with the private sector, to facilitate inter-firm collaboration and scientific performance 
in an attempt to foster global competitiveness (Paier and Scherngell, 2011). A key 
challenge for European R&D policy makers is to define an optimal collaboration 
scale for fund mobilization across local, regional, national and international 
cooperative partnerships to promote a vibrant and prosperous socio-economic 
environment.  
Likewise, the British government also recognised that nanotechnologies could 
revolutionise communities as its developments could render existing modus operandi 
obsolete due to some disruptive modifications to the structure of materials in 
production; drastic advancement in drug discovery, sensible reduction in the use of 
energy, efficient techniques in recycling used substances and enhanced 
miniaturisation in semiconductor assembly. With the aim of propagating information 
on nanotechnology around the UK, the National Initiative on Nanotechnology (NION) 
was launched in 1986 by the National Physical Laboratory (NPL) and the 
Department of Trade and Industry (DTI).  
The LINK Nanotechnology Programme (LNP) was subsequently launched in 1988 
for an eight year period; with the Science and Engineering Research Council (SERC) 
joining in 1989; followed by the Defence Research Agency (DRA) in 1990. The main 
recommendation from the Nanotechnology Theme Day in 1999 was a committed 
and focused R&D programme that aid interdisciplinary collaborations. In 2002, Prime 
Minister Tony Blair in a speech to the Royal Society was quick to single out 
nanotechnology as a vital field of research and states that “Visionaries in this field 
talk about machines the size of a cell that might, for example, identify and destroy all 
the cancerous cells in a body.  
Nanomachines might target bacteria and other parasites, dealing with tuberculosis, 
malaria and antibiotic-resistant bacteria”. The labour government in 2003 
commissioned the Royal Society and the Royal Academy of Engineering to analyse 
whether there was a need for greater oversight after Prince Charles lobbied some 
scientists to ‘look into grey goo nightmare’ in order to generate wider attention. The 
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House of Commons then suggested to the Treasury the necessity for greater 
investments into nanotechnology research were needed in order to sufficiently 
position the UK as the top destination for R&D activities. The Engineering and 
Physical Sciences Research Council (EPSRC) since 1997 made an annual R&D 
expenditure of £40 million and disburses about 10% of its total £1billion grants to 
research in nanotechnology. Through managed programmes and interdisciplinary 
research collaborations such as the National Initiative in Nanotechnology, EPSRC 
has promoted useful integrating initiatives which create a mixture of instruments and 
systems that enhance the precision manipulation of matter a molecular level in the 
UK.  
Consequently, the Japanese government has supported the advancement of 
nanotechnology particularly since the year 2001 with the second Science and 
Technology Basic Plan (STBP) which prioritised this field as one of the national 
issues of interest.  The funding from the government has increased over the years 
and targeted semiconductor technology, clean energy and life sciences innovations. 
Also, the private sector has invested into the development of nanotechnology for 
commercial purposes, as it is considered to be a key field which could revitalize 
industries. The Japanese government set their nanotechnology policies at the 
cabinet level by the Council for Science and Technology with main strategies to 
solve problems that relates to society and industry as well as ensure market 
competitiveness by promoting social acceptance, accurate measurement, effective 
commercial policies, and providing R&D infrastructures. About $260 million per 
annum is budgeted and channelled through key sectors such as Energy, Trade, 
Industry, Education, Health and Science & Technology. The second Science and 
Technology Basic Plan from 2001 – 2005 was the crucial initiative that prioritised 
areas of funding and facilitated interdisciplinary, inter-firm and international 
collaborative partnership among nanotechnology experts and organisations.  
Governments in developing nations have the opportunity to leapfrog into an 
advanced innovative system by navigating away from the missteps of early 
innovators developed nations by using taxation, regulation, infrastructure 
development and public venture capital (Appelbaum et al., 2016). The Chinese 
communist government has increased funding and improved R&D infrastructure in 
order to significantly advance nanotechnology publications, commerce and 
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industrialisation. One of the key basic research field supported by the Chinese 
government’s Medium and Long-Term Development Plan was nanotechnology (Jiao 
et al., 2016). Developing countries have been creating national systems of 
innovation in R&D intensive field like nanotechnology in order to transition their 
economies away from low value creating industries. Preferential treatments have 
been given to their local high-tech companies as large funds are devoted to 
developing basic and applied research, building research centres, recruiting 
renowned scientists and even financing entrepreneurial high-tech ventures 
(Appelbaum et al., 2016).   
Table 4.1:      Modern Periods of Nanotechnology Development 
 2001–2010 2011–2020 
Measurements Indirect, using time and 
volume averaging 
approaches 
Direct, with atomic precision in 
the biological or engineering 
domains, and femtosecond 
resolution 
Phenomena Discovery of individual 
nanostructures 
Complex simultaneous 
phenomena; nanoscale 
integration 
New R&D 
paradigms 
Multidisciplinary 
discovery from the 
nanoscale 
Focus on new performance; new 
domains of application; an 
increased focus on innovation 
Synthesis and 
manufacturing 
processes 
Empirical/semi-empirical; 
dominant: top-down 
miniaturization; 
nanoscale components; 
polymers and hard 
materials 
Science-based design; increasing 
molecular bottom-up assembly; 
nanoscale systems; increasingly 
bio-based processes 
Products Improved existing 
products by using 
nanocomponents 
Revolutionary new products 
enabled by creation of new 
systems; increasing bio-medical 
focus 
Technology From fragmented 
domains to cross-sector 
clusters 
Toward emerging and converging 
technologies 
Nanoscience & 
engineering 
penetration 
into new 
technologies 
Advanced materials, 
electronics, chemicals, 
and pharmaceuticals 
Increasing to: nanobiotechnology, 
energy resources, water 
resources, food and agriculture, 
forestry, simulation-based design 
methods; cognitive technologies 
Education From micro- to 
nanoscale based 
Reversing the pyramid of learning 
by earlier learning of general 
nanotechnology concepts 
(Roco, 2003b) 
Societal 
impact 
Ethical and EHS issues Mass application; expanding 
sustainability, productivity, and 
health; socio-economic effects 
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Governance Establish new methods; 
science-centric 
ecosystem 
User-centric ecosystem; 
increasingly participatory; techno-
socio-economic approach 
International Form al S&T community; 
establish nomenclature, 
patent, and standards 
organizations 
Global implications for economy, 
balance of forces, environment, 
sustainability 
Source: Roco (2011). 
4.2.3  Public and Private R&D Funding in Nanotechnology Innovations 
Nanotechnology is believed to play a central role in the future technological 
development and economic transformation.  Hence why government policies have 
tried to aid and promote the commercialisation of nanotechnology by providing R&D 
funds, building world-class infrastructure and encouraging global scientific alliances 
(Rao et al., 2013). Despite the huge public R&D investments and adequate 
intellectual property rights protection in European countries, there has been an 
unsuccessful conversion of scientific breakthroughs and technological achievements 
into financial performing high-tech industries. Commercialisation of R&D activities in 
nanotechnology requires large funds, extraordinary care towards public safety, and 
adequate exchange of information between managers, researchers and policy 
makers (Rao et al., 2013). 
It is paramount for the nanotechnology industry to continuously receive government 
funds since SMEs lack research resources and instrumentation for its early-stage 
development; and large companies have low financial motivation for its long-term 
resource commitments (Palmberg, 2008). Private companies are yet to fully 
participate in the commercial application of nanotechnology, while universities and 
government laboratories continue to dominate in the productivity of scientific 
outcomes (Miyazaki and Islam, 2007). One of the conditions required to attract long 
term foreign in high-risk R&D investments into a country’s innovative system is a 
predictable sets of policies and objectives proceeding from government agencies 
with emphasis on technological breakthroughs specialised fields such as ‘targeted 
drug delivery, ultra-light carbon-based materials, greatly enhanced water filtration, 
highly efficient low-cost energy production, and high-speed computing’ (Appelbaum 
et al, 2016). 
Nanotechnology is in an embryonic stage that requires long-term exploratory R&D 
investments from governmental agencies in different key sectors to stimulate its 
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successful commercialisation which is estimated to be worth $1 Trillion by 2020 and 
spark the second industrial revolution (Lo et al., 2012). Governments in developing 
countries heavily depend on luring expatriate scientists and acquisition of foreign 
technology. Weaning themselves of such dependence usually leads to the 
construction of industrial policies which focuses public R&D investments into key 
areas of basic science, applied engineering and industrial technology for the purpose 
of driving new product innovation among domestic high-tech companies in order to 
foster economic growth. Although, most emerging market economies benefit greatly 
from incremental process innovations by re-engineering and refining existing 
products (Appelbaum et al., 2016). 
Figure 4.2:        Nanotechnology R&D Investments Worldwide 
    
Source: Cientifica 
4.2.4  Collaborative Partnership among Universities and Nanotechnology R&D Firm 
Commercialisation of nanotechnology requires an effective innovation strategy which 
manages large groups of inventors and their stakeholders for exploiting economic 
gains (Mangematin and Walsh, 2012).  R&D policy initiatives have been set up by 
governments to encourage collaborative partnership between stakeholders in order 
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to boost effective transfer of nanotechnology (Palmberg, 2008). The key pathways 
for nanotechnology commercialisation are usually the transfer of valuable scientific 
proficiencies from academia to industry through R&D collaborative partnerships in 
research clusters and corporate incentives based on tax relief (Rao et al., 2013). The 
innovative capacity of a country relies on the strengths of the public research 
laboratories, firms and universities. When well-functioning connections are 
established among these players, economic growth would be stimulated and many 
societal problems could be successfully addressed (Weckowska, 2015). The nature 
of nanotechnology as an early-stage technology requires companies operating within 
its industry to develop substantial links with universities due to fact that advances in 
the basic research outpaces developments in technological applications (Rao et al., 
2013). 
 Governments have undertaken various measures to facilitate R&D collaboration 
between university and industry so as to enhance technological innovation, strategic 
competitiveness and economic growth (Motoyama, 2014).  For a nation to 
successfully leverage its innovative system in maximising economic development 
and wealth creation, effective technological transfer must occur through established 
mechanisms, from scientific discoveries in research laboratories to innovative 
products in the marketplace (Gibson and Naquin, 2011). The process of transforming 
scientific discoveries into saleable products is an entrepreneurial skill university 
research need to acquire. Commercialisation of university research output enhances 
the sales of innovative high-tech products. Traditionally, R&D investments have been 
mostly on tangible infrastructural projects such as science parks but nowadays 
funding collaborative partnerships in high-tech commercial projects has taken more 
priority due to the expectation for greater returns and better economic impact 
(Gibson and Naquin, 2011).  
Schott (1991) argues that scientific activities are organised by individuals who 
operate under local, regional, national and international institutions at various levels 
of spatial proximity and who are in communication with one another in order to 
create and diffuse scientific knowledge. Schott (1991) further argues that 
collaboration among scientists from different societies implicitly confirms and 
explicitly reinforces their belief in the virtues of universal validity as it fosters 
consensus and facilitates diffusion within the scientific community. The prerequisite 
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for a global diffusion of scientific knowledge is prevalent in the belief in universal 
validity, wider dissemination, and intensive collaboration (Schott, 1991). According to 
Mehta et al (2012), the results of systematically assessing international research 
collaborations in nanotechnology elucidate the associations between national 
research policies and the development of transnational scientific networks. Mehta et 
al (2012) argues that as a way of facilitating international collaborations around the 
globe, governments have provided resources as well as incentives to promote rapid 
growth and dissemination of scientific knowledge in order to promote indigenous 
innovation, exploit research synergy, and enhance scientific excellence. Stichweh 
(1996) argues that the pathway to a contemporary global scientific community 
usually goes through a transitionary period of strong nationalistic identity in science 
and technology. Stichweh (1996) concludes that the nationalization of reference 
groups is compensated in due course by the addition of new processes and systems 
into an existing scientific community by means of a progressive internal 
differentiation of science and technology.  
Mehta et al., (2012) conclude that in contrast to the European scientific community, 
emerging economies (such as the Chinese) scientific development was led by state 
actors and tailored towards the applied sciences. Stichweh (1996) observes that the 
national scientific institutions usually function as a policy initiative due to the reliance 
on state funds. Stichweh (1996) suggests that one of the salient determinants of the 
global interconnectedness of scientific communities is the complex dynamics of the 
internal differentiation of science. Stichweh (1996) argues that the international 
interconnectedness of scientific communities is not due to the emergence of a 
unipolar world of scientists who share a common set of normative and cognitive 
presumptions; but due to continuous proliferation of ever new societies of scientists 
with increasingly constrained jurisdictions that standardizes the social and cognitive 
universe of science in a way which is irreconcilable with the confines of national 
scientific societies. Katz and Martin (1997) observe that collaboration is usually 
peculiar to experimental research as it is interdisciplinary in nature and involves the 
use of large or complex instrumentation such as telescopes and CT scanners. Katz 
and Martin (1997) identifies the factors contributing to collaboration within scientific 
communities as: changes in levels of funding; desire for visibility and recognition 
among researchers; increasing demand for the rationalisation of scientific 
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manpower; rapid specialisation in science; and growing proliferation of science. Lee 
and Bozeman (2005) observes that the custom among scientific research 
communities for some years now has been collaboration and this is due to the 
increasingly complex, very expensive and highly interdisciplinary characteristics of 
modern scientific endeavours. 
Bayh-Dole Act 1980 is a classic example of an economically driven innovation 
policies which served as a catalyst for transforming scientific productivity in 
universities and public R&D organisations into innovative products that create high 
financial performance in the marketplace (Gibson and Naquin, 2011). Policy makers 
have in recent years put out initiatives to create a ‘third mission’ for their universities 
in order to foster a knowledge-based economy where there is an easy transfer of 
technological discoveries into commercially efficient vehicles (Perkmann et al., 
2013). Prioritising, with massive funding, of the application of basic research 
activities in universities and public R&D organisations into solving societal 
challenges, is a key factors that has led to more collaborative partnership between 
academia and industries (Taheri and Geenhuizen, 2016). 
4.2.5 Key Performance Indicators of Nanotechnology Advancement 
The performance of nanotechnology companies (as per the great commercial 
promise) provides a useful case study to evaluate the effectiveness of large public 
R&D investments into promotion of competitive economic advantages in high 
technology (Appelbaum et al., 2016). The return on R&D investments could be the 
exponential rise of scientific publications and patent applications originating from 
research centres and technology laboratories. However, profit-seeking high-tech 
ventures in emerging markets do not just emanate from the creation of dedicated 
science parks due to the gap between R&D systems and industries; the difficulty in 
technology transfer from poor intellectual property right protection; low private VC 
fund participation to encourage risk-taking; and the deficiencies adequate 
sophisticated technology managers (Rao et al., 2013).  
According to Roco (2011), I describe the key performance indicators of 
nanotechnology development as the five Ps of nano progress, namely: Papers, 
Patents, Products, People, and Profits.  
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4.2.5.1 Scientific Publications 
R&D Strategies for enhancing the competitive edge derived from conducting 
extensive basic and applied research in nanotechnology which is aimed at aligning 
scientific outputs with business development goals in order to establish a national 
system of innovation for effective technological transfer (Ikezawa and Ueda, 2013). 
Smith (1958) initially suggests that multi-author papers can be used as a proxy for 
measuring the level of collaboration among research groups. Although, Katz and 
Martin (1997) argue that co-authorships in scientific publications simply provide 
partial insight into the level of collaboration between two or more researchers due to 
the fact that; the accurate nature and size of collaboration cannot be clearly 
determined by survey techniques. Katz and Martin (1997) observes that most policy 
initiatives are geared at facilitating collaboration not on individual basis but on a 
higher level of public/private or foreign partnership. Wagner and Leydesdorff (2005) 
argue that collaboration on an international scale is a network of self-organising 
researchers with preferential attachments and social constraints. Wagner and 
Leydesdorff (2005) further argue that the international collaborative networks are 
very dynamic, rapidly increasing, and highly influential. Lee and Bozeman (2005) 
observes that collaboration is a robust predictor of publishing productivity when the 
total number of scientific publication is used as its measurement but when the 
allocated contribution is weighted into the number of authors, collaboration does not 
significantly relate to publishing productivity as other factors are kept constant. Katz 
and Martin (1997) observe that collaboration in scientific communities provides 
several benefits such as the transfer of knowledge, skills and techniques; the cross-
fertilisation of concepts and ideas; the provision of intellectual companionship; and 
enhancing of the prominence of research work. Ponds et al. (2007) observes that 
when geographical proximity is high amongst science based technologies between 
universities, companies and government research institutes; collaboration in 
scientific research is apparently more likely to be successful since their physical 
distance is close because of the tacit character of knowledge which requires face-to-
face interaction. Ponds et al. (2007) argues that high geographical proximity can 
compensate for the deficiencies in institutional differences during collaboration; that 
is, research collaboration concerning different types of organisations is more 
spatially localised because of shared interest in labour exchange, access to local 
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funding, and mutual trust facilitated by informal contact and interactions. Bozeman 
and Corley (2004) argues that the closer potential collaborators are in geographical 
proximity; the more likely there could be an informal communication among them 
which leads to a collaborative event.  
4.2.5.2 Patent Applications 
The accumulations of patents in nanotechnologies have been spearheaded by large 
companies and have preferred to acquire entrepreneurial ventures that are able to 
overcome technological and market uncertainties through strong financial 
performance and high growth prospects. Large companies have withheld 
commercialising some discontinuous innovations which will affect the status quo 
(Maine et al. 2012). High-tech start-ups and spin-offs boost market competitiveness 
within their industries by developing patentable discoveries that hold great promise 
of value creation to end users (Saidi and Zeiss, 2016). Ponds et al. (2007) observe 
that scientific research is profoundly different from industrial innovation because the 
former is primarily concerned with adding and diffusing new knowledge into the 
existing body of knowledge while the latter is more interested in adding to the 
streams of income from the exclusive rights of hoarding private information. 
Stichweh (1996) observes that the global exploitation of science and technology by 
multi-national corporations better describes the much greater rate of growth of 
international patent applications than the growth rate of national patent applications.  
4.2.5.3 Portfolio of New Product Development 
One of the most challenging organisational behaviour in the high-tech sector has 
been shifting from producing scientific publications based on basic research and 
applied experiments to developing new nano-products within an SME or large 
corporation with the goals of meeting customer preferences and maximising 
stakeholders’ wealth. In order to grow high-tech industries which promote rapid 
economic growth, there must be a concerted effort to bring nascent technology that 
meets consumer demand to the marketplace (Lo et al., 2012). By enabling critical 
thinking and disruptive innovations, nanotechnology creates new manufacturing and 
service orientation which produces a myriad of commercial opportunities due to the 
breaking of existing norms, shift away from previous design and the creativity 
available to meet consumer preferences (Lo et al., 2012). The ability to create 
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innovative products that eventually attain international brand identification is what 
truly brings about the commercialisation of high technology (Appelbaum et al., 2016). 
The transformational effect nanotechnology could have on most high-tech products 
in the marketplace would be greater than the sway transistor had on information and 
communication technology in the 20th century, which makes its pursuit an 
investment and insurance policy against economic and technological degradation 
(Linton and Walsh, 2012). Without a doubt, high-tech industrialisation provides the 
most important avenue for competition among companies and between nations. The 
advancement of nanotechnology offers a unique source of wealth accumulation 
through the strengthening of industrial positions in global markets; growth of wide-
reaching scientific output and continuous development of innovative products 
(Ikezawa and Ueda, 2013). 
Figure 4.3:          Global Valuation of Nanotechnology-related products 
 Source: Roco, 2011 
 
Nanotech companies that exploit process-based innovations are confronted with 
higher uncertainty in value chain positioning, greater scope in market coverage, 
diverse groups for customisation, and frequent changes to target users but this is not 
the case for nanotech companies developing product-based innovations 
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(Mangematin and Walsh, 2012). The key problems facing the development of new 
products are idea generation & evaluation, market orientation and interaction, and 
uncertainty (Linton and Walsh, 2008). Some of the rewards that emanates from 
nanotechnology is associated with materials. Since these peculiar materials are 
employed in the production of numerous high-tech and other products, generating a 
ripple effect which extends to a broad stream of applications, variety of devices and 
abundance of new equipment technologies; thereby providing a wealth of business 
opportunities in many industries (Ikezawa and Ueda, 2013).  
Research groups from different fields assemble to carry out studies at the 
nanoscale in technological hubs in order to incorporate nanotechnology-based 
materials into existing products and enshrined into new manufacturing processes 
(Mangematin and Walsh, 2012). Transforming R&D activities into the production of 
innovative products for consumer use tends to go through different processes such 
as laboratory experiments, product trials, entrepreneurial financing, and market 
targeting (Rao et al., 2013). Nanotechnology could be classified into nanomaterials, 
nanoequipment, nanodevices, and nanobios; which could be adapted to different 
scientific fields to enhance further innovations (Lo et al., 2012). The emergence of 
specialist nano-instruments for vital improvements in advanced materials and 
production techniques could lead to future competitiveness of national industries 
(Miyazaki and Islam, 2007).  
4.2.5.4 Revenue Generation and Long-term Profitability in Nanotechnology 
Firms 
Hi-Tech industries such as nanotechnology, value creation has to be at the 
forefront of R&D activities because existing methodologies could easily become 
obsolete and prices of new products can quickly change or rapidly decline in value 
(Ikezawa and Ueda, 2013). The level of R&D breakthrough, the features of the high-
tech product and the scale of meeting consumers’ needs drastically improves the 
likelihood of generating a sustainable revenue stream (Lo et al., 2012). A high level 
of market acceptance based on value created increases the chances of survival and 
profitability of high-tech products (Lo et al., 2012). Ex post commercialisation 
performances of high-tech companies in nanotechnology have rarely been 
empirically studied (Lo et al., 2012). The profitability of high-tech companies is 
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dependent on their ability to develop or acquire nascent technology and build new 
products commercially viable in the marketplace (Lo et al., 2012).  
4.2.6 Internal and External Determinants of Successful Nanotechnology Firms 
The internal and external factors which influence the likelihood of a successful 
nanotech R&D organisation are important to study because policy makers and 
business strategists could understand the determinants of nanotech firm 
performance. Nanotech companies are examined based on the academia/industry 
links, government sponsorships; VC participation; and foreign affiliations (Rao et al., 
2013). Nanotechnology is scientist-driven and in its early developmental stages, 
although exogenous to an economic system, it is touted as the engine for future 
growth and linked to industries with high level of R&D intensity (Nikulainen and 
Palmberg, 2010). There are several cultural dimensions which impede a country’s 
innovative capacity and economic development (Appelbaum et al, 2016). 
Commercialisation of nano-tech products is hampered by the absence of effective 
communication links between academia and industry; the low appetite across 
industries in procuring high R&D expenditure for frontier knowledge; and the 
incomprehensive laws and regulations due to quality control and safety assessment 
of nano-materials or nano-processes (Jiao et al., 2016). 
It cannot be overemphasized that governments of developing nations have to ensure 
that their legal systems are open and honest in addition to an educational structure 
which promotes experimental thinking and scientific recognition with a zero tolerance 
for corruption (Appelbaum et al, 2016). Management of nanotech companies would 
be wise to invest in absorptive capacity, new instrumentation and state-of-the-art 
R&D facilities (Palmberg, 2008). Financial crises increase the need to invest in R&D 
alliances for the purpose of facilitating economic growth (Gibson and Naquin, 2011). 
One of the challenges which hamper nanotechnology commercialisation is the lack 
of academic entrepreneurs who are able to identify business opportunities from their 
scientific discoveries (Palmberg, 2008). The international scientific community 
provides the direction for R&D activities in which scientists and entrepreneurs usually 
through cross-border collaboration and M&A alliances (Rao et al., 2013).  The 
globalisation of the high-technology has led to the mobilisation of world-class talents 
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and internationalisation of start-up capital across industries and between nations 
(Rao et al., 2013).  
4.2.6.1 Venture Capital Investments 
Historically, venture capital usually gravitates toward successful high-tech centres 
where innovative companies seek for early stage and growth financing from 
sophisticated investors. A prominent economic growth strategy adopted by some 
developing nations has been to massively fund venture capital activities to assist 
indigenous high-tech state-owned companies with the resources to re-innovate 
foreign technologies and adapt established business models in developed nations 
(Appelbaum et al, 2016). VC investments fill the gap between the scientific 
productivity of research outputs and the profitability of innovative products in the 
market place. VCs provide young high-tech companies with the financial aid and 
commercial expertise required to cross the so-called “valley of death”. However, 
government R&D funding policies still remain vital in creating a successful national 
system of innovations (Rao et al., 2013). The conservative investment strategy 
implemented by most foreign venture capital firms in developing countries are due to 
the constraints posed by the unstructured regulatory systems and the non-existence 
of an established legal framework; which reduces risky early-stage financing of 
undeveloped breakthrough ideas that are ‘far from market’ and focuses on high-tech 
companies with already marketable products and well-trusted founders (Appelbaum 
et al, 2016).   
4.2.6.2 Organisational Size 
SMEs in other high tech industries (such as biotechnology and microelectronics) 
usually bridge the gap between public research organisations and large companies 
by specialising in the emergence of innovative ideas from new scientific discoveries 
through collaborations with pioneering researchers (Mangematin and Walsh, 2012). 
Start-up firms in high-tech industries devise value creation strategies which connect 
advances in basic and applied research with solving societal problems for 
commercial rewards (Maine et al. 2012). The development of nanotechnologies is 
made by a small number of large clusters of scientists scattered across the globe 
while the formation of strategic alliances to market nanotechnologies are conducted 
by large companies and top universities (Mangematin and Walsh, 2012).  
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4.2.7    Hypotheses Formulation 
Innovative and Financial Performance Measurement – Patents, NPD, Revenue and 
Profits 
 H1: Nanotech R&D organisations that operate in Common Law countries are 
more innovative and profitable than those in non-Common Law countries. 
 H2: Nanotech organisations that operate in countries with higher on export 
demand for high-tech products have greater innovative and financial 
performance. 
 H3: Nanotech organisations that operate in countries with tolerance for 
ambiguity and uncertainty have more performing nano-products and 
profitability. 
 H4: Nanotech organisations that operate in countries with high R&D 
investments in national nanotechnology initiatives are more innovative and 
profitable.  
 H5: Nanotech organisations that operate in countries with high real economic 
(GDP) growth rate experience greater innovative and financial performance. 
 H6: Nanotech organisations that operate in countries with high corporate 
income tax regime have lesser innovative and financial performing nano-
products. 
 H7: Nanotech organisations that receive VC funds are able to secure more 
innovative and financial performing nano-products. 
 H8: Nanotech organisations that have high research intensity are able to 
create more innovative and profitable assets. 
 
4.3 RESEARCH METHODOLOGY 
4.3.1 Data Collection 
The commercial R&D organisations in my data samples possess different 
characteristics of nanoscience and nanotechnologies such as the development of 
nanotubes and nanowires for electrical and biological consumption, plus the use of 
nanoparticles and the construction of nano-instruments for manufacturing and 
communication purposes. Specifically, these nanotech R&D firm’s activities include 
but are not limited to: electrical discharge machining, multi-component injection 
moulding, electroforming, powder injection moulding, X-ray lithography, 
nanoimprinting, nanometer-scale measurement, chemical vapour deposition, 
selective laser sintering and future tooling technology.  
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In order to assemble the datasets for my study, I first used Orbis database of 
Bureau van Dijk (BvD) to collect innovative and financial performance metrics on 
1,407 nanotech R&D organisations from 2001 – 2015 in the US, UK, Germany, 
Australia, France, Denmark, Spain, Switzerland, Japan, South Korea, and China. I 
further extracted numerical and categorical data on their industry classifications, type 
of financing; amount of nano-products developed; number of patents secured; 
existence of domestic or foreign strategic alliances; and receipt of government 
sponsorships. I then merged the data with those from Zephyr database of BvD and 
contain VC funding and M&A deal information for all the nanotech firms in my 
sample.  
Also, I also collected, from the World Bank database, the annual GDP growth rates 
and export demand for high-tech products for the relevant countries and during the 
period of the 2001 - 2015. Likewise, I included the legal origin index developed by La 
Porta et al., (1999); subsequently modified by Beck et al., (2003); Spamann, (2009); 
and Cooray, (2011). The legal origins index represents the legal adaptability of 
countries where nanotech R&D commercialisation takes place. My measurement 
here focused on the legal dynamics affecting the performance of nanotech R&D 
organisations.  
Finally, I added some of the Hofstede’s cultural attributes like the uncertainty 
avoidance and feminine index. Similar to the legal variables, I adopted the national 
cultural dimension indexes proposed by Hofstede (1983; 1994) for all the nanotech 
R&D firms in my dataset to provide the measurement for societal attitude towards 
ambiguity and the public appreciation for feminine values. I then carried out multiple 
regression and panel data analysis to evaluate my data and provide empirical tests 
of my research hypotheses.  
4.3.2   Research Design 
The research design of this study covers the legal, fiscal, cultural and socio-
economic external environment of all the nanotech R&D firms in the countries 
selected from the year 2001 to 2015. The longitudinal dataset of this research report 
consists of a collection of quantitative and qualitative cross-country nanotech R&D 
organisational observations from various secondary open sources over a fifteen year 
commercialisation period. The purpose of adopting this research method is to 
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overcome unobserved heterogeneity problems by controlling for omitted unobserved 
variable biases that may occur in ordinary multiple regressions (Stock and Watson, 
2003).  
I adopt a data structure where only key innovative and financial performance 
metrics that are influenced by certain internal and external factors were considered 
in this study. In order to observe the determinants of annual nanotech performance 
at different hierarchy of firm performance; I aggregated nanotech commercial 
success from each country and regressed the resultant country’s organisational 
observation against a series of country & firm-specific explanatory variables that are 
also aggregated over time. Also, I examined the correlation coefficients among all 
dependent and independent variables so as to perform a series of OLS regressions 
in which I estimated variance inflation factors (VIFs). In addition, I used Hausman 
Test to observe the correlation between the time-variant and time-invariant variables 
(Anderson and Hsiao, 1982). 
 Figure 4.4:         Research Outline of the Study 
                          
Source: Author 
I employed a mixed research method to critically examine the external complexities 
that affect the performance of nanotech firms. Figure 1 shows the research outline of 
this study. The conceptual framework is based on theories of firm performance, 
Data Analysis from Regression Results, Further Discussions and 
Multiple Implications 
Validation of Hypotheses, Testing of Models & Robustness Check 
Additional Secondary Data Collection for External Factors from 
World Bank, IMF & NNI Databases on Countries of Nanotech firms 
Secondary Data Collection for Internal Factors from Orbis & Zephyr 
BvD Databases  on Nanotechnology Companies 
Developing Hypotheses for the Internal & External Determinants of 
Nanotechnology Organisational Performance 
Theoretical Framework on Nanotechnology Commercialisation 
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national culture influences on inter-organizational behaviour, legal origin as a 
determinant of financial development, and the international demand for 
technologically advanced products. These theories provide the basis for constructing 
and testing my hypotheses to produce empirical results on the internal and external 
factors that affect the success of nanotech R&D firms during the commercialisation 
period.  
4.3.3 Dependent and Independent Variables 
The four dependent variables in this chapter which aim to provide observations on 
the variations of innovation and financial performance across the US, UK, Germany, 
Australia, France, Denmark, Spain, Switzerland, Japan, South Korea, China, Russia, 
Brazil, Turkey, and Israel. Using a similar method adopted by Falope and Ajilore 
(2006) in this chapter, there are four dependent variables for the four regression 
models. The first dependent variable is the sum total of the number patents secured 
by all nanotech R&D organisation in a country and for the given years; the second 
dependent variable is the sum total of all the new products developed within the 
nanotechnology industry of a country for the given years; the third response variable 
is the natural log of the sum of the sales generated in the nanotech industry of a 
country for the given years; and the fourth is the average profit margin of the 
nanotech firms in a country for the given years. Each of the dependent variable 
contains annual observations of nanotech firm performance in 15 countries for the 
time period of 2001 – 2015. The linear relationship is depicted below: 
Nano - Performance 𝑖,𝑡   = α + ∑ 𝛽𝑚
𝑀
𝑚=1
 ∁𝑚,𝑖,𝑡 + 𝜀𝑖,𝑡 
Where3: 
 Nanotech firm Performance = Patents, NPD, Revenue and Profit Margins in 
nanotech R&D organisation in the country (i) for each year (t).   
The independent variables remained, for the most part, the same in the four models 
used in this study. They were employed to determine the factors which that influence 
                                                          
3
 Where M is lag length that varies with t; Cm,i,t are legal, cultural, economic, technological & fiscal 
factors with some control variables during year t. (Thiengtham, 2010). 
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the innovation and financial performance of nanotech firms across countries during 
the commercialisation era. Among the variables which help explain the variations in 
the success of nanotech firms across the globe include: the country’s annual R&D 
expenditure (% of GDP); entrepreneurial indexes; corporate tax rates; level of export 
demand for high-tech products; and the economic growth rates (collected from World 
Bank Open Data from 2001 - 2015) and the legal origins of countries (dummies for 
Scandinavian, French and German Civil Law – La Porta et al., 1999); the Hofstede’s 
national culture indexes for uncertainty avoidance, power distance, and  Masculinity 
vs Femininity. These are the explanatory variables for this chapter are a variety of 
country factors and organisational determinants; that were used to evaluate the 
degree to which its periodic changes affect nanotech firm performance. Table 4.2 
shows the list and describes the variables and their expected relationship with the 
observed variable in the panel data models.  
Table 4.2:       Key Variables, Expected Relationships, and Brief Description 
S/N Variables Effects Description 
1 Liquidity + The average ratio of the ability of nanotech firms in a 
country to meet their financial obligations when they 
fall due. 
2 Employee 
Turnover 
+ The average ratio all nanotech firms ability to retain 
key scientists in a given country for the stated years. 
3 Industry Diversity 
 
+ A dummy variable (1) indicating the multiple industry 
affiliation of nanotech firms and (0) otherwise. 
4 Long term 
Orientation 
+ A dummy variable (1) indicating long term strategic 
planning of nanotech firms and (0) otherwise.  
5 Legal Origin 
Index 
_ Nominal variable coded (1-3) for countries with 
French, German and Scandinavian Civil Law Origins 
and English Common Law origins (0) as the base. 
6 VC Investments + The natural log of the average annual VC invesments 
into nanotech firms for a country.  
7 Masculinity(vs) 
Femininity 
+ Hofstede’s cultural index of societal attitude towards 
feminine values in countries selected in my sample. 
8 Uncertainty 
Avoidance 
_ Hofstede’s cultural index of tolerance for uncertainty 
and ambiguity in countries selected in my sample. 
9 Power Distance _ Hofstede’s cultural index of power distance in 
countries selected in my sample. 
10 Entrepreneurial 
Index 
_ Annual index of the health of the entrepreneurship 
ecosystem in countries selected in the sample and for 
the given period of time. 
11 Export demand 
for High-Tech 
Products Index 
+ The country’s average export demand for high-tech 
products from 2001 – 2015. 
12 Corporate Tax + The percentage of corporate taxes for nanotech firms 
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Rate in each country for the given period.  
13 Economic 
Growth 
+ The average rate of annual GDP growth for countries 
in the given period. 
14 R&D Expenditure 
(% of GDP) 
+ The average annual R&D expenditure as a 
percentage of GDP for the countries and in the given 
years. 
15 Government 
Subsidy 
+ A dummy variable (1) represents receipts of 
government subsidy and (0) otherwise. 
16 
 
Organisational 
Size 
+ The net assets divided by the number of employees 
in a nanotech R&D organisation in a given country. 
17 
 
Solvency + The average financial for all nanotech firms in the 
sample countries for the given years. 
18 
 
R&D Intensity + The average  expenditure by all nanotech firms in 
each country on research and development. 
19 
 
Foreign 
Affiliations 
+ A dummy variable (1) for those nanotech firms that 
are associated with foreign partners. 
20 
 
Total Assets 
Growth 
+ The average annual growth rate of the total assets of 
nanotech firms in a given country. 
21 
 
Independent 
Board 
+ A dummy variable (1) represents independent board 
and (0) otherwise. 
Key variables for my study and expected relationships in my data analysis 
4.3.4 Control Variables 
I controlled for the organisational size and average VC investments into nanotech 
firms in the country in which they operate. Dummy variables were employed to 
quantify the categorical variables in order to enrich my dataset when running the 
regressions while the natural logarithm was used to scale the large amounts. 
Controlling these variables helped me better understand the effects of my 
independent variables on the observed variable. These variables are held constant 
in order to effectively evaluate the relationship that exists between nanotech 
performances in a country and the legal, regulatory, cultural and fiscal external 
environments.  
4.3.5 Multi Regression Models  
Since the performance of the commercial activities of nanotech R&D firms can be 
observed in several ways, I developed four multiple regression models which are 
aimed at incorporating the different forms of innovative and financial performance of 
nanotech R&D firms. I used multiple linear regression models to derive OLS 
estimates which that minimize the squared residuals of best fit. I specify my multiple 
regression models for this research study in the equation 2 below: 
𝛾𝑖 =  𝛽0 +  𝛽1𝑋1𝑖 +  𝛽2𝑋2𝑖 + ⋯ + 𝛽𝑘𝑋𝑘𝑖 +  𝜀𝑖   
120 
 
Where γ is the dependent variable for the ith observation, which is the number of 
patents in the nanotech firm before the start of commercial activities; β0 is the 
constant or intercept which that depicts the relationship that exists without the inputs 
of my explanatory variables. β1 to βk are the parameters and Ҳ1 to Ҳk are the 
coefficients, while ε is the error term which that describes the random element of the 
linear relationships between explanatory and response variables.  
4.3.6 Panel Data Analysis 
According to Berrington (2006), panel data is frequently used to overcome the 
limitations of static cross-sectional data such as unobserved variable bias, 
endogeneity bias and indeterminacy over the sequencing of the causal mechanism. 
Panel data has been employed in this report to tackle the time ordering of variables 
and to detect the trajectories over time in order to accommodate the possibility that 
observations for the same unit over time is unlikely to be independent of one 
another. 
4.3.6.1 Mixed Model Approach 
Mixed model provides a flexible platform for multi regression analysis because it 
generally permits the modelling of a vast array of correlation patterns. Mixed model 
is the combination of fixed and random -effects which provides the error term with an 
interesting structure. Seltman (2012) defines mixed model as ‘the panel dataset that 
allows regression coefficients to vary across values of a higher order variable’. As 
proposed by Wooldridge (2008), the model below provides the equational structure 
for analysing a panel dataset; it is the fixed effects transformation. 
?̈?𝑖,𝑡 =  𝛽1?̈?𝑖,𝑡1 +  𝛽2?̈?𝑖,𝑡2 + ⋯ +  𝛽𝑘?̈?𝑖,𝑡𝑘 +  ü𝑖,𝑡 , 𝑡 = 1,2, … , 𝑇. 
Where:  
 ÿ = is the time-demeaned data of the dependent variable y; 
 ẍ = is the time-demeaned data of the independent variables x1, x2 … xk; 
 ü = is the time-demeaned data of the error term; 
 i = No. of Countries; t = No. of Years;  
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I adopted fixed-effects since I am interested in evaluating the impact of both 
internal and external variables which vary over the commercialisation period of 
nanotechnology. I used fixed-effects to explore the relationship between predictors 
and response variable within a country. While I assume that each country in my 
dataset possesses its own idiosyncratic characteristics that could influence some of 
the independent variables, I control for this by assuming that the correlation between 
a country’s error term and the predictor variables. The purpose of applying fixed-
effects is to eliminate the impact of time-invariant features in order to evaluate the 
net effect of the predictors on the response variable. Hausman test was carried out 
to check if the error terms are correlated.  The equation for the fixed effects model is: 
𝛾𝑖,𝑡 =  𝛼𝑖 + 𝛽1𝑋𝑖,𝑡 +  𝑈𝑖,𝑡 
 The key to resolving the problem of correlated within subject errors in this research 
study is to let each subject have their individual intercept and slope randomly 
deviating from the mean intercept for each country (Seltman, 2012). I would 
aggregate nanotech firm performance by country and regress the resultant country 
observation against a series of country-specific explanatory variables that are also 
aggregated over time. The linear relationship between nanotech performance and 
changing firm- and country-specific factors are shown below: 
∆𝑁𝑎𝑛𝑜 − 𝑃𝑒𝑟𝑓𝑜𝑟𝑚𝑎𝑛𝑐𝑒𝑖,𝑡 / 𝐹𝑖𝑟𝑚 𝑆𝑖𝑧𝑒𝑖,𝑡 = 𝛼 + ∑ ∑ 𝛽𝑚,𝑠
1
𝑠=0
𝑀
𝑚=1
∆∁𝑚,𝑖,𝑡−𝑠  +  𝜀𝑖,𝑡  
Where: 
 Δnanotech firm successi,t is the % change in number of 
patents/NPD/Revenue/PBIT in country i during year t (i.e. From year t-1 to 
year t), s is lag length which varies with t. 
 
 Cm,i,t-s are changes in the changes in corporate income taxes, indicator 
variables that measure positive/negative changes in a country’s economic 
growth during year t and the prior year. 
 
  
4.3.7 Handling Collinearity problems 
Naes and Mevik (2001) argues that Collinearity problems significantly affect the 
prediction and classification ability of the panel data; in terms of instability of the 
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small eigenvalues and the consequences this may have on the empirical inverse 
covariance matrix which is involved in regression. I would examine the correlation 
coefficients among all dependent and independent variables so as to perform a 
series of OLS regressions in which I estimate variance inflation factors (VIFs). Also, I 
conducted Hausman Test to examine the correlation between the time-variant and 
time-invariant variables. 
4.4 DATA ANALYSIS 
The extant empirical studies on the performance of nanotechnology activities have 
generally concentrated on the factors which influence the scientific publications and 
patent applications of researchers and R&D organisations. Also, another common 
approach has been the assessment of the new nano-products in relation to meeting 
consumer preferences where nanotech R&D firms marketable goods and services 
which generate revenue that can be sustained over a period of time. In this study, I 
analyse the success of nanotech firms during the period of intensive R&D initiatives 
which boosts the commercial prospects of nano-products in the market place.  
4.4.1  Descriptive Statistics 
Table 4.3 below shows the summary statistics for this research report. It depicts the 
mean, standard deviation, minimum and maximum values as well as the number of 
observations for each variable. The total number of nanotech firms is 1,407 and is 
used to provide sufficient framework to analyse the success of these high-tech firms.  
The number of patents and new nano-product developed are converted to natural 
logarithm to reduce the influence of outliers and provide a proxy for the innovative 
performance of nanotech firms. Also, the domestic or foreign affiliations of the 
nanotech firms were taken into account by considering the location of their 
manufacturing base; a dummy variable is used to indicate cross-border effects on 
their success. In addition, the sectors to which the nanotech companies belongs 
helps to identify the different industry which they operate in.  
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Table 4.3:               Descriptive Statistics and Correlation Matrix 
 
Table 4.3 shows the descriptive statistics and correlation matrix for this Chapter 
Variables
Mean
Std. Dev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
1
Liquidity
25.11592
9.2290806
1
2
Employee Turnover
2.056414
6.96266
0.6211
1
3
Long term Orientation
29.19755
18.5603
-0.0923
0.0316
1
4
Industry Diversity
3.90517
20.51651
0.1765
0.1933
0.3489
1
5
Legal Origins
18.01848
1.61193
-0.1211
-0.2475
0.1087
0.0605
1
6
VC Investment
0.7063369
0.4556155
0.0314
-0.3541
0.1985
-0.2475
0.1697
1
7
Masculinity vs Femininity
55.802318
4.2976627
0.3612
0.3021
0.0308
-0.3541
0.0195
0.2395
1
8
Uncertainty Avoidance
47.857805
8.9280148
-0.1388
-0.0761
0.0474
0.3021
0.2779
0.0191
0.0314
1
9
R&D Intensity
3.063875
7.596558
0.0938
0.1989
0.5093
0.0579
0.3591
-0.139
-0.657
0.1697
1
10Total Assets growth
15.379414
8.215785
-0.1649
0.0143
-0.304
-0.0808
0.1996
-0.33
-0.059
0.0195
-0.029
1
11Export Demand for High-Tech
40.719289
4.0501818
0.1697
-0.3838
0.1481
0.3088
0.5093
0.2496
-0.029
0.1459
0.1745
0.0249
1
12Entrepreneurial Index
12.68769
105.838
0.0195
0.1124
0.1958
0.0474
-0.304
-0.174
-0.086
-0.243
0.0147
0.3237
0.0195
1
13Economic Growth
5.218258
35.8802
0.2779
-0.2663
0.0424
0.3511
0.1481
0.3237
0.0516
-0.222
-0.155
0.3088
-0.081
-0.194
1
14Power Distance
159.0521
202.8128
0.0999
-0.1944
0.3591
-0.0104
0.1958
-0.174
-0.162
0.0605
0.2395
0.0474
0.3237
-0.165
0.1958
1
15Solvency
38.56146
38.15551
0.3271
0.0443
0.0984
0.0165
0.0424
0.0316
-0.189
-0.248
0.0191
0.3511
-0.174
0.1697
0.0424
-0.174
1
16Government Subsidies
0.8106646
0.3919263
0.0727
0.0101
0.1745
0.0474
0.3591
0.1933
0.4543
-0.354
-0.008
-0.01
0.0316
0.0195
0.3591
0.3237
0.1765
1
17Foreign Affiliations
0.2990726
0.4580287
-0.1051
0.3088
-0.1741
0.1765
0.0984
0.1367
0.1448
0.3021
0.2478
0.0165
0.1933
0.2779
0.0984
-0.174
-0.121
0.1124
1
18Corporation Tax Rate
0.0942813
0.2923326
0.0121
0.0474
0.3237
-0.1211
0.1745
0.3488
0.2933
0.0579
-0.139
0.2779
0.1367
0.0999
0.1745
0.0316
0.0314
-0.266
-0.304
1
19Organisational Size
13.44915
50.29794
0.0195
0.3511
-0.1741
0.0314
-0.174
0.0573
0.1901
0.5283
0.0938
0.0999
-0.042
0.0424
0.1459
0.1933
0.0314
-0.194
0.1481
0.1124
1
20Independent Board
0.028471
0.57466
-0.1007
0.1721
0.1851
0.1985
0.0145
-0.354
0.0556
0.0195
0.2779
0.2129
0.0579
0.3271
0.1124
-0.058
0.2009
0.3484
0.1481
0.2779
0.3021
1
21R&D Expenditure
4.82355
20.48787
-0.0947
0.1958
0.1022
0.0308
0.0463
0.3021
0.0326
0.3591
0.0121
-0.417
-0.081
0.0727
-0.266
-0.118
-0.036
0.7645
0.1958
0.0999
0.1548
0.1801
1
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Table 4.4:                            Multiple Regression Coefficients 
Internal 
Dynamics 
 
Model 1 
(Patents) 
Model 2 
(NPD) 
Model 3 
(Sales) 
Model 4 
(Profits) 
 
R&D Intensity 0.0122** 0.0125**  0.0121** 0.0280*** 
  (2.61) (2.81) (2.76) (4.11) 
Organisational 
Size 0.00206* 0.00213** 0.00241** 0.00149 
  (2.49) (2.72) (3.08) (0.87) 
Employee 
Turnover 0.0052* 0.00627* 0.000473 -0.00637 
  (1.20) (1.52) (0.11) (-1.01) 
Solvency -0.00579 -0.00429 0.000344* 0.0000464* 
  (-1.40) (-0.70) (0.7) (0.06) 
Liquidity -0.00455 0.000354 0.0192** 0.0255** 
  (-1.55) (0.69) (1.37) (1.15) 
Total Asset 
Growth -0.00234 -0.00211 0.00147* 0.00364* 
  (-1.04) (-0.99) (0.69) (0.88) 
Independent 
Board 0.00887 0.0101 0.00572* 0.00669* 
  (1.35) (1.62) (2.06) (2.40) 
Government 
Subsidy 0.00196 -0.000597 0.0125* 0.0316* 
 (0.43) (-0.14) (2.00) (2.16) 
VC Participation 0.022 0.000209 1.127*** 1.118*** 
 (1.58) (0.43) (3.74) (3.54) 
                  
External 
Dynamics     
R&D 
Expenditure 0.596*** 0.438** 0.434** 0.144 
 
(3.5) (2.68) (2.67) (0.65) 
Technological 
Adv. 0.479* 0.309* 0.345** 0.531** 
 
(1.96) (1.32) (1.48) (1.87) 
Corporation Tax 0.123 0.0904 -0.0278* -0.0646* 
  (0.67) (0.52) (-0.15) (-0.27) 
Economic 
growth 1.312*** 1.188*** 1.177*** 0.912** 
  (5.26) (5.01) (4.96) (2.97) 
Entrepreneurial 
Index  0.244 0.299* 0.253** 0.396** 
  (1.64) (2.12) (1.79) (1.93) 
Foreign 
Alliances -0.481** -0.300* -0.285 -0.16 
  (-3.09) (-2.00) (-1.89) (-0.81) 
Legal Origins 0.186** 0.238* 0.244* 0.296* 
125 
 
  (1.24) (1.67) (1.71) (1.53) 
Uncertainty  0.00929** -0.108 -0.14 0.599** 
 Avoidance (1.73) (-0.19) (-0.50) (1.15) 
Femininity 
Values 0.00193 -0.154 0.0466* 0.484* 
  (0.04) (-1.05) (0.20) (0.90) 
Power Distance 
 
0.0873*** 
(4.71) 
0.0779* 
(1.88) 
0.615*** 
(6.75) 
1.547** 
(1.91) 
Long-term 
orientation 
 
0.765** 
(1.30) 
0.590* 
(1.31) 
0.778*** 
(2.48) 
0.745** 
(0.173) 
Industry 
Diversity 0.00863 162.3 0.447*** 0.00823** 
  (4.12) (0.11) (5.37) (1.84) 
Constant 17.39*** 18.81*** 18.18*** 15.98*** 
  (49.67) (47.61) (43) (20.59) 
Observations 1407 1407 288 288 
t statistics in parentheses: * p < 0.05, ** p < 0.01, *** p < 0.001 
 
Also, where the national culture of countries is that masculine values heavily 
dominate over feminine ones, there are usually fewer performing dimensions of 
nanotech companies. Regulatory barriers, as well as low female participation in 
science and technology, are possible reasons for these cultural effects on the 
performance of nanotech R&D ventures. My results show that a country’s cultural 
attitudes concerning uncertainty and feminine values affect the way nanotech R&D 
companies are managed. A high intolerance for ambiguous nanotech R&D ventures 
within a society brings about centralized governance mechanisms, which lead to less 
innovative outcomes. Likewise, a dominant masculine culture within a society means 
that nanotech R&D ventures tend to have centralized governance mechanisms that 
seek to achieve organizational objectives at the earliest possible time frame.  
Also, I find that the economic expansion of a country enhances the all performance 
dimensions of nanotech R&D ventures, due to the additional sources of funds 
available for R&D expenditure. As expected, a high GDP growth positively influences 
the number of patents secured, the amount of new nano-products developed, the 
sales revenue received from marketing these high-tech products and the level of 
profitability in the overall commercial operations among nanotech R&D ventures. 
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Also, a high GDP growth rate is more likely to have a positive effect on the time 
spent in developing innovative assets by nanotech ventures, as funding from R&D 
expenditure increases from government agencies. Similarly, an active VC fund 
manager’s participation in the strategic activities of nanotech firms significantly adds 
to the successful commercialization of nanotech companies; I believe this is in order 
to monitor and supervise the R&D projects so that financial performance is attained 
as the earliest possible time. 
Larger nanotech companies are capable of performing better than their SME 
counterparts, because they have greater financial resources and better human 
capital (Zheng et al., 2014). The innovative assets of these large nanotech R&D 
firms negatively affect their profitability since they hoard secret commercial 
information for competitive advantages. High export demand for technologically 
advanced products and services tend to have a significant effect on the sales 
revenue generated by nanotech companies.  My results show that legal origins 
significantly affect the governance mechanisms of nanotech R&D companies. I find 
that nanotech firms that carry out their collaborative R&D projects in countries with 
French and German Civil Law origins have centralized governance mechanisms, 
compared with English Common Law origin, because of the need to tightly control 
the activities of their partners to adhere to stringent regulatory policies. Also, 
countries with French Civil Law origins are likely to weaken the value networks of 
nanotech R&D companies, compared with those with legal origins in English 
Common Law countries.  
4.4.3 Discussion of Findings 
I identify possible opportunities and challenges for policy-makers and 
organizational strategists to exploit or guard against, with the objective of enhancing 
various dimensions of innovative and financial performance of nanotech R&D 
ventures. Countries with French Civil Law Origins have a less rigorous legal system 
(La Porta et al., 1999). Nanotechnology is an emerging technology that has few laws 
regulating its industry. The French and German legal systems provide a lesser 
degree of flexibility for securing patents and higher level of predictability for 
estimating litigation outcomes. This makes it less profitable for nanotech R&D 
companies, because there are lots of regulations that either restrict the nature and 
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scale of research exploration and  commercial exploitation or that could pose a huge 
threat and raise the possibility of large losses – unlike the English legal system, 
where there is an inherent rule to have minimum standards of care. 
The level of tolerance for uncertainty within a nation reveals their cultural attitude 
towards risks and ambiguity (Sriwindono and Yahya, 2012). A country with a high 
uncertainty avoidance index is more likely to have rigid belief systems that are 
intolerant of unorthodox and risky behaviours, because the majority of people with 
such cultural values are sensitive to, and feel uncomfortable with, unstructured or 
changeable environments. However, a low uncertainty avoidance index evinces that 
members of a society are more likely to be forbearing towards ambiguous or 
uncertain R&D ventures, because they are entrepreneurial in nature and are likely to 
feel comfortable in risky and less structured environments. In these countries, 
nanotech R&D firm managers can take advantage of the politically active and 
informed populations by making quick decisions that exploit innovative concepts. 
Feminine values are another important cultural trait to seriously consider, as this 
trait affects the some of the dimensions of nanotech company performance. A high 
proportion of female involvement in science and technology within a country would 
more likely increase the strength of value networks and reduce the innovative 
capacity of nanotech R&D ventures. In contrast, a more dominant male presence 
usually leads to ego-oriented inter-firm relationships that promote fierce competition 
and focus on profit maximization, irrespective of the impact on the external 
environment. Cultural values do not easily change in the short run and are usually 
passed from one generation to another, so it is expedient for policy-makers and 
corporate strategists interested in nanotech firm performance need to understand the 
possible implications and predictable behaviours relating to risk tolerance, 
procedural controls, and adherence to norms within a community that they operate 
in, so as to promote discussions that alleviate unproven claims, improve negotiating 
processes, and reduce litigation costs (Hong, Heikkinen, and Blomqvist, 2010). In 
knowledge-based economies, the expansion of economic activities usually leads to a 
rise in R&D expenditures. Most R&D organisations normally obtain massive funds 
from research councils and industry partners to finance their R&D ventures, with the 
aim of building innovative high-tech industry and foster regional economic growth 
(This corresponds with the findings of Bilbao-Osorio and Rodriguez-Pose, 2004; 
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Guerrero, Cunningham, and Urbano, 2015). Periods of economic growth positively 
affect the innovative and financial performance of nanotech R&D ventures, as a 
result of the availability of several funding prospects, the prevalence of commercial 
opportunities, and the rise in labour participation.   
An increase in the external R&D activities of high tech firms has resulted in the 
rapid rise of inter-organizational relationships, which lead to patent licensing 
agreements and the development and production of new products. The 
commercialization of R&D activities via university-industry collaborative partnerships 
has brought not only economic development but also the technological advancement 
of nations, due to the international demand for their high-tech products, which are 
usually emerging or disruptive know-how. Having exclusive rights to an innovative 
product in the form of a patent provides nanotech firms with the required protection 
for their intellectual property and encourages more R&D projects in the future. As a 
result of globalization, many countries have been able to unlock localized industries 
by taking advantage of new and existing export opportunities for high-tech products 
and services around the world (Mehta et al. 2012). World trade organization has 
alleviated most barriers and challenges in international commerce, as advanced 
nations and large corporations are able to attract high-skilled labor and sophisticated 
investments into emerging and disruptive industries to provide technologically-
advanced products and services for worldwide consumption. The export demand for 
high-tech products evinces the level of technological advancement in a country. Most 
MNCs have their internal R&D capabilities at their headquarters, and many external 
R&D projects are organized in their home country. Nanotech firms that operate in 
advanced technological nations are more likely to sell their newly developed 
innovative products to international markets. They are also more likely to spend less 
time in collaboration, due to their centralized governance mechanisms and 
comprehensive value networks. 
A high financial position or status of nanotech firms equips R&D project managers 
with sufficient tangible and intangible resources to engage into complex collaborative 
partnerships which yield innovative performing outcomes. In order words, a highly 
profitable, solvent and liquid nanotech firm would be able to form large collaborative 
partnerships with international reach so as to coordinate useful networks which are 
more likely to contribute significantly to the development of new products during 
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commercialisation. The operations of a financially stable nanotech firm provide 
implicit guarantees and explicit endorsements that the R&D products would likely 
succeed due to the availability of additional resources which could be deployed if 
needed. For instance, a high solvency in nanotech firms creates a huge valuable 
financial position which is able to ensure initial funding from long-term reserves and 
relative stability in R&D operations during constricting economic periods and in times 
of rising unexpected litigation costs. Also, financial institutions and government 
agencies are willing to participate in the funding of nanotech R&D projects when the 
firms in collaborative partnerships have serviceable debt levels which do not bring 
additional economic liabilities or legal constraints. Nanotech firms with evidence of 
strong past financial performance in terms of profitability and liquidity are placed on a 
higher status during negotiations as weaker or smaller new partners are happy to 
make some concessions in other to be part of an exclusive R&D project which has a 
good chance of success. In general, some financial performance indicators could 
provide a significant insight on factors that influence the innovative performance of 
R&D projects. The presence of VC funding in collaborative nanotech R&D projects 
means that a much specialised financial expert would provide useful counsel on the 
most commercially viable path to pursue in the quest to create an innovative product 
which meets profitable consumer needs because of the active participation and 
strong influence VC fund managers usually obtain through contractual obligations.  
The ability of a nanotech firm to retain previous knowledge and integrate it into their 
current operating system means that new external knowledge would likely be 
efficiently managed to stimulate innovative outcomes because the best industry 
practice and successful previous processes would be adopted effectively to take 
advantage of key business opportunities which enhance the innovative performance 
of nanotech R&D firms. A critical issue here could be developing a governance 
mechanism which provides nanotech R&D project managers with a reasonable level 
of discretion in making key resource reallocation decisions and gives their financial 
sponsors adequate monitoring tools to reduce information asymmetry. Previous 
experiences provide ample ammunitions to R&D project managers in the form of 
collaborative knowledge. Having an awareness of what to look out for and guiding 
against common pitfalls are some of the advantages of obtaining useful previous 
experiences in R&D collaboration. However, R&D project managers should be 
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mindful of the fact that previous experience is only a guide and do not necessarily 
affect future R&D ventures. This means that old organisational procedures and 
strategies should be moderated to accommodate new types of foreign partners and 
new ways to maximize the contributory effects on the innovative performance of 
nanotech R&D projects. It must be emphasized that adequate documentation of 
previous collaborative partnerships is imperative because of the need for constant 
referrals on what works or on what should be avoided. Innovative assets are 
considered as a main determinant of innovative performance in R&D ventures.  
4.5 CONCLUSION 
In this final section, I would identify possible opportunities and challenges for policy 
makers and organisational strategists to exploit or guard against; in order to enhance 
the innovative and financial performance of nanotech companies.  
4.5.1 Managerial Implications 
A large number of foreign partners in nanotech R&D collaborative partnership 
provide a bundle of diversification benefits which influences the creativity and 
productivity in R&D projects. However, foreign alliances only facilitate the 
development of new products and do not significantly affects the securing of patents 
or the profitability of newly developed products. It means that R&D project managers 
or organisational strategists must focus on unique procedures which integrates each 
aspect of the collaborative partnership in such a way that all parties involved are 
required to understand and appreciate the legal and commercial external dimensions 
of the R&D ventures so that early profitable opportunities are identified, legal barriers 
are mitigated, intellectual property rights are secured and future market trends are 
recognised and exploited. 
The value network of a collaborative partnership in nanotech R&D projects is 
considered to be very strong when it is deeply integrated vertically and horizontally 
from their supply-chain in order to meaningfully enhance the innovative performance 
of R&D projects. However, a strong value network does not necessarily mean that 
new products will be developed because of the complexities in nanotechnology 
production. Nonetheless, R&D project managers are required to maximize human 
resources in a way that circumvents the challenges and riskiness of developing new 
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products which are safe and viable in the market place. This would require having a 
structural procedure in place which seeks to facilitate timely interactions among all 
partners in such a way that the conceptualisation of new products are harmonised at 
inception and strategically evaluated by top managers so that adequate resources 
could be channelled into the development of these new products on time.   
4.5.2 Key Recommendations 
4.5.2.1 Policy Recommendations 
Nanotechnology is an interdisciplinary field that requires a great deal of physical 
closeness among R&D partners, who use very complex instruments to develop 
innovative products and services through a decentralized system of governance that 
minimizes contingency risks (Steinmo and Rasmussen, 2016). The lack of a 
concentration of nanotechnology experts within a local scientific community in the 
past has created a need for international collaborations with a distributive 
organizational structure, in spite of the drawbacks from their geographical closeness 
(Kabo et al., 2014). Nanotech R&D ventures usually involves large funds and 
expertise, which divert managerial resources away from internal R&D projects. 
Institutionalizing collaborative partnerships is extremely challenging, because R&D 
projects demand new organizational structures and procedures that harness 
available resources to achieve set objectives.  
As a discontinuous innovation-based technology, nanotechnology has few laws that 
regulate its industry. It requires highly skilled scientists from different disciplines to 
work in close proximity and operate complex instruments to create innovative new 
products within a specified period of time. Nanotechnology is an interdisciplinary field 
that requires a great deal of physical closeness among R&D partners, despite the 
advancements in ICT as well as the free movement of capital and labour across 
Europe. Globalisation has helped many countries to unlock localized industries, by 
taking advantage of new and existing export opportunities for high-tech products 
across the globe. Universities involved in discontinuous innovation-based R&D 
projects have specialized interdisciplinary centers, which are capable of collaborating 
with more industrial partners because of their access to additional financing. Patents 
and other intellectual property should be used to meet the needs of low-end and 
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prospective customers. Also, academic institutions are now benefiting from the 
legitimate financial considerations of supplementing patents with publications. 
Advanced nations and large corporations are able to attract high skilled labour and 
sophisticated investments into emerging and disruptive industries to provide 
technologically advanced products and services for worldwide consumption. Also, a 
high proportion of female involvement in science and technology within a country 
would likely increase the strength of value networks and reduce the period of 
collaborative partnerships in nanotech R&D projects. The existence of VC funding in 
nanotech R&D projects indicates that there are significant commercial opportunities 
available, and that entrepreneurial prowess is prevalent in such collaborative 
partnerships. Certain legal systems, which provide both a greater level of flexibility 
for securing patents and a higher level of predictability for estimating litigation 
outcomes, are likely to be more appealing to nanotech R&D project managers, 
because there is little regulation restricting the nature and scale of research 
exploration and commercial exploitation or that could pose a huge threat and the 
possibility of large losses. Also, countries with high uncertainty avoidance index are 
more likely to have rigid belief systems that are intolerant of unconventional and 
hazardous behaviours, because the majority of the population feel anxious about 
unpredictable environments. A low uncertainty avoidance index evinces that 
members of the public are more likely to be tolerant towards ambiguous or uncertain 
R&D ventures because of their entrepreneurial mind-set which is at ease with risky 
and unstructured environments.  
4.5.2.2 Sales (Marketing Strategy) Recommendations 
Nanotechnology will underpin the future global economy and knowledge of its 
commercial possibilities along with the environmental impact has to be fully explored 
and exploited to the level of its technological development (Mangematin and Walsh, 
2012). The development of nanotechnology provide vast reservoir of latent 
innovative capacities which create business opportunities for manufacturing firms 
and a substantive remedial solution to the gradually hollowing-out of core 
competencies and existing industrial prowess in advanced countries (Ikezawa and 
Ueda, 2013). Another level of competition in nanotechnology occurs at the setting of 
optimal management policies besides the scientific and technological dimensions 
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(Nicolau, 2004). Nanotechnology would cause the next surge in technological 
development which would be characterised with components of radical innovation 
across various fields (Maine et al. 2012). Commercial motivations is likely enhanced 
in nano-scientists as their research activities are applied in nature, receive huge 
public funding and have little regulatory barriers (Nikulainen and Palmberg, 2010). A 
collaborative partnership among nanotech organizations with foreign designations 
could be employed as a market entry corporate strategy into tightly controlled 
nanotech industries to circumvent regulatory constraints.  
4.5.2.3  Ethical Recommendations 
The fierce global competition in the development of nanotechnologies raises 
legitimate concerns whether ethics could become a casualty in the race for technical 
superiority. So it is incumbent of industry participants to undertake self-examination 
for early risk identification and avoidance of harsh regulatory measures (Linton and 
Walsh, 2012). The impact of nanoscience and nanotechnologies has been keenly 
highlighted by prominent individuals, interest groups and even in the movies, so as 
to promote thorough risk assessments and further regulatory activities, and ensure 
that a high level of ethical standards are employed during commercial development. 
These assurances have significantly reduced the British public’s concerns about the 
ambiguities in nanoscience and nanotechnology. Therefore, it is imperative for 
nanotech firms in countries with an English Common Law origin to take into 
consideration the additional cost required to make risk assessments about their R&D 
ventures publicly available, in order to enhance public awareness and reduce the 
general intolerance for uncertainties associated with nanotechnology.  
 
 
 
 
 
 
134 
 
Chapter 5: Financial & Non-Financial Determinants of the Exit Performance 
of Venture Capital (VC) and non-VC backed Nanotechnology Portfolio 
Companies 
 
5.1 INTRODUCTION 
5.1.1 Brief Overview of Venture Capital 
At the turn of the 20th century, venture capital (VC) was mostly in the domain of 
wealthy individuals and families such as J.D. Rockefeller, J.P. Morgan and the 
Wallenberg’s. They all sought to acquire strategic but also lucrative private 
companies in order to gain significant control of particular industries within the U.S. 
economy. After the stock market crash of 1929 and subsequently the great 
depression that ensued in the 1930s; large solvent corporations with massive cash 
reserves were able to take advantage of the shutdown of the financial system by 
purchasing bankrupt industry-leading companies and revolutionary business 
ventures at their ‘fire sales’ value.  
According to Hsu and Kenney (2004), the modern origins of VC could be traced to 
the formation of the American Research and Development Corporation (ARD) in 
1946 by Georges Doriot, who is regarded as the father of venture capitalism. After 
World War II4, the United States government was eager to promote job opportunities 
for returning veterans and others alike in order to stimulate economic activities. 
Consequently, financing start-ups became even more essential at the time; with the 
need for a specialist organisation to identify and fund innovative concepts, unknown 
technologically advanced products and superior industry services. The United States 
is generally regarded as the birthplace of VC activities; and it is no surprise that it 
has the most sophisticated VC industry in the world. A huge portion of the global VC 
industry operations can be attributed to the entrepreneurial spirit prevalent in the 
United States.  
Traditional financial institutions such as banks are unable or unwilling to finance 
and monitor high-tech entrepreneurial activities due to their complexities, riskiness, 
illiquidity and untested markets and/or products. Over the years, VC has played an 
                                                          
4
 Lerner (2002) argues that ARD funded new technologies developed during World War II. 
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instrumental role in financing companies with little or no economic track record in 
order to capitalise on revolutionary discoveries in emerging and disruptive 
technologies like information & communication technologies (ICT) and bio-
nanotechnology. During the Dot-Com economic boom in the Mid 1990s, for instance, 
VC firms around the world provided seed finance and other kinds of support like 
accounting, marketing, legal, and industry network to lots of young IT companies so 
as to capitalise on the huge gains from the sale of these IT stocks through various 
exit platforms. Thiengtham (2010) describes ‘venture capital as a long term 
investment in equity capital of new, potentially high growth, and non-publicly traded 
companies that produce new and innovative products and services for new 
customers in new markets in return for capital gains rather than interest income and 
dividend yields’.  
Although, VC activities have considerably and rapidly spread across the globe; 
Schwienbacher (2005) argues that there still exist substantial differences between 
the U.S. VC industry and the rest of the world particularly in areas such as - the use 
of convertible securities, the need for change of management upon investment and 
the degree of deal syndication. Nevertheless, since the advent of globalisation in the 
1990s, the access OECD countries have to efficient capital markets; skilled 
workforce, effective intellectual property protection and sophisticated research 
facilities have significantly increased their VC activities (Djankov et al, 2008). 
According to Aizenman and Kendall (2008), the UK is regarded as one of the top net 
recipients of foreign VC investments because the government has endeavoured to 
create conducive environment that enhances VC performance. Samila and Sorenson 
(2009) obverse that due to the positive effects VC has on a country’s sustainable 
economic growth and youth employment; governments around the world are eager 
to create a more favourable atmosphere for VC investments in order to meet 
stakeholders’ expectations.  
5.1.2 Structure of VC Investments 
In this research report,  ‘VC is defined as an independent, professionally managed, 
dedicated pools of capital that focus on equity or equity-related investments in 
privately held, high growth companies’ (Gompers and Lerner, 2001). VC firms are in 
the business of investing in, building up and selling off companies for a profit in order 
136 
 
to create value for all stakeholders. The complex nature of VC investments require 
certain level of specialty within a longer working framework (usually 5-7 years); 
making it an ideal alternative investment asset class for sophisticated boutique 
financiers. According to Jeng and Wells (2000), VC is a type of private equity which 
involves equity investments made, typically in new and entrepreneurial companies, 
for the launch of a seed or start-up company, early stage development, or expansion 
of a business. Schwienbacher (2005) defines VC as an illiquid investment into high 
risk firms which initially do not possess positive cash flows but provide viable exit 
avenues from which investors maximize fund earnings.  
VC funds are a collective investment scheme used in making investments in 
various portfolio companies. The legal structures of VC funds are usually limited 
liability partnerships which allow fund providers capital gains tax exemptions and 
diversification benefits. The legal framework consists of limited partners (i.e. 
suppliers of VC funds) and general partners (i.e. directors of VC firms). VC funds 
require partnership deeds between VC firms and VC fund Suppliers which is usually 
a well-structured legal agreement that includes the minimum fund size; the expected 
fund life; common goal; conflict resolution mechanism such as disclosure policies 
and review procedures; and also the compensation framework. According to 
Landstrom (2007), the ‘three’ main VC activities can be divided into: ‘fundraising’ 
from limited partners, government sponsors and fund of funds; ‘investing’  into the 
controlling shareholdings of high growth start-up companies; and exit strategies for 
‘divestment’ and fund reallocation. The returns on VC investments are dependent on 
the growth and profitability of their portfolio companies. The returns are earned when 
VC firms sell their shareholdings to the public through initial offerings (IPOs) and/or 
to its industry competitors via mergers and acquisitions (M&As). While bankrupt 
portfolio companies are regarded as losses to the VC funds and negative goodwill to 
the VC firms. 
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Figure 5.1:   Structural Diagram of VC Industry Activities                 
Source: http://www.agilevc.com/blog/2014/10/29/where-do-venture-capital-dollars-actually-come-from.html 
 
5.1.3 Key Activities in the Venture Capital Industry 
According to Landstrom (2007), the ‘three’ main VC activities are: ‘fundraising’ from 
limited partners and via fund of funds; controlling ‘investments’ in high growth start-
up companies; and exit strategies for ‘divestment’ and fund reallocation. The returns 
on VC investments are dependent on the growth and profitability of their portfolio 
companies. The returns are earned when VC firms sell their shareholdings to the 
public through initial offerings (IPOs) and/or to its industry competitors via mergers 
and acquisitions (M&As). While bankrupt portfolio companies are regarded as losses 
to the VC funds and negative goodwill to the VC firms. 
5.1.3.1 VC Fundraising 
VC fundraising is basically all the activities undertaken by VC firms to attract funds 
from limited partners (LPs) in order to secure private equity financing for the 
purchase of unlisted stocks of high growth portfolio companies. Investopedia defines 
VC funds as ‘an alternative investment asset class which seeks and manages 
private equity stakes in small- and medium-size start-ups’ characterized by high- 
risk/return opportunities.  
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Due to the lacklustre returns from VC investments and the tight exit markets since 
the global financial crisis (GFC) in 2008; LPs have been reluctant and sometimes 
unable to provide sufficient funds to GPs. The annual sum of new financial 
commitments made by LPs in the U.S. from 2009 to 2014 continues to be 
significantly less than the annual VC deals (NVCA Yearbook, 2014). VC fundraising 
has been challenging and competitive in recent years; nevertheless, VC firms have 
outperformed other players in the private equity (PE) industry. 
5.1.3.2 VC Investing – Deal Making 
VC deals cover the process of screening, identifying, negotiating, announcing and 
managing investments in portfolio companies for the sole aim of maximizing 
stakeholders’ value. General Partners (GPs) make financial commitment towards 
their portfolio companies as VC deals are reached with the young entrepreneurs at 
different stages of their business life cycle. 
5.1.3.2.1 Stages of Financing for VC Investments 
‘Seed Stage Financing’ is when VC investments at this initial phase in the business 
life cycle of the start-up companies involve the provision of a token amount of private 
capital for pre-marketing purposes. Young entrepreneurs receive finance to - prove a 
concept, test a product, further develop a computer program, carry out a market 
research, write up a professional business plan and/or secure a patent. ‘Early Stage 
Financing’ is when VC directors at this critical stage are concerned with funding 
business activities in - product marketing, industry networking, leasing contracts, 
regulatory formality and human resources. The aim of this sort of VC investments is 
to make the start-ups commercially viable.   
‘Expansion Stage Financing’ is when VC firms provide funds to portfolio companies 
at this growth stage in order to - mitigate negative cash-flows, maximize highly 
profitable opportunities, meet new industry expectations, advertise product/service to 
target audience, acquire greater service licence, increase production capacity, adapt 
to regulatory changes and/or improve customer relations. VC directors become more 
strategic at this financing stage because of the maturity of the portfolio company. 
‘Later Stage Financing’ is when VC funds at this stage are used to finance - research 
& development (R&D) programs, mergers and acquisitions (M&As), and also multi-
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regional/national ventures of the portfolio companies. The stable growth-rate and 
established cash-flows at this mature stage of the business life cycle of the VC 
backed companies make it attractive for traditional or distressed investments. Most 
VC directors would be devising their optimal exit strategy in order to divest and 
reallocate funds to young and promising enterprises. 
5.1.3.3 VC Exit Strategies 
Exit strategies are established avenues VC firms employ whenever divestments are 
deemed necessary. As VC backed companies reach maturity usually within 5-7 
years, divestments become essential due to the need to ensure the liquidity of VC 
funds in order to - distribute returns, evaluate performance and/or reallocate 
entrepreneurial finance. A classic example of VC divestments is Macintosh (1997) 
five types of VC exits: initial public offerings, strategic acquisitions, secondary sales 
to other institutional investors, buybacks from management and write offs during 
bankruptcy. Jeng and Wells (2000) conclude that IPOs are the most useful tool of 
VC investments. IPOs are regarded by VC industry experts as the most profitable 
exit platform for portfolio companies since it provides greater access to external 
finance.  
Nevertheless, VC directors exit more of their investments via Buy-outs due to the 
ease and cost of conducting trade sale. VC exits and other activities are highly 
dependent on the socio-economic, cultural and geo-political external environments 
because it determines on the - timing, volume, amount and/or viability of VC industry 
operations. Cochrane (2005) argues that the performances of VC investment are 
could be assessed whenever the portfolio companies undertake new financing, gets 
acquired or goes public.  According to Barnes and McCarthy (2003), the 
performance of a VC investment can effectively be evaluated through the proceeds 
of the initial public offerings or trade sales. Gompers and Lerner (2001) argue that 
VC exits through IPOs provide greater returns than any other exit strategy.  
Bankrupt portfolios are written off by VC directors usually using fire sales; and non-
disclosure restrictions are sometimes placed on all parties involved. The worldwide 
aggregate value and number of VC backed exits were meaningfully affected by the 
global financial crisis in 2008/2009. Also, it is useful to note that write-offs and sale to 
GPs have increased during this period in relation to the other VC divestment. Black 
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and Gilson (1998) conclude that countries with vibrant stock market rather than bank 
based financial system facilitate greater VC activities. Levis (2008) concludes that 
venture capital investments exited via an IPO are regarded as key performance 
indicator of the success of a VC fund. According to Cochrane (2005), the maximum-
likelihood estimate technique can be employed in order to measure the performance 
of VC investments because it adjust for any selection bias which may arise as a 
result of bankrupt portfolio companies.  
5.1.4   Demand for and Supply of Venture Capital 
The demand for VC funds among young entrepreneurs is quite astonishing - about 
10% of the total numbers of business plans submitted to VC firms are thoroughly 
screened and only 1% of the entrepreneurial concepts secure financing from GPs. 
The factors that significantly affect the demand for VC funds are – quality of the 
prospective management team, viability and profitability of the business 
plan/concept, prevailing market conditions, level of youth unemployment, cultural 
perceptions associated with business success or failure, minimum capital amount 
required; and the tax regimes at the head office region of the start-ups. 
The supply of VC funds by LPs is largely due to the - track record of the VC 
directors, diversification benefits accrued to the VC fund supplier, regulatory burden, 
cost of VC capital, religious affinity, demography, liquidity considerations, legal 
structure, capital gains tax regime, fund size, level of private property protection, 
judicial independence and cultural obligation. This report would be focusing only on 
the supply-side of VC investments and exits. Government agencies around the world 
have participated in facilitating the demand for and supply of VC funds. Policy 
makers in various countries have adopted schemes and instituted vehicles that 
enhance VC activities in order to - reduce political risk, suppress youth 
unemployment figures, stimulate economic growth, encourage innovation  and foster 
wealth creation amongst its citizenry. 
5.1.5   VC in Developed Countries vs Emerging Economies 
A large portion of the global VC industry operations can be attributed to the 
entrepreneurial spirit prevalent in the United States. Also, the access OECD 
countries have to efficient capital markets, skilled workforce, effective intellectual 
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property protection and sophisticated research facilities enhance their VC activities 
and performance (Djankov et al, 2008). Das (2010) depicts with empirical evidence 
that emerging market economies (EMEs) such as those of the BRICS nations - aim 
to attract global private investments by implementing certain economic policy 
reforms; paying specific attention to exchange rate regimes; providing affordable 
education in order to improve the skills of her workforce; and also investing in new 
technologies so as to facilitate communication, transportation, and other 
infrastructural development. Eid (2006) observes that VC investments are the 
principal source of finance for entrepreneurship in most EMEs. 
According to Ewing (2004), VC plays a vital role in building a vibrant private sector 
in EMEs through the channelling of funds to young entrepreneurs unable to access 
seed capital from banks due to their very low appetite to finance unproven business 
ventures and industries. VC investments are highly essential to EMEs due to: 
knowledge transfer through partnerships; high liquidity which facilitate sustained 
economic growth; employment generation and youth empowerment; and the 
identification and funding of winning firms and ideas. VC in the United States and 
Europe plays the most dominant role in global VC activities due to their superior 
governance and free market principles. China, on the other hand, has begun to 
embrace more liberal economic policies in recent years and it is no surprise their VC 
industry has significantly grown ever since. The VC in developed countries is 
primarily focused on funding Bio-tech and IT/Software firms while VC in emerging 
markets concentrate on finance for the manufacturing and agricultural industry. 
5.1.6   The Future of Venture Capital – ‘Equity Crowdfunding’ 
Sullivan (2006) coined the term ‘crowdfunding’ and describes it as the newest 
evolutionary form of micro financing. Golic (2013) defines crowdfunding as a new 
and innovative platform which links investors and entrepreneurs together through the 
internet in order to finance business ventures and communal activities using 
relatively small individual commitments but from large number of volunteers. Bradley 
and Luong (2014) argue that crowdfunds are a type grass root finance that is 
unregulated and could be traced as far back as the early 1700’s. 
Manchanda and Muralidharan, (2014) observes that angel investors and venture 
capitalists have always been considered gatekeepers of entrepreneurial finance; but 
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crowdfunding has now brought about a global paradigm shift in start-up financing 
where customers as well as the general public could become owners of a private 
business entity with relatively low transaction costs. Dorff (2012) argues that the 
‘JOBS Act 2012’ in the U.S. opened a new frontier in start-up financing because for 
the first time, small companies can sell their stocks on the internet without registering 
with the Security and Exchange Commission (SEC). The global growth of 
crowdfunding in recent times has been quite extraordinary; the United Kingdom in 
2013 crowdfunded business ventures to the tune of £120 million. 
5.1.7   Research Questions 
The research objective for this paper is to examine the main financial and non-
financial determinants of the exit performance of VC backed nanotech portfolio 
companies in the United Kingdom. I want to evaluate the key performance indicators 
that influence the exit routes of VC backed nanotech companies. I aim to study the 
relationships that exist between predictors of financial performance and exit 
outcomes of VC investments in the UK. The research questions for this study are: 
what are the financial and non-financial variables that significantly influence the exit 
performance of VC backed nanotech portfolio companies? Do divestments within the 
city of London perform better than the others within the UK? Does the size of the exit 
deal amount affect VC performance? Do cross-border VC exits outperform those of 
domestic VCs? 
5.2 LITERATURE REVIEW 
A company’s financial structure is irrelevant for real investment decisions in an 
efficient capital market (Modigliani and Miller, 1958). However, due to market 
imperfections, firm investment decisions are influenced by its financial status (Cleary, 
1999). Identifying financial determinants which precisely estimate the performance of 
a company is crucial because it provides useful and comparable information for 
effective decision making (Delen et al, 2013). Firm performance measurements 
depict the efficiency with which the management of a company utilises its assets to 
maximize profits (Barkham et al., 1996). The internal growth can be qualified as a 
key measure of company success while controlling for externalities. 
5.2.1 Performance Measurement of VC Investments 
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The extant literature on VC research has focused on fund level analysis for a while 
when measuring the performance of VC activities. The discounted cash flows from 
VC investments have provided useful financial metrics to assess the performance of 
VC funds in order to compare them with similar within the alternative investment 
class. It is only recently that firm level analysis has been incorporated into 
performance measurement of VC divestments. Chenhall and Langfield-Smith (2007) 
argues that management accounting has provided useful internal metrics to assess 
the financial performance of a firm. McKelvie and Davidson (2009) further argue that 
the dynamic capabilities of business entities lie at the heart of their competitive 
advantage. Murphy, et al. (1996) concludes that accurate performance measurement 
helps management with an insight into understanding the possibility of a new 
business failing or succeeding.  
5.2.1.1 Discounted Cash-flow Returns – IRR 
Discounted cash flow returns provide an effective evaluation mechanism by which 
VC activities can be measured for their investment attractiveness. Mason and 
Harrison (2002) argue that the customary measure used to ascertain the 
performance of funds within VC industry is the internal rate of return (IRR). This 
performance metrics takes into account the cash-on cash returns derived VC 
investments in portfolio companies that have been realised or not and net of 
management fees (Mason, 2010). 
5.2.1.2  Firm Growth – Employee or Turnover Changes 
There are significant differences between a firm’s growth and its financial 
performance as companies that perform well may not necessarily grow and vice 
versa. Matsumoto et al (1995) concludes that the most important performance metric 
used by security analysts are growth ratios followed by valuation and profitability 
measures. Barkham et al. (1996) argue that the growth performance of a firm are 
usually measured based on their revenue stream or the human capital employed. 
Barkham et al. (1996) further argues that turnover is likely the most appropriate 
indicator of how a firm is performing among its competitors. 
5.2.2   Accounting Data as Key Predictor of Firm Performance 
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Beaver (1966) describe financial ratios as a quotient of two numbers which have 
predictive capability to determine the likely performance outcome of a business 
venture and are derived from elements of a financial statement prepared under 
generally accepted accounting principles. Gallizo and Salvador (2003) argues that 
accounting ratios make available valuable quantitative financial information that 
could be employed by both analysts and researchers to assess the operations of a 
firm and evaluate its position within a sector over time.  
Financial ratio analysis depends on the principle of proportionality which could help 
explain the firm performance and their size effects (Cinca et al., 2005). Accounting 
ratios which are derived from the financial statements of a company provide vital 
information to creditors and suppliers; evaluate the competitive positions of rivals; 
measure the financial performance of a potential target acquisition, predict future 
performance using historical data, and assess management efficiency for reward 
purposes (Delen et al., 2013). Financial reports are the main source of information 
for financial performance analysis which then provides top management with 
valuable acumen for developing effective strategies (Marginean et al., 2015). 
Edmister (1972) concludes that financial ratios are very useful tools for predicting 
whether a small business enterprise fails or survives. Maricica and Georgeta (2012) 
argue that financial ratios provide early warning signals about the evolution of a 
company’s health and potential risks. Wang and Lee (2008) observe that financial 
ratios have patterns; and it would be expedient to cluster those with similar features 
in order to produce concise evaluation criteria for a variety of performance 
measurements. Liang et al., (2016) conclude that the most important factors that 
affect bankruptcy predictions are solvency and profitability ratios as well as the board 
and ownership structure. Cinca et al., (2005) observes that small firms have higher 
probability of failure than large firms.  
5.2.2.1 Profitability Ratios 
Since profit making is one of the key objectives of most business entity, evaluating 
the performance of any firm must at some point involve looking at the returns from 
investment. Due to the illiquid and complex nature of VC activity, stakeholders have 
to wait for a significant period of time before they enjoy the rewards from sponsoring 
such business ventures.  
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Profitability ratios are a group or class of financial metrics that are employed when 
assessing a firm’s ability to generate sufficient income so as to exceed its 
expenditure and create some reserves for further expansion their growth activities or 
distribution to shareholders for a specific period of time. These ratios are profit 
margin, return on capital employed, return on total assets, etc. 
5.2.2.2 Solvency Ratios 
The long term survival of a firm is determined by its ability to meet future debt 
obligations with expected future cash flows. For a company to guarantee its going-
concern status; there has to be sufficient funds available to cover its long term 
liabilities. In order to evaluate a business venture’s ability to avoid default, it is 
important to envisage the probability of defaulting on future debt payments. Solvency 
ratios are a financial metric which provides insight into a company’s long term 
viability and stability (Lewellen, 2004). 
5.2.2.3 Liquidity Ratios 
Working capital management is at the heart of liquidity in any business entity 
because it determines the funds needed for smooth day to day operations. Proper 
management of these funds are crucial for the survival of a firm as daily activities 
could be shut down due to lack of such vital cash or bank deposits. Liquidity ratios 
provide insights into a firm’s ability to meet its short term debt obligations as they fall 
due. Liquidity ratios measure a company's ability to meet short term debt obligations 
and offer a reasonable margin of safety for their operations. These financial metrics 
include current ratio, quick ratio and operating cash flow ratio. A company could be 
solvent and illiquid at the same, causing short term crisis for financing its daily 
operation and then risking the possibility of bankruptcy.  
5.2.3    Theories of VC Exit Performance 
The performance of VC backed portfolio companies can be assessed along several 
dimensions. According to Zhang (2007), a successful VC funded start-up is expected 
to survive as a going concern, raise funds via IPOs, become very profitable in its 
operations and create adequate job opportunities for its stakeholders. In this 
research report, the numerous dimensions employed to evaluate performance are 
restricted to the availability of data. Wennberg and DeTienne (2014) argue that the 
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performance of portfolio companies is a critical element that determines the 
possibility of a successful exit, the nature of such exit and the process in which 
divestments occur. 
Figure 5.2:   VC backed IPOs from 1995 - 2015 
 
Source: NVCA Yearbook 2016 
Baygan and Freudenberg (2007) argues that venture capital enhance their portfolio 
companies’ performance in terms of survival rates, innovation and growth. Sahlman 
(1990) argues that the ability for VC firms to make a profitable exit lies at the heart of 
VC activities in portfolio companies. Gompers and Lerner (2001) observe that exit 
routes provide VC fund managers with an essential avenue for overcoming liquidity 
challenges; as divestments from portfolio companies are recycled into new ventures 
in order to facilitate the survival and growth of the VC firm. Black and Gilson (1998) 
conclude that exits enable VC firms to continue other activities, recover used funds, 
recognise unrealised profits, measure current fund performance and build a strong 
reputation.  
Cumming and MacIntosh (2003) purports that VC will exit their investments when 
the projected marginal value added as a result of the VC’s efforts, at any given time 
period, is less than the projected cost of these efforts. They further observe that the 
incentives for VC to exit their investments exist when there are windows of 
opportunity to sell into the public market or to a strategic acquirer when valuations 
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are particularly high i.e. over-valued. Rosa et al (2003) defines VC as the pre-exit 
capital provided by professional investors who actively monitor the portfolio 
companies and argues the most preferred exit strategy of VC fund managers are the 
initial public offerings. Loughran and Ritter (1995) conclude that in the three years 
post-IPO, VC backed portfolio companies significantly underperformed a group of 
similar of non VC backed companies because of the unwarranted over-optimistic 
assessment of the long run performance by investors. 
5.2.3.1 Partial & Full VC Exits 
According to Cumming and MacIntosh (2003), full exit for VC backed IPOs could be 
defined as the sale of all equity stake in the portfolio company within one year of the 
deal financing completion while partial exit is the disposition of some but not all of the 
shareholdings within the same period. For VC backed M&As, the method of exit 
payment matters in determining whether there was a partial exit or not; cash 
payment indicates full exit while payment via stock points to partial exit. For VC exit 
through liquidation, write-down of book value would be considered partial exit while 
write-offs would be seen as full exit. 
There are several factors such as the VC fund size and investment stage; the 
prevalent economic conditions; the reputation of the VC firm; the degree of 
information asymmetry amongst the parties of the exit transaction; the VC fund 
location and pre-exit performance; the legal and regulatory framework; etc., that 
influence the likelihood of a full exit during VC divestment (Arthurs and Busenitz, 
2006). Bock and Schmidt (2015) observes that for VC exits via IPOs, the underwriter 
usually imposes a six month lockup period on the vendor to retain their investments 
in order to signal to new investors greater confidence in future share price thereby 
reduce uncertainty. 
Partial exits are more likely to signal greater performance prospects to new 
investors as the information asymmetry increases between a vendor and an acquirer 
of VC Portfolio Company. There is ample empirical evidence in the literature which 
shows that partial ownership retention is an indicator of under-valuation of the 
portfolio company during VC exit (Paeglis & Veeren, 2013). The different types of 
exit employed by VC fund managers to divest from their portfolio companies are 
uniquely affected by the possibility of there been a partial exit. 
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Espenlaub et al., (2015) argues that the timing of exit is very significant to VC 
directors because the cost of further monitoring and illiquidity issues has to be 
weighed in against the additional value that could be introduced to the portfolio 
company before exit. Some of the previous studies suggest that the timing of exits 
are determined by several factors such as the stock market capitalisation, the quality 
of the legal system and other economic activities. 
5.2.3.2 Cross-border VC Divestments  
Schertler and Tykvova (2012) observe that the internationalisation of the VC 
industry in the 1990s has allowed for the vast and steady increase in cross-border 
VC investments around the world such that foreign VC participation in local portfolio 
companies now account for one third of global VC activities. Wang and Wang (2011) 
argue that one of the effects of globalisation has been the facilitation of cross-border 
VC activities due to the relative ease in labour restrictions, capital controls and 
banking regulations among developed countries and emerging markets. 
According to Aizenman and Kendall (2012), the bulk of VC activities in the US are 
domestically funded but as for the UK and the rest of the world, foreign participation 
has been very crucial to the development of their VC industry. Black and Gilson 
(1998) observe that cross-border VC investments have considerably reduced the 
cost of the learning process for VCs as a result of the increased human capital into 
the domestic VC industry. Espenlaub et al., (2015) observes that cross-border VC 
investments are exited more quickly than domestic VC investments because of the 
greater marginal cost of monitoring incurred by the foreign VCs. Makela and Maula 
(2005) suggests that foreign VCs could provide better access to technology and/or 
markets for their portfolio companies than domestic VCs. 
5.2.3.3 Government-sponsored VC Activities  
Lerner (2002) asserts that there has been considerable government involvement in 
financing VC activities particularly in the funding of the operations of new high tech 
companies. Munari and Toschi (2015) observe that throughout Europe and around 
the world, various government agencies have actively develop VC initiatives which 
aims to mitigate the VC funding gap, leverage private VC investments and enhance 
the performance of technologically-driven companies. Government organisations 
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usually justify their intervention into VC markets with the arguments that it would 
create employment opportunities, boost economic growth and foster successful 
innovative enterprises within the country.  
Zarutskie (2010) purports that based on the human capital theory; government-
sponsored VC firms are less likely to attract and retain talented fund managers due 
to low performance expectation. Luukkonen et al., (2013) argues that public VC firms 
are less involved in professional activities such as change of management team, 
identifying a suitable acquirer or recruit new board members; when compared with 
private VC firms. Cumming et al. (2017) observes that public VC firms lack 
independence in their decision making process; have weak compensation schemes; 
and are created by statute.  
5.2.3.4 Macro-economic Factors 
Gompers and Lerner (1999) argue that certain macro-economic variables (such as 
GDP growth, interest rates, unemployment and inflation) have a significant impact on 
venture capital activities. Black and Gilson (1999) support this argument with 
empirical evidence showing a positive relationship between GDP growth and VC 
investment activity. Gompers and Lerner (1999) show that a high interest rate level 
negatively affects VC fundraising but positively affects VC investments. Black and 
Gilson (1999) conclude that due to the illiquid nature of VC investments, a vibrant 
stock market provides the VC industry with: a crucial exit platform, a means to 
evaluate their performance and an instrument to facilitate the cycle of VC activities.  
Beck et al., (2003) observes that VC investments in OECD countries considerably 
promote start-up activities which in turn facilitate job employment particularly among 
the youths. Berger and Udell (1998) argues that VC funds serves as an engine for 
economic growth due to the provision of entrepreneurial finance to new bio-tech and 
IT firms as well as to emerging market economies. Schertler (2003) argues that the 
rigidities in the labour market have a negative effect on all VC activities especially on 
early stage fundraising. Black and Gilson (1999) further argues that labour market 
regulations such as lay-off restrictions and financial compensation rules imposed in 
Germany and other European countries severely affect the vitality of start-ups and 
provides further explanation of the differences in the level of VC activities across 
nations. Lerner (2002) asserts that there has been considerable government 
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involvement in financing VC activities particularly in the funding of the operations of 
new high tech companies.  
5.2.3.5 Fiscal Factors 
Poterba (1989) concludes that variations in capital gains tax rates significantly 
affect those VC investors with personal tax liabilities and potential entrepreneurs but 
exclude institutional investors like Pension funds. Auerbach and Selmrod (1997) 
observe that after the Tax Reform Act of 1986 was enacted, there has been 
considerable increase in various financial transactions that aims to avoid tax 
amongst very wealthy individuals. Gompers and Lerner (2004) assert that a 
decrease in capital gains tax significantly accelerates VC commitments at the firm, 
industry and country levels. Romain and Pottelsberghe (2004) assess the effects of 
corporate income taxation on VC investments in OECD countries from 1990 to 2000 
and conclude that there exists an inverse relationship between changes corporate 
tax rates and VC investments.   
5.2.3.6 Regulatory Restrictions 
Kortum and Lerner (2001) argue that the regulatory restrictions imposed on 
pension fund managers with regards to investing in VC funds directly affect the 
supply and demand of venture capital in OECD countries. Jeng and Wells (2000) 
observe that the level of a country’s private pension fund strongly influences VC 
activities in the long run. Ueda and Hirukawa (2008) further argue that certain 
favourable regulatory changes such as ERISA of 1979 and Bayh-Dole Act of 1980 
facilitates the activities and performance of the VC industry in the United States.  
Krishnan et al., (2011) argues that the reinterpretation of ERISA in 1979 is generally 
considered as the birth of the modern VC industry due to the crucial role pension 
funds now play in the provision of VC funds. Timmons and Bygrave (1986) conclude 
that as overall VC investments increased substantially from 1979, so did initial stage 
financing for highly innovative start-up surge. Black and Gilson (1999) argue that the 
differences in the size of pension funds and the degree of regulatory restrictions to 
VC funding help explain the discrepancies in VC activities across countries. Also, the 
quality of financial reporting as evidenced by strong accounting standards seriously 
affects VC funding as a result of the heavy burden it places on start-up firms (Jeng 
and Wells, 2000). 
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5.2.3.7 Cultural Considerations 
Hofstede (1994) defines culture as the collective programming of the mind with the 
objective of producing a unique value system and communal identity which 
distinguishes a group of people from another. Hofstede (1983) identifies four cultural 
dimensions which act as differentiators in order to capture the complexity of nuances 
that describes culture. Franke et al., (1991) observes that as VC firms become more 
global in their operations, the need to understand national cultures is very essential 
because it partly determines VC performance into their cultural environment in order 
to be effective in the attainment of organisational goals. 
Harris (2000) argues that multinational corporations are faced with the onus of 
creating an organisational culture that embraces diversity in order to harness fully 
the skills and talents of all their employees. Basu and Yoshida (2012) assert that 
globalisation has facilitated the increase of trade among nations and this has 
resulted in the convergence of cultures and collision of linguistic practices. Based on 
a cross-country study which analyse cultural effects on business, Hofstede (1983) 
argues that the attitude of professionals could be derived from their religion and 
other cultural phenomenon. Licht et al., (2001) concludes that cultural variables 
explain the discrepancies in investor protection rights better than the legal traditions 
of countries and such variables as language and religion affects financial market 
development. Chandler and Hanks (1994) conclude that market attractiveness and 
resource-based capabilities influences the location and performance of VC firms. 
5.2.3.8 Geographical and Other Dynamics 
Beck et al (2003) argues that the geographical location and disease environment of 
colonies influenced the settlement strategies of European great powers which in turn 
affected the development of financial institutions and private property rights. 
Hofstede (1983) further argues that institutional fund managers are very much 
interested in the identity, traditions and politics of the region that their investments 
flow into. Gupta and Sapienza (1992) concludes that the different features of VC 
firms such as fund size, financing stage, management experience and ownership 
structure strategically determine the industry diversity and geographical location of 
their investments. Using dataset that encompasses countries from different world 
locations such as Japan, Israel, U.K., and Germany, Mayer et al. (2005) depict the 
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geographical impact on VC investment activity where the greater the distance 
between venture capitalists and portfolio companies, the higher possibility of a lesser 
monitoring and support. There are no significant diversification benefits for VC 
investors with regards to location of their portfolio companies.  
Romain and Pottelsberghe (2004) concludes that the rate of growth in R&D 
investments, the availability of knowledge stock and the size of high level patents 
substantially influence the VC industry in any country. More severe protection of 
intellectual property rights enhances the growth and performance of VC activities. 
According to Gompers and Lerner (1999), the level of research and development 
(R&D) activities within a country significantly affects its VC fundraising due to the 
likely increase in the demand for VC funds.  Kortum and Lerner (2001) points out 
that the greater the VC investments, the higher the rates of patents. Using a proxy 
variable for the entrepreneurial culture in a given country, Romain and Pottelsberghe 
(2004) show that the growth rate of human knowledge influences the size of people 
in start-ups companies. 
Kim (2008) analyse the cross-country effect of politics and stock market 
development and show that there exists a positive relationship between the two 
variables. Using data from the U.S. and Germany, Coeurderoy and Murray (2008) 
reveal that political uncertainty significantly affects the attractiveness of VC 
investments and exits. Bonini and Alkan (2009) argue that the level of corruption 
within a country poses a serious political risk for VC investments in all stages. Using 
economic geography model to study if the home market effects from individual 
demand on production patterns could be predicted for a set of OECD countries; they 
conclude that there was evidence that economic geography model could determine 
the production structure of OECD countries. 
 
5.2.4  Hypotheses Formulation 
 H1:  VC backed portfolio companies that have exited via living dead are less 
likely to be profitable than those exited via IPOs and M&As, and more likely to 
be profitable than those that are liquidating.  
 
 H2:  VC backed portfolio companies that have exited via living dead are less 
likely to be solvent than those exited via IPOs and M&As, and more likely to 
be solvent than those that are exiting via liquidation.  
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 H3:  VC backed portfolio companies that have exited via living dead are less 
likely to be liquid than those exited via IPOs and M&As, and more likely to be 
profitable than those that are liquidating.  
 
 H4:  VC backed portfolio companies that have exited via living dead are less 
likely to be optimally leveraged than those exited via IPOs and M&As, and 
more likely to be profitable than those that are liquidating.  
 
 H5:  VC backed portfolio companies that have exited via living dead are less 
likely to be profitable than those exited via IPOs and M&As, and more likely to 
be profitable than those that are liquidating.  
 
5.3 RESEARCH METHODOLOGY 
5.3.1  Data Collection 
In order to assemble the dataset for the research study, I use FAME and Zephyr 
databases of Bureau van Dijk (BvD) to collect 1,294 VC exit outcome of nanotech 
portfolio companies and their corresponding book-value performance ratios from 
1997 – 2016 in the UK. I extract both numerical and categorical data from Zephyr 
database on - the VC exit types; the total deal amount; the key sectors; whether exit 
is full or partial; if VC investment is domestic or foreign; Portfolio Company’s age at 
deal year; and the total numbers of employees, directors and shareholders before 
and after year exit year. Using the unique BvD id numbers, I then merge the data 
with those from FAME which comprises of the pre and post exit performance ratios 
of all the VC portfolio companies. 
5.3.1.1 Dependent Variables 
Using a similar method adopted by Cumming (2008), in this research report, exit 
performance is operationalised as a qualitative dependent variable with four mutually 
exclusive categories. There are multi dependent variables, as the exit strategies for 
VC backed nanotech portfolio companies in the UK are sub-divided into four main 
categories namely: Mergers and Acquisitions (M&As), Initial Public Offerings (IPOs), 
Living Dead (i.e. young companies due exit but are unable to as their low 
performance) and Liquidation (Insolvency, Bankruptcy, Administration, Write-offs, 
etc.). There is no intrinsic ordering to the nominal dependent variables because of its 
qualitative features; nevertheless, the Living Dead portfolio companies are used as 
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the base or reference group due to their high likelihood of occurrence among other 
categories of the response variables in the dataset.  
5.3.1.2 Independent Variables 
The continuous independent variables for this research study are accounting exit 
performance measurements that indicate the portfolio company’s profitability, 
leverage, solvency, liquidity, employee growth, etc. I consider the average portfolio 
companies’ book-value ratios for 24 months after the VC fund managers have partly 
or fully exited their investments. This provides me with the explanatory variables for 
the study, as I try to assess the impact of the different types of exit strategy executed 
by the VC firms. I capture the changes in the level of profit margins, turnover, 
number of employees and shareholders, size of total assets and cash-flows in order 
to predict the internal factors that affect the exit performance of VC investments in 
the UK. 
5.3.1.3 Control Variables 
I controlled for the amount of the exit deals, the UK location of the portfolio 
company, whether the VC exit was full or partial and the key sectors of operation. 
Dummy variables were employed to quantify the categorical variables in order to 
enrich my dataset when running the regressions while the natural logarithm was 
used to scale the exit deal amount.  
 
5.3.1.4 Expectations of Variables 
Table 5.1:    Relationship of Key Variables   
Variables of Interest Effect 
Profit Margin +/- 
Return of Capital Employed (R.O.C.E.) +/- 
Liquidity  +/- 
Solvency  +/- 
Gearing  
Salaries/Turnover 
Employee Turnover 
Total Asset Growth 
Full Exit  
London HQ 
Deal Value 
Shareholders 
Manufacturing Sector 
+/- 
+/- 
+/- 
+/- 
+/- 
+/- 
+/- 
+/- 
+/- 
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Services Sector 
Cash Payment 
Stock (Shares) Payment  
Foreign Funding 
VC Financing 
+/- 
+/- 
+/- 
+/- 
+/- 
 
5.3.2  Multinomial Logistic Regression Model 
Firstly, I use multiple linear regressions to study the financial factors that affect VC 
portfolio companies’ exit performance in the UK using the average turnover growth 
as the dependent variable and profitability, leverage, solvency and liquidity ratios as 
predictors. Then, I change the response variable to the VC exit strategies of which 
are polytomous in nature and use the multinomial logistic regression model to create 
a platform from which careful consideration of the sample size is made and thorough 
examinations of the outlying cases are realised. The variable selection for the 
multinomial logistic regression is quite similar to that of the standard multiple 
regression. 
According to Cumming et al. (2017), the multinomial logit model is the most 
preferred statistical tool used to differentiate the exit routes of VC backed portfolio 
companies. In my study, I use this model to classify the exit strategies into four 
groups with each explanatory variable having an individual value for each group. In 
order to overcome the difficulty of differentiating between the effects of several 
variables, collinearity is assumed to be very low as there is little use for explanatory 
variables to be statistically independent from each other. I also assume that the odds 
of VC directors choosing one exit strategy over another do not depend on the 
presence or absence of other irrelevant alternatives (Moske and Starkweather, 
2011). 
This lets the choice of K alternatives to be presented as a set of K-1 independent 
binary choices where VC Exits through Buy-Out is chosen as the base outcome and 
other K-1 exit strategies compared individually against it. My model aims to predict 
the probability of the different possible outcomes of the categorically distributed 
dependent variable given the stipulated set of predictor variables (Jain, 2001; 
Cumming, et al., 2017). For the nominal response variable with k categories, the 
model estimates k-1 logit equations. The fundamental essence of the logits is to use 
logarithmic function to restrict the probability values to (0.1). 
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5.3.2.1 Linear Predictor Function 
The idea behind using the multinomial logit model is to build a linear predictor 
function that generates a score from the set of weights that are linearly combined 
with the independent variables of a given observation using a dot product. The score 
is interpreted as the utility associated with VC directors i choosing exit strategy k. 
The predicted outcome is usually the one with the highest score which happens to 
be Buy-Outs in my study. The linear predictor function estimates the probability that 
observation i has outcome k, of the following form:  
 
𝑓(𝑘, 𝑖) =  𝛽0,𝑘 + 𝛽1,𝑘𝑥1,𝑖 + 𝛽2,𝑖𝑥2,𝑖 + ⋯ + 𝛽𝑀,𝑘𝑥𝑀,𝑖 
 
Where:  
βm,k  - is the regression coefficient associated with the mth explanatory variable and 
the kth outcome.   
βk  - is the set of regression coefficients associated with outcome k. 
Xi - is the set of explanatory variables associated with observation i.              
Yi = K - is the set of response variables associated with observation i. 
 
I introduce separate sets of regression coefficients, one for each possible outcome; 
I then derive the exponents for both sides and solve for the probabilities. Based on 
the fact that all K of the probabilities must sum to one; finally, I use the equation to 
find the other probabilities. 
 
𝑃𝑟(𝑌𝑖 = 1) =  
𝑒𝛽1.𝑋𝑖
1 + ∑ 𝑒𝛽𝑘.𝑋𝑖𝐾−1𝑘=1
 
𝑃𝑟(𝑌𝑖 = 2) =  
𝑒𝛽2.𝑋𝑖
1 + ∑ 𝑒𝛽𝑘.𝑋𝑖𝐾−1𝑘=1
 
 … …  
𝑃𝑟(𝑌𝑖 = 𝐾 − 1) =  
𝑒𝛽𝑘−1. 𝑋𝑖
1 + ∑ 𝑒𝛽𝑘.𝑋𝑖𝐾−1𝑘=1
 
 
5.3.2.2 Estimating the Coefficients 
The unknown parameters in each vector βk were jointly estimated by a slight 
modification of the maximum likelihood using regularization of the weights to avoid 
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pathological results. I model the logarithm of the probability of detecting a specified 
output using the linear predictor along with an added normalization factor. I 
determine the value of Z by applying the constraint which requires all probabilities to 
sum to 1. The factor is constant as it is not a function of Yi which is the variable that 
defines the probability distribution. Nevertheless, it is certainly not constant in 
relation to the unknown regression coefficients βk which is used to determine the 
optimization procedure.  
I determine the value of Z by applying the constraint which requires all probabilities 
to sum to 1. The factor is constant as it is not a function of Yi which is the variable 
that defines the probability distribution. Nevertheless, it is certainly not constant in 
relation to the unknown regression coefficients βk which is used to determine the 
optimization procedure. I set the constant so that one of the vectors becomes 0, and 
all of the other vectors are converted into the difference between those vectors and 
the vector I chose. As a result, it is conventional to set C = - βk  (or alternatively, one 
of the other coefficient vectors). Essentially, I set the constant so that one of the 
vectors becomes 0, and all of the other vectors get transformed into the difference 
between those vectors and the vector I chose. This is equivalent to "pivoting" around 
one of the K choices, and examining how much better or worse all of the other K-1 
choices are, relative to the choice are pivoting around. 
5.3.2.3 Estimation of Intercept 
The separate odds ratios are determined for all the independent variables for each 
group of exit strategy with the exception of the base category which is omitted from 
the analysis (i.e. the Buyouts). The exponent of the beta coefficient denotes the 
change in the odds of the dependent variable being in a particular group in relation to 
the base category, associated with a one unit change of the corresponding 
independent variable. 
5.3.2.4  Evaluating goodness of fit 
Pseudo R2 depicts the proportion of variance in the criterion that is explained by the 
independent variables. The likelihood ratio denotes the proportional reduction in the 
deviance in which the deviance is treated as a measure of variation similar but not 
the same as the variance in linear regression analysis. The downside of using 
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pseudo R2 is that it does not represent the proportionate reduction in error because 
the error variances vary in each value of the predicted score. 
 
5.4 DATA ANALYSIS & FINDINGS 
5.4.1 Bureau van Dijk Databases 
Most of the extant empirical analysis on the performance of VC investments has 
been based on the evaluation of fund-level transactions using the internal rate of 
return as a metric for the response variable. Also, another common approach in 
measuring VC performance has been the assessment of the duration between 
receipt and exit of VC investments using survival analysis. In this study, I am limited 
to analysing the success of VC backed portfolio companies to only the types of exit 
as BvD databases  does not provide adequate data on VC firms’ characteristics. The 
amount and date of the VC and non-VC deals and their exits in the UK were 
collected from Zephyr database and the BvD identification numbers were used to 
generate historical financial and non-financial data for the portfolio companies from 
FAME.  
5.4.2  Descriptive Statistics and Correlation Matrix 
The total number of VC and non-VC backed exits and non-exits in the UK from 
1997 to 2016 were 1,294 while some of the financial performance predictors are 
noticeably less than the total observations, it still provides sufficient framework to 
analyse the success of VC portfolio companies. The value of the exit deals are 
converted to natural logarithm to reduce the influence of outliers and provide a proxy 
for the size to the portfolio companies which received VC and non-VC funds. Also, 
the domestic or foreign affiliations of the VC funds were taken into account by 
considering the location of the VC firms; a dummy variable is used to indicate cross-
border effects on their success. In addition, the sectors to which the portfolio 
companies belongs helps to identify the different industry which they operate in. 
 
The deal payment method and planned nature of exit provide further parameters in 
determining the probability of a successful exit. In addition, the number of 
shareholders in the portfolio companies gives a proxy for the size of their corporate 
governance environment. Table 5:2 below depicts the correlation coefficients 
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between each variable and the others and is used to examine the dependence 
between the different variables at the same. There are both low and high correlation 
between some variable as expected.   
Table 5.2:               Descriptive Statistics and Correlation Matrix 
 
Table 5.2 shows the descriptive statistics and correlation matrix for this Chapter 
Variables
Mean
Std. Dev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
1
Profit Margin
45.2126
22.19246
1
2
Return of Capital Employed
4.154
9.959324
0.0679
1
3
Liquidity Ratio
2.3333
7.44078
0.2308
-0.1065
1
4
Solvency Ratio
1.7111
13.0212
0.0015
0.0252
-0.2623
1
5
Gearing Ratio
16.588
44.1996
0.1462
-0.0798
0.1943
-0.3378
1
6
Employee Turnover
8.7971
4.4124
0.01808
0.2196
0.1062
0.5013
0.2951
1
7
Total Asset Growth
40.3325
6.3688
0.2474
0.0115
0.1166
0.1851
-0.3087
0.1718
1
8
Salaries/Turnover
0.23214
0.8198
-0.1948
-0.1331
0.3638
0.1022
0.4221
-0.4836
-0.167
1
9
London HQ
0.4547
0.5265
-0.0369
0.1777
0.1951
-0.1777
0.644
-0.3301
0.4723
-0.1554
1
10Exit Deal Value 
83.5191
14.2449
0.0556
0.1022
0.4509
0.4766
-0.3088
0.2496
0.3088
0.2395
0.3449
1
11Manufacturing Sector
0.3333
2.9043
0.0326
-0.0846
-0.1129
0.3155
-0.2181
-0.1741
0.0474
0.0191
-0.0761
0.1087
1
12Services Sector
9.4402
3.2217
0.1303
0.0605
0.2441
-0.2313
-0.1052
0.0988
0.3511
-0.0081
0.1989
0.1985
0.1055
1
13Shareholders
0.1557
0.44813
0.1287
0.0446
0.258
0.1874
-0.058
0.0093
-0.0104
0.2478
0.0143
0.0308
0.1212
-0.2168
1
14Cash Payment
0.88801
1.91552
0.4301
0.0111
0.2566
-0.0215
-0.1179
0.2495
0.0665
0.0057
-0.3838
0.0474
-0.1342
-0.2002
-0.0471
1
15Stock Payment
15.5844
33.10245
0.1484
-0.3488
0.7898
0.1446
0.0683
0.3052
0.7039
0.0785
-0.0457
-0.1139
0.0243
0.00576
0.0098
-0.0434
1
16Foreign Funding
0.24744
1.115549
-0.0684
-0.0939
0.54484
-0.1774
0.0121
0.1544
0.4871
0.1515
0.5154
0.1465
-0.0864
0.4854
-0.4154
0.1166
0.144
1
17VC financing
0.45489
2.333449
0.0749
-0.0833
0.48777
-0.1656
0.0474
0.8774
0.4248
0.1144
0.1544
0.2144
-0.2425
0.5877
-0.1454
0.3638
0.345
0.0041
1
18Full Exits
0.14857
5.525848
-0.0997
0.1481
0.21545
0.4865
0.3237
-0.184
0.3526
0.1584
0.7841
0.3874
0.0147
0.4487
-0.4485
0.1951
-0.002
0.1419
0.0046
1
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 5.4.3  Empirical Findings 
The objective of this paper is to examine the financial performance predictors of VC 
backed portfolio companies at their exit. In order words, I evaluate the financial and 
non-financial determinants of the success of entrepreneurial firms that received VC 
or non-VC funding at their seed and growth development stage. The aim is not to 
assess the impact of VC and non-VC finance on their performance but rather to 
consider the internal factors that influence the types of exit these companies 
encounter at their later stage. 
5.4.3.1 Multinomial Logistic Estimates 
Using a multinomial logistic regression model where the response variable is 
categorical in nature, I evaluate the effects of performance indicators on the 
probability of an exit outcome of VC and non-VC backed portfolio companies; I find 
that the key performance metric for liquidation exits when compared with living dead 
non-exits is the salaries to sales ratio. This simply means that VC backed portfolio 
companies that exit via liquidation are more likely to lay off employees as the cost of 
sales per employee is high when compared with the base category. As per exits via 
Mergers and Acquisitions (M&A); when comparing them with the reference category, 
I find that M&A exits are less likely to be profitable in terms of returns on equity 
employed. Considering the premium paid on the target company to the VC firm for its 
strategic value, it is understandable. Also, I find that M&A exits are likely to 
experience higher growth in the shareholder numbers but surprisingly they have 
lower growth in their employee size. Finally, I find that M&A exits are more likely to 
be full exits. 
VC IPO exits are more likely to be solvent (i.e. meet their financial obligations as 
they fall due) when compared with the base category. As the portfolio company goes 
public, it has greater access to funds than the reference group. Also, IPO exits - are 
more likely to have their head office in London; are more likely to have access to 
some form of foreign finance, are more likely to be in the manufacturing sector and 
are more likely to expand their operations.  Table 5.2 below contains the multinomial 
logit estimates. There are no estimates for Living-Dead non-exits as they are the 
base category. Model 1, 2 and 3 are similar but few variables are excluded to 
provide further insights for analysis.  
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Table 5.2:  Multinomial Logistic Estimates for VC Performance 
 
 
Model 1 Model 2 Model 3 
Liquidation Exit 
Outcome 
   Profit Margin 0.0075 0.00246 0.00176 
  (-0.55) (-0.17) (-0.13) 
R.O.C.E. -0.00498 -0.00495 -0.00479 
  (-1.16) (-1.27) (-1.24) 
Solvency -0.0269 -0.0279 -0.0264 
  (-1.93) (-1.96) (-1.88) 
Gearing -0.00123 -0.00168 -0.00175 
  (-0.75) (-1.00) (-1.05) 
Liquidity 0.0597 0.0402 0.0366 
  (-1.89) (-1.27) (-1.18) 
Salaries/ Turnover 0.0289* 0.0286* 0.0246* 
  (-2.24) (-2.32) (-2.1) 
Total Assets Growth 0.00652 0.00537 0.00544 
  (-1.13) (-0.98) (-1.01) 
Employee Turnover -0.0112 -0.00985 -0.00912 
  (-0.94) (-0.80) (-0.77) 
Deal Value 0.0532 0.155 0.153 
  (-0.3) (-0.9) (-0.89) 
Shareholders 0.0215 0.0128 0.0113 
  (-0.63) (-0.37) (-0.32) 
Manufacturing -0.104 -0.0174 
   (-0.15) (-0.02) 
 Services 0.989 0.955 
   (-1.12) (-1.13) 
 Full Exits 0.999 0.737 0.781 
  (-1.16) (-0.92) (-0.98) 
Cash 0.616 
    -0.94 
  Shares -1.529* 
    (-2.48) 
  Foreign Funding -0.217 -0.152 -0.112 
  (-0.42) (-0.30) (-0.23) 
London HQ 0.532 0.446 0.461 
  (-1.12) (-0.96) (-1) 
VC Financing 0.415 0.469 0.454 
  (-0.77) (-0.91) (-0.88) 
Constant -3.775 -5.643 -5.481 
  (-1.10) (-1.65) (-1.60) 
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Living Dead Exit 
Outcomes 
Base 
outcome 
  Constant 0 0 0 
M&A Exit Outcomes 
   Profit Margin 0.00883 0.00722 0.00734 
  (-0.75) (-0.62) (-0.63) 
R.O.C.E. -0.00742** -0.00772** -0.00758** 
  (-2.75) (-2.79) (-2.70) 
Solvency ratio -0.000973 -0.000502 0.0000846 
  (-0.08) (-0.04) (-0.01) 
Gearing ratio 0.00165 0.00162 0.00161 
  (-1.39) (-1.37) (-1.38) 
Liquidity ratio -0.382* -0.385* -0.386* 
  (-2.06) (-2.05) (-2.07) 
Salaries/ Turnover -0.00136 0.000601 -0.00177 
  (-0.13) (-0.06) (-0.18) 
Total Assets Growth 0.00945 0.00924 0.00954 
  (-1.69) (-1.66) (-1.72) 
Employee Turnover -0.0251** -0.0250* -0.0252** 
  (-2.58) (-2.56) (-2.59) 
Deal Value -0.605*** -0.613*** -0.620*** 
  (-4.60) (-4.79) (-4.89) 
Shareholders 0.0398 0.0378 0.0368 
  (-1.83) (-1.79) (-1.75) 
Manufacturing -0.165 -0.166 
   (-0.38) (-0.39) 
 Services 0.298 0.225 
   (-0.5) (-0.38) 
 Full Exits -1.604*** -1.560*** -1.553*** 
  (-4.22) (-4.13) (-4.14) 
Cash -0.0668 
    (-0.10) 
  Shares -0.435 
    (-1.18) 
  Foreign Funding 0.0762 0.0732 0.076 
  (-0.2) (-0.2) (-0.2) 
London HQ 0.647 0.66 0.647 
  (-1.78) (-1.83) (-1.82) 
VC Financing -0.283 -0.264 -0.279 
  (-0.71) (-0.66) (-0.70) 
Constant 11.13*** 10.99*** 11.07*** 
  (-4.57) (-4.57) (-4.62) 
IPO Exit Outcomes 
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Profit Margin 0.0167 0.0183 0.018 
  (-1.43) (-1.61) (-1.61) 
R.O.C.E. -0.00215 -0.00208 -0.00175 
  (-1.31) (-1.26) (-1.07) 
Solvency -0.0266* -0.0275** -0.0273** 
  (-2.54) (-2.66) (-2.68) 
Gearing -0.00211 -0.00212 -0.00224 
  (-1.62) (-1.63) (-1.76) 
Liquidity -0.0259 -0.0257 -0.0236 
  (-0.42) (-0.41) (-0.40) 
Salaries/ Turnover -0.00173 -0.00365 -0.0084 
  (-0.18) (-0.38) (-0.95) 
Total Assets Growth 0.00277 0.00294 0.00333 
  (-0.55) (-0.58) (-0.66) 
Employee Turnover -0.0165 -0.0163 -0.0183* 
  (-1.95) (-1.96) (-2.22) 
Deal Value -0.656*** -0.634*** -0.670*** 
  (-5.38) (-5.42) (-5.82) 
Shareholders -0.0337 -0.0153 -0.0171 
  (-0.36) (-0.22) (-0.25) 
Manufacturing -0.708* -0.716* 
   (-2.07) (-2.11) 
 Services -0.581 -0.511 
   (-1.18) (-1.05) 
 Full Exits 0.644 0.628 0.597 
  (-1.33) (-1.29) (-1.23) 
Cash 0.341 
    (-0.57) 
  Shares 0.328 
    (-1.020 
  Foreign Funding 1.188** 1.212** 1.172** 
  (-2.97) (-3.03) (-2.94) 
London HQ 0.555 0.513 0.406 
  (-1.71) (-1.6) (-1.3) 
VC Financing 0.00818 0.0219 0.0317 
  (-0.03) (-0.07) (-0.1) 
Constant 10.88*** 10.76*** 11.13*** 
  (-4.83) (-4.88) (-5.11) 
Pseudo R2 0.221 0.205 0.197 
AIC 826.5 829.4 824.5 
BIC 1055 1033.9 1004.9 
Observations 407 407 407 
* p < 0.05, ** p < 0.01, *** p < 0.001 
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5.4.3.2     Endogeneity Issues and Robustness checks  
The principal challenge in evaluating the determinants of VC performance 
emanates from the rarity of private equity data as most relevant information is not 
available to the general public. Specialist VC databases and country-specific data 
sources require huge monetary considerations and privileged associations in order 
to assemble useful dataset for performance analysis. It has become incumbent on 
VC researchers to develop robust econometric models and/or create proxies which 
closely represent the true parameters of interest so as to circumvent possible 
endogeneity problems. Performance drivers relating to value-added activities from 
the VC firms such as proficiency in deal syndication, networking ability, fund 
specialization, industry experience, and contractual obligation are difficult to measure 
precisely. Also, performance drivers relating to the characteristics of VC backed 
portfolio companies such as geographical proximity, industry growth, founder 
experience and firm development stage are less challenging to compute.  In my 
research study, omitted variable biases and measurement errors constitute the bulk 
of the endogeneity concerns. 
The complex dynamics of PE and VC investments has over the years given birth to 
a myriad of performance measurements. Early research studies on VC success were 
focused on fund-level analysis using the IRR as a metrics that depicts the discounted 
rate of return on VC Investment. For firm-level analysis, employee and revenue 
growth of VC backed portfolio companies has been used in several papers as 
appropriate performance metrics. In recent studies, the duration before divestment 
and the actual exit outcome has been used as effective measures to assess both VC 
fund and firm performance. These different performance measures have enabled 
researchers to use various econometric techniques to analyse VC data and this have 
given rise to some endogeneity problems. One of the key concerns in my study is 
whether the observed exit outcome is caused by the financial idiosyncrasy of the 
portfolio companies rather than the value-added performance drivers of venture 
capitalists (Cumming, 2008). In order to avoid omitted variable bias, I control for VC 
cross-border financing, experience of VCs and VC board membership; to enable me 
account for VC value-added performance indicators.    
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Also, simultaneity bias is believed to be avoided as my financial performance 
predictors are collected ex-ante i.e. three years before exit of the portfolio 
companies. Measurement error would have been present as a result of the use of 
historical book-value and not the true market performance metrics. I try to circumvent 
this by controlling for interest rate, FTSE AIM index and whether a portfolio company 
meets the international accounting standards (IAS). The sample selection was 
designed to carefully ensure proper randomisation of data collected for the research, 
hence, I collected both VC and matched non-VC backed portfolio companies. I 
performed sensitivity analyses to confirm the robustness of my results and provide 
evidence of structural validity for my study. In general, the results obtained through 
this checks are consistent with and reinforce my overall findings in this paper. The 
significance of my model is measured using the likelihood ratio test. 
5.5 CONCLUSION 
5.5.1   Limitations of the Research Study 
I focus mainly on internal determinants of VC success while controlling for some 
external factors. The use of accounting based predictors is the major limitations of 
the study. Since historical costs of assets do not reflect the most recent valuation of 
their real values. This is a working paper and hence there are still lots of room for 
improvement. I intend to construct a book to market ratios for this firms and the exit 
timing of VC divestments using survival analysis. 
5.5.2   Discussion 
I study the factors that influence venture capital exit performance. My model is used 
to predict the probability of the different exit outcomes of the categorically distributed 
dependent variable given the stipulated set of performance predictor variables. I use 
FAME and Zephyr databases of Bureau van Dijk (BvD) to collect 1,294 VC exit 
strategies and the corresponding portfolio companies’ book-value performance ratios 
from 1997 – 2016 in the UK. In order to overcome the difficulty of differentiating 
between the effects of several variables, collinearity is assumed to be very low as 
there is little use for explanatory variables to be statistically independent from each 
other. I also assume that the odds of VC directors choosing one exit strategy over 
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another do not depend on the presence or absence of other irrelevant alternatives 
(Moske and Starkweather, 2011). 
I find that M&A exits are likely to experience higher growth in the shareholder 
numbers but lower growth in employee size within the first 24 months of exit. Finally, 
I find that M&A exits are more likely to be full exits. VC IPO exits are more likely to 
be solvent (i.e. meet their financial obligations as they fall due) when compared with 
the base category. As the portfolio company goes public, it has greater access to 
funds than the reference group. Also, IPO exits - are more likely to have their head 
office in London; are more likely to have access to some form of foreign finance, are 
more likely to be in the manufacturing sector and are more likely to expand their 
operations. 
The key contribution would be to provide founders of young high-tech companies 
and VC fund managers with useful empirical insights into factors within their control 
which influences the long-term continuity of their business venture with or without 
their active participation. My model is used to predict the probability of the different 
exit outcomes of the categorically distributed dependent variable given the stipulated 
set of performance predictor variables. I use FAME and Zephyr databases of Bureau 
van Dijk (BvD) to collect 1,294 VC exit types and the corresponding portfolio 
companies’ book-value performance ratios from 1997 – 2016 in the UK.  
In order to overcome the difficulty of differentiating between the effects of several 
variables, collinearity is assumed to be very low as there is little use for explanatory 
variables to be statistically independent from each other. I also assume that the odds 
of VC directors choosing one exit strategy over another do not depend on the 
presence or absence of other irrelevant alternatives (Moske and Starkweather, 
2011). I find that M&A exits are likely to experience higher growth in the shareholder 
numbers but lower growth in employee size within the first 24 months of exit. Finally, 
I find that M&A exits are more likely to be full exits. VC IPO exits are more likely to 
be solvent (i.e. meet their financial obligations as they fall due) when compared with 
the base category. As the portfolio company goes public, it has greater access to 
funds than the reference group. Also, IPO exits - are more likely to have their head 
office in London; are more likely to have access to some form of foreign finance, are 
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more likely to be in the manufacturing sector and are more likely to expand their 
operations. 
5.5.3  Relevant Implications 
The theoretical implication is that managers’ of SMEs in high-tech industries could 
employ key internal performance indicators in determining the long-term exit firm 
behaviour. This could provide room for strategic alliance to strengthen internal 
weaknesses and exploit external opportunities in other to establish competitive 
advantages. Also, VC fund manager can use these accounting metrics to forecast 
eligibility for further funding rounds.  A practical implication would be considering the 
financial status of a high-tech company in order to explore reasonable sources of 
growth funds for business expansion. 
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Chapter 6: Conclusion 
6.1 Theoretical Contributions 
A model for the relationships between the strength and duration of collaboration and 
the size of the partnership was proposed; which demonstrates that an effective inter-
firm collaboration is dependent not only on the number of partners but also on the 
quality of input delivered into the nanotech R&D projects over a sustained period of 
time. I argue that the greater the strength and the longer the duration of R&D 
collaboration, the lesser the number of their partners. As the strength and duration 
increases, the sizes of both industrial and overall partners will most likely decrease, 
based on their interaction effects. I theorised that for collaborative partnerships in 
high-tech industries to be strong and lasting, the number of the partners must be 
reduced to the most optimal level. Also, I developed a model where the dimensions 
of collaboration among nanotech R&D organisations are affected two major forms of 
proximity: geographical and functional. The geographical proximity to the funding 
and industrial partners were categorised into different levels (local, regional, national 
and international) and functional proximity based on the governance mechanism and 
the value chain of the partners in the R&D collaboration. 
Incorporating the effects of legal origin on R&D collaboration is another theoretical 
contribution made in this thesis. I built from the theory of law and finance initiated by 
La Porta et al., (1999), which stipulates that countries with English Common Law 
origin generally possess stronger shareholder and creditor protection than countries 
with French, German or Scandinavian Law origins (La Porta et al., 2008). I theorised 
that countries which possesses the English Common Law better protect investors 
against expropriations due to the effectiveness of its legal enforcement, which 
highlights the independence of the judiciary and reduces agency problems that result 
in higher dividend pay-outs (Djankov et al., 2008). Integrating the cultural dimensions 
in R&D collaboration is yet another theoretical contribution. I theorised that the 
greater the degree of society’s intolerance for ambiguous and uncertain business 
ventures, the lower the overall partnership size, the more centralized governance 
mechanism, the weaker the value network and the shorter the duration of 
collaborative partnerships in nanotech R&D projects.  
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Also, I proposed that the higher the degree to which masculine values prevail in 
society over feminine values, the greater the partnership’s size, the more centralized 
the governance mechanism, the shorter the duration and the weaker the value 
network of collaborative partnerships in nanotech R&D projects. International 
demand for technologically-advanced products - Higher export performance is 
usually associated with efficient, innovative firms that can create top-quality products 
at reasonably high prices for effective distribution to distant markets (Fajgelbaum, 
Grossman and Helpman, 2011). I theorise that the higher the export demand for a 
country’s technologically advanced products, the greater the number of partners, the 
more centralized the governance mechanism, the shorter the duration and the 
stronger the value network of collaborative partnerships in nanotech R&D projects. 
The higher the rate of economic growth within a country, the greater the partner’s 
size, the more decentralized the governance mechanism, the stronger the value 
network and the longer the duration of collaborative partnerships in nanotech R&D 
projects.  
The ranking of the accomplishments in university and industry R&D collaborative 
partnerships for high-tech innovations is another theoretical contribution - The model 
was constructed from OECD’s National Innovation Systems 1997 future research 
recommendations for measuring innovative performance of R&D projects. It depicts 
the phases in which new knowledge is produced and commercially secured, then 
further developed into innovative product/service for market consumption. The 
scientific productivity to technological profitability model describes the hierarchical 
success levels of inter-organisational R&D collaborations. The active interaction 
between academic scientists and industrial researchers in developing innovative 
products in high-tech industries is critical to building comparative advantage in 
knowledge-based economy. The growth of academic entrepreneurs has led to the 
commercialization of novel concepts derived from scientific endeavours.  
Highlighting the importance of VC fund manager’s participation in nanotech R&D 
projects is a huge contribution as VC plays a vital role in building a vibrant private 
sector by channelling funds to young entrepreneurs, who are unable to access seed 
capital from banks due to their reluctance to finance unproven business ventures 
and industries (Ewing, 2004). VC investments are essential to SMEs due to: 
knowledge transfer through partnerships; high liquidity, which facilitates sustained 
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economic growth; employment generation and youth empowerment; and the 
identification and funding of winning firms and ideas. A high level of VC funding in 
nanotech R&D projects result in a greater innovative performance in collaborative 
partnership.  
6.2 Managerial Implications 
Nanotechnology is an interdisciplinary field that requires a great deal of physical 
closeness among R&D partners, who use very complex instruments to develop 
innovative products and services through a decentralized system of governance that 
minimizes contingency risks (Steinmo and Rasmussen, 2016). The results show that 
external factors – such as the geographical and functional proximities to key 
partners, a country’s legal origin, cultural dimensions, economic growth rate and the 
level of the export demand for advanced high-tech products – meaningfully influence 
the partnership size and governance mechanism, strength and duration of 
collaboration in nanotech R&D projects. The closeness, regarding geography and 
functional space, of nanotech R&D firms most influences the dimensions of their 
R&D collaborations.  
Also, nanotech firms operating in countries with French Civil Law origin are inclined 
to establish a centralized system of governance in their R&D collaborative 
partnerships, due to the high level of legal predictability. Countries with a legal origin 
in English Common Law are less predictable, while those with French Civil Law are 
less flexible (Beck et al., 2003). Legal systems which provide both a greater level of 
flexibility for securing patents and a higher level of predictability for estimating 
litigation outcomes, are likely to be more appealing to nanotech R&D project 
managers because there is little regulation restricting the nature and scale of 
research exploration and commercial exploitation or that could pose a huge threat 
and the possibility of large losses. However, a collaborative partnership among 
nanotech organizations could be employed as a market entry corporate strategy into 
tightly controlled industries to circumvent regulatory constraints.  
In countries that seem to have a low level of uncertainty avoidance, most members 
of their public are more likely to be tolerant towards ambiguous or uncertain R&D 
ventures because of their entrepreneurial mind-set, which is at ease with risky and 
unstructured environments. Countries with high uncertainty avoidance index are 
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more likely to have rigid belief systems that are intolerant of unconventional and 
hazardous behaviours, because the majority of the population feels anxious about 
unpredictable environments. A low uncertainty avoidance index evinces that 
members of the public are more likely to be tolerant towards ambiguous or uncertain 
R&D ventures. Also, a high proportion of female involvement in science and 
technology within a country would likely increase the strength of value networks and 
reduce the period of collaborative partnerships in nanotech R&D projects. 
Also, I find that the innovative capacity and organizational size of nanotech firms also 
affect the dimensions of their R&D collaborations (Fiedler and Welpe, 2010). I argue 
that, because nanotech R&D projects are inherently very complex, nanotech firms 
that operate with a more decentralized internal organizational structure and in a 
simpler external environmental framework will be more effective in their R&D 
collaborations and hence can produce better innovative outcomes for a more 
abundant world. The study shows that large nanotech R&D organizations have fewer 
industrial partners who spend less time to develop new products, due to their strong 
value networks and centralized systems of governance in collaborative partnerships. 
Meanwhile, smaller nanotech R&D firms require more time and a greater number of 
industrial partners to develop new products, as a result of their willingness to impose 
a decentralized organizational structure in R&D collaborative partnerships.  
Most large high-tech firms deliberately seek to capitalise on economic opportunities 
from their existing portfolio of intellectual properties in order to take advantageous 
position in negotiations and strengthen their bargaining chips for cross-licensing 
other patented technologies. The bundle of diversification benefits which a large 
number of partners provide in a high-tech collaborative partnership influences the 
scientific productivity and innovative performance in nanotech R&D projects. For 
instance, the existence of a financially stable and profitable high-tech firm in 
collaborative partnerships provides implicit guarantees and explicit endorsements 
that such R&D projects would likely succeed due to its accessibility to additional 
resources which could be deployed to ensure support and provide some valuable 
liquidity for R&D operations during periods of economic decline and unexpected 
litigation costs. 
172 
 
The value network of a collaborative partnership in nanotech R&D projects is strong 
when it is intensely incorporated vertically and horizontally from their supply-chain in 
order to meaningfully enhance the innovative performance of R&D projects. 
However, a strong value network does not necessarily mean that new products will 
be developed because of the complexities in nanotechnology production. A large 
number of foreign partners in nanotech R&D collaborative partnership provide a 
bundle of diversification benefits which influences the creativity and productivity in 
R&D projects. However, foreign alliances only facilitate the development of new 
products and do not significantly affects the securing of patents or the profitability of 
newly developed products. It means that R&D project managers or organisational 
strategists must focus on unique procedures which integrates each aspect of the 
collaborative partnership in such a way that all parties involved are required to 
understand and appreciate the legal and commercial external dimensions of the 
R&D ventures so that early profitable opportunities are identified, legal barriers are 
mitigated, intellectual property rights are secured and future market trends are 
recognised and exploited. 
I find that VC funding in nanotech R&D projects usually leads to VC’s active 
participation in the strategic management of these collaborative partnerships, in 
particular to influence the size and duration of the cooperative engagements and 
ultimately their innovative and financial performance. The existence of VC funding in 
nanotech R&D projects indicates that there are significant commercial opportunities 
available, and that entrepreneurial prowess is prevalent in such collaborative 
partnerships. Also, VC fund manager can use these accounting metrics to forecast 
eligibility for further funding rounds.  An implication would be considering the 
financial status of a high-tech company in order to explore reasonable sources of 
growth funds for business expansion. I find that M&A exits are more likely to be full 
exits while VC IPO exits are more likely to be solvent (i.e. meet their financial 
obligations as they fall due) when compared with the base category. As the portfolio 
company goes public, it has greater access to funds than the reference group. Also, 
IPO exits - are more likely to have their head office in London; are more likely to 
have access to some form of foreign finance, are more likely to be in the 
manufacturing sector and are more likely to expand their operations.  
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Nanotechnology will underpin the future global economy and knowledge of its 
commercial possibilities along with the environmental impact has to be fully explored 
and exploited to the highest level of its technological development (Mangematin and 
Walsh, 2012). The development of nanotechnology provide vast reservoir of latent 
innovative capacities which create business opportunities for manufacturing firms 
and a substantive remedial solution to the gradually hollowing-out of core 
competencies and existing industrial prowess in advanced countries (Ikezawa, 
2013). Nanotechnology would cause the next surge in technological development 
which would be characterised with components of radical innovation across various 
fields (Maine et al. 2012). Commercial motivations is likely enhanced in nano-
scientists as their research activities are applied in nature, receive huge public 
funding and have little regulatory barriers (Nikulainen and Palmberg, 2010). A 
collaborative partnership among nanotech organizations with foreign designations 
could be employed as a market entry corporate strategy into tightly controlled 
nanotech industries to circumvent regulatory constraints.  
R&D project managers are required to maximize human resources in a way that 
circumvents the challenges and riskiness of developing new products which are safe 
and viable in the market place. This would require having a structural procedure in 
place which seeks to facilitate timely interactions among all partners in such a way 
that the conceptualisation of new products are harmonised at inception and 
strategically evaluated by top managers so that adequate resources could be 
channelled into the development of these new products on time. The fierce global 
competition in the development of nanotechnologies raises legitimate concerns 
whether ethics could become a casualty in the race for technical superiority. So it is 
incumbent of industry participants to undertake self-examination for early risk 
identification and avoidance of harsh regulatory measures (Linton and Walsh, 2012). 
The impact of nanoscience and nanotechnologies has been keenly highlighted by 
prominent individuals, interest groups and even in the movies, so as to promote 
thorough risk assessments and further regulatory activities, and ensure that a high 
level of ethical standards are employed during commercial development. These 
assurances have significantly reduced the British public’s concerns about the 
ambiguities in nanoscience and nanotechnology. Therefore, it is imperative for 
nanotech firms in countries with an English Common Law origin to take into 
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consideration the additional cost required to make risk assessments about their R&D 
ventures publicly available, in order to enhance public awareness and reduce the 
general intolerance for uncertainties associated with nanotechnology.  
6.3 Limitations 
One of the main research limitations of the thesis is that scientific productivities (such 
as peer-to-peer publications) in inter-firm R&D collaboration were not captured. My 
research objective was focused on the innovation and financial performance of the 
nanotech R&D projects which limited the spectrum of the performance analysis of 
the inter-firm collaborations. The availability of data on the process innovation of 
nanotech companies is scarce, so in this study, only focused on the nanotech 
companies which have significantly engage in product innovation. Specialist 
database like Nanowerk are costly to access and it still has limited data on the 
process innovation of nanotech R&D firms. 
Although, the sample size was not too small to carry the needed statistical tests 
However, it was however small. 30 one-one-one interviews with top executives of 
nanotech organisations were conducted and 97 questionnaires given to senior 
administrators of nanotech R&D projects across 12 European countries. To expand 
the sample size in the future, Skype call could be employed to reach greater number 
of top executive and senior administrators in nanotech R&D organisations and 
extract useful information for further analysis. The primary focus in high tech industry 
was on nanotechnology R&D organisations. Sufficient comparison between Biotech, 
ICT, Fintech and other high tech industries was not adequate due to the scope of the 
research study. Although, nanotechnology has a very high level of inter-firm 
partnership but it would be useful gain insight into the factors that influence the 
dimension of collaboration in other high-tech industries. 
There are other significant variables, not included in these models, which influence 
the ability of nanotech companies to collaborate and successfully invent profitable 
products that can secure long term performance. Certain key features of a company 
– such as its age, size, market position, and corporate governance – could be useful 
tools for predicting the propensity to enter successful collaborative partnerships.  
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6.4 New Avenues for Research 
Suggestions for future research usually come from the limitations in the research 
study. In the future, it would be interesting to see how the internal and external 
factors (used in this thesis) influence the performance of R&D collaboration which 
leads to process innovation in nano and other high-tech industries. The 
enhancement of the process of developing a high-tech product or service is much 
difficult to measure because it involves modifications across all the value chain 
activities of the R&D organisation, including improved manufacturing processes and 
effective media strategy.  
Future research should consider observing and analysing the dimensions of inter-
firm R&D collaboration across the globe, instead of only the continent of Europe, as 
was in this thesis. The US, for instance, has a very large number of inter-firm R&D 
collaborations and it would be useful to know the level of influence. The rise of young 
fin-tech companies which could disrupt the traditional financial institutions is a 
phenomenon researchers can explore; their innovation and financial performance 
would be interesting to analyse when compared with other high-tech industries. It 
would be interesting to know how other alternative finance differs from venture 
capital. Crowdfunding is a good example of a potential source of R&D investment for 
high-tech industries.  
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Appendix B 
Collaboration of SMEs  
Preliminary Data Analysis Tables  
2016 10 31 
 
 
Sort by  
(1) 3. Country,  
(2) 2. Public,  
(3) 5. Size 
(4) 1. Name 
 
 
1. Your organisation 
30 unique companies  
 
4. Name of project (Acronym) 
97 unique projects 
 
2. Type of organisation [Public (Univ. and PRI); Private]  
Private Dummy 1 43 
Public Dummy 0 54 
Missing Try BvD: IMEGO: IMU-INS 0 
Total  97 
 
3. Country  
country # Legal origin  Religion, etc. … 
Austria 2 Civil German 2  
France 5 Civil French 3  
Germany 38 Civil German 2  
Greece 2 Civil German 2  
Hungary 5 Civil German 2  
Italy 1 Civil French 3  
Netherlands 4 Civil French 3  
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Slovenia 2 Civil German 2  
Spain 12 Civil French 3  
Sweden 11 Scandinavian 1  
Switzerland 2 Civil German 2  
UK 13 Common Law 0  
Total 97    
 
5. Size of organisation (No. of employee)  
40 5 Dummy 1 
>250 85 Dummy 0 
<250 7 Dummy 1 
Total 97  
 
 
 
6. Collaboration scale (national/international)  
Institutional 6 Scale 1 
International 42 Scale 4 
National 43 Scale 3 
Regional 6 Scale 2 
Total 97  
 
7.Collaboration mechanism / type(…..)  
centralized 27 Scale 1 
decentralized 26 Scale 2 
distributed 44 Scale 3 
Total 97  
 
8. Total number of partners (public and private)  
 
 Scale 1: 1 to 4 
 Scale 2: 5 to 9 
 Scale 3: 10 and more  
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9. Number of industrial partners (private only)  
 Scale 1: 0 
 Scale 2: 1 to 4 
 Scale 3: 5 and more  
8. Total number of partners (public and private)  
1 10 
2 12 
3 8 
4 6 
5 12 
6 5 
7 6 
8 6 
9 7 
10 2 
11 1 
12 2 
13 2 
14 2 
15 1 
16 1 
20 1 
23 1 
24 1 
25 3 
29 1 
30 1 
35 1 
36 2 
40 1 
50 1 
Missing 1 
Total 97 
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9. Number of industrial partners (private only)  
0 24 
1 13 
2 8 
3 8 
4 9 
5 3 
6 3 
7 3 
8 1 
9 3 
10 1 
12 4 
13 2 
18 1 
19 1 
20 1 
21 1 
25 1 
40 1 
Missing 9 
Total 97 
 
10. Origin of funding for the nanotech R&D projects  
EU 30 Scale 1 
Industry 4 Scale 3 
Institutional 4 Scale 3 
National 43 Scale 2 
National, EU 1 Scale 1 
National, EU, Industry 2 Scale 1 
National, Industry 6 Scale 2 
Other 3 Scale 3 
Regional 4 Scale 3 
Total 97  
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11. Collaborative structure for nanotech R&D projects  
(A) Single organisation, no partnership 12 Scale 1 
(B) Horizontal value chain - you work with 
complementor(s) 
34 Scale 3 
(C) Vertical value chain -- you work with 
supplier(s) and customer(s) 
13 Scale 2 
(D) Value network -- you work with 
complementor(s) as well as supplier and or 
customer(s) 
38 Scale 4 
Total 97  
 
12. Level of collaboration with the partners   
A. Strong, short term relationship 22 Scale 2 
B. Strong, long term relationship 51 Scale 4 
C. Weak, short term relationship 3 Scale 1 
D. Weak, long term relationship 12 Scale 3 
Missing 9 Missing 
Total 97  
 
 
16. Main market sector(s) covered: Market 2  
Aerospace/Space Science 3 Dummy 1 
autarkic sensors 1 Dummy 1 
Automation 1 Dummy 1 
Automotive and Transport 6 Dummy 1 
Biotechnology 4 Dummy 2 
Construction 1 Dummy 3 
Consumer Products (Electrical, Games,  ...) 12 Dummy 4 
Food 2 Dummy 4 
Industry (equipment manufacturers, metrology 
equipment) 
1 Dummy 1 
Information and Communication 10 Dummy 5 
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logistic 1 Dummy 6 
Medical/Surgical 7 Dummy 2 
non destructive evaluation (NDE) 1 Dummy 7 
Pharmaceutical 5 Dummy 2 
Scientific/Academic Community 3 Dummy 8 
Security 1 Dummy 5 
Missing 38 Missing 
Total 97  
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17. Main market sector(s) covered: Market 3  
Aerospace/Space Science 4 Dummy 1 
Automation 1 Dummy 1 
automation... 1 Dummy 1 
Automotive and Transport 1 Dummy 1 
Biotechnology 3 Dummy 2 
cold chain 1 Dummy 9 
Consumer Products 
(Electrical, Games,  ...) 
6 Dummy 4 
Domestic Products (Clothing, 
Furnishings, ...) 
1 Dummy 4 
Electronics Industry 1 Dummy 4 
Energy/Chemical 6 Dummy 10 
Food 1 Dummy 4 
Geo-surveying 1 Dummy 5 
Information and 
Communication 
4 Dummy 5 
Medical/Surgical 8 Dummy 2 
Metrology instrumentation 1 Dummy 2 
Optics 1 Dummy 2 
Missing 50 Missing 
Total 91  
 
 
 
 
 
 
 
 
